id	sid	tid	token	lemma	pos
hls-11340	1	1	hrev_master	hrev_master	NOUN
hls-11340	1	2	healthcare	healthcare	NOUN
hls-11340	1	3	in	in	ADP
hls-11340	1	4	low	low	ADJ
hls-11340	1	5	-	-	PUNCT
hls-11340	1	6	resource	resource	NOUN
hls-11340	1	7	settings	setting	NOUN
hls-11340	1	8	2023	2023	NUM
hls-11340	1	9	;	;	PUNCT
hls-11340	1	10	volume	volume	NOUN
hls-11340	1	11	11(s2):11340	11(s2):11340	NUM
hls-11340	1	12	the	the	DET
hls-11340	1	13	effect	effect	NOUN
hls-11340	1	14	of	of	ADP
hls-11340	1	15	vitamin	vitamin	NOUN
hls-11340	1	16	d	d	NOUN
hls-11340	1	17	deficiency	deficiency	NOUN
hls-11340	1	18	on	on	ADP
hls-11340	1	19	glycemic	glycemic	ADJ
hls-11340	1	20	control	control	NOUN
hls-11340	1	21	in	in	ADP
hls-11340	1	22	patients	patient	NOUN
hls-11340	1	23	with	with	ADP
hls-11340	1	24	type	type	NOUN
hls-11340	1	25	2	2	NUM
hls-11340	1	26	diabetes	diabetes	NOUN
hls-11340	1	27	mellitus	mellitus	NOUN
hls-11340	1	28	neveen	neveen	PROPN
hls-11340	1	29	rashad	rashad	VERB
hls-11340	1	30	mostafa,1	mostafa,1	NOUN
hls-11340	1	31	abeer	abeer	PROPN
hls-11340	1	32	ahmed	ahmed	PROPN
hls-11340	1	33	mohamed	mohamed	PROPN
hls-11340	1	34	ali,2	ali,2	PROPN
hls-11340	1	35	roy	roy	PROPN
hls-11340	1	36	rillera	rillera	PROPN
hls-11340	1	37	marzo3,4	marzo3,4	PROPN
hls-11340	1	38	1department	1department	NUM
hls-11340	1	39	of	of	ADP
hls-11340	1	40	internal	internal	ADJ
hls-11340	1	41	medicine	medicine	NOUN
hls-11340	1	42	;	;	PUNCT
hls-11340	1	43	2department	2department	NUM
hls-11340	1	44	of	of	ADP
hls-11340	1	45	chemical	chemical	ADJ
hls-11340	1	46	pathology	pathology	PROPN
hls-11340	1	47	,	,	PUNCT
hls-11340	1	48	medical	medical	PROPN
hls-11340	1	49	research	research	PROPN
hls-11340	1	50	institute	institute	PROPN
hls-11340	1	51	,	,	PUNCT
hls-11340	1	52	alexandria	alexandria	PROPN
hls-11340	1	53	university	university	PROPN
hls-11340	1	54	,	,	PUNCT
hls-11340	1	55	egypt	egypt	PROPN
hls-11340	1	56	;	;	PUNCT
hls-11340	1	57	3department	3department	NUM
hls-11340	1	58	of	of	ADP
hls-11340	1	59	community	community	NOUN
hls-11340	1	60	medicine	medicine	NOUN
hls-11340	1	61	,	,	PUNCT
hls-11340	1	62	international	international	ADJ
hls-11340	1	63	medical	medical	ADJ
hls-11340	1	64	school	school	NOUN
hls-11340	1	65	,	,	PUNCT
hls-11340	1	66	management	management	NOUN
hls-11340	1	67	and	and	CCONJ
hls-11340	1	68	science	science	NOUN
hls-11340	1	69	university	university	PROPN
hls-11340	1	70	,	,	PUNCT
hls-11340	1	71	shah	shah	PROPN
hls-11340	1	72	alam	alam	PROPN
hls-11340	1	73	;	;	PUNCT
hls-11340	1	74	4global	4global	NUM
hls-11340	1	75	public	public	ADJ
hls-11340	1	76	health	health	NOUN
hls-11340	1	77	,	,	PUNCT
hls-11340	1	78	jeffrey	jeffrey	PROPN
hls-11340	1	79	cheah	cheah	PROPN
hls-11340	1	80	school	school	PROPN
hls-11340	1	81	of	of	ADP
hls-11340	1	82	medicine	medicine	NOUN
hls-11340	1	83	and	and	CCONJ
hls-11340	1	84	health	health	NOUN
hls-11340	1	85	sciences	sciences	PROPN
hls-11340	1	86	,	,	PUNCT
hls-11340	1	87	monash	monash	PROPN
hls-11340	1	88	university	university	PROPN
hls-11340	1	89	malaysia	malaysia	PROPN
hls-11340	1	90	,	,	PUNCT
hls-11340	1	91	kuala	kuala	PROPN
hls-11340	1	92	lumpur	lumpur	PROPN
hls-11340	1	93	,	,	PUNCT
hls-11340	1	94	malaysia	malaysia	PROPN
hls-11340	1	95	abstract	abstract	ADJ
hls-11340	1	96	multiple	multiple	ADJ
hls-11340	1	97	factors	factor	NOUN
hls-11340	1	98	are	be	AUX
hls-11340	1	99	involved	involve	VERB
hls-11340	1	100	in	in	ADP
hls-11340	1	101	the	the	DET
hls-11340	1	102	development	development	NOUN
hls-11340	1	103	of	of	ADP
hls-11340	1	104	type	type	NOUN
hls-11340	1	105	2	2	NUM
hls-11340	1	106	diabetes	diabetes	NOUN
hls-11340	1	107	mellitus	mellitus	NOUN
hls-11340	1	108	(	(	PUNCT
hls-11340	1	109	t2	t2	NOUN
hls-11340	1	110	dm	dm	PROPN
hls-11340	1	111	)	)	PUNCT
hls-11340	1	112	,	,	PUNCT
hls-11340	1	113	but	but	CCONJ
hls-11340	1	114	an	an	DET
hls-11340	1	115	imbalance	imbalance	NOUN
hls-11340	1	116	between	between	ADP
hls-11340	1	117	free	free	ADJ
hls-11340	1	118	radical	radical	ADJ
hls-11340	1	119	formation	formation	NOUN
hls-11340	1	120	and	and	CCONJ
hls-11340	1	121	antioxidant	antioxidant	ADJ
hls-11340	1	122	removal	removal	NOUN
hls-11340	1	123	is	be	AUX
hls-11340	1	124	the	the	DET
hls-11340	1	125	main	main	ADJ
hls-11340	1	126	cause	cause	NOUN
hls-11340	1	127	of	of	ADP
hls-11340	1	128	diabetic	diabetic	ADJ
hls-11340	1	129	complications	complication	NOUN
hls-11340	1	130	.	.	PUNCT
hls-11340	2	1	micronutrients	micronutrient	NOUN
hls-11340	2	2	with	with	ADP
hls-11340	2	3	antioxidant	antioxidant	ADJ
hls-11340	2	4	properties	property	NOUN
hls-11340	2	5	may	may	AUX
hls-11340	2	6	have	have	VERB
hls-11340	2	7	a	a	DET
hls-11340	2	8	role	role	NOUN
hls-11340	2	9	in	in	ADP
hls-11340	2	10	the	the	DET
hls-11340	2	11	development	development	NOUN
hls-11340	2	12	of	of	ADP
hls-11340	2	13	diabetes	diabetes	NOUN
hls-11340	2	14	mellitus	mellitus	NOUN
hls-11340	2	15	(	(	PUNCT
hls-11340	2	16	dm	dm	PROPN
hls-11340	2	17	)	)	PUNCT
hls-11340	2	18	and	and	CCONJ
hls-11340	2	19	its	its	PRON
hls-11340	2	20	complications	complication	NOUN
hls-11340	2	21	.	.	PUNCT
hls-11340	3	1	vitamin	vitamin	NOUN
hls-11340	3	2	d	d	NOUN
hls-11340	3	3	has	have	AUX
hls-11340	3	4	recently	recently	ADV
hls-11340	3	5	been	be	AUX
hls-11340	3	6	found	find	VERB
hls-11340	3	7	to	to	PART
hls-11340	3	8	have	have	VERB
hls-11340	3	9	membrane	membrane	ADJ
hls-11340	3	10	antioxidant	antioxidant	ADJ
hls-11340	3	11	effect	effect	NOUN
hls-11340	3	12	and	and	CCONJ
hls-11340	3	13	a	a	DET
hls-11340	3	14	relationship	relationship	NOUN
hls-11340	3	15	to	to	ADP
hls-11340	3	16	the	the	DET
hls-11340	3	17	development	development	NOUN
hls-11340	3	18	of	of	ADP
hls-11340	3	19	t2	t2	NOUN
hls-11340	3	20	dm	dm	PROPN
hls-11340	3	21	,	,	PUNCT
hls-11340	3	22	as	as	SCONJ
hls-11340	3	23	it	it	PRON
hls-11340	3	24	can	can	AUX
hls-11340	3	25	modify	modify	VERB
hls-11340	3	26	its	its	PRON
hls-11340	3	27	risk	risk	NOUN
hls-11340	3	28	.	.	PUNCT
hls-11340	4	1	whether	whether	SCONJ
hls-11340	4	2	vitamin	vitamin	NOUN
hls-11340	4	3	d	d	NOUN
hls-11340	4	4	deficiency	deficiency	NOUN
hls-11340	4	5	has	have	VERB
hls-11340	4	6	an	an	DET
hls-11340	4	7	effect	effect	NOUN
hls-11340	4	8	on	on	ADP
hls-11340	4	9	hyperglycemia	hyperglycemia	NOUN
hls-11340	4	10	in	in	ADP
hls-11340	4	11	diabetic	diabetic	ADJ
hls-11340	4	12	patients	patient	NOUN
hls-11340	4	13	or	or	CCONJ
hls-11340	4	14	not	not	PART
hls-11340	4	15	need	need	VERB
hls-11340	4	16	further	further	ADJ
hls-11340	4	17	study	study	NOUN
hls-11340	4	18	.	.	PUNCT
hls-11340	5	1	our	our	PRON
hls-11340	5	2	aim	aim	NOUN
hls-11340	5	3	was	be	AUX
hls-11340	5	4	to	to	PART
hls-11340	5	5	examine	examine	VERB
hls-11340	5	6	the	the	DET
hls-11340	5	7	effect	effect	NOUN
hls-11340	5	8	of	of	ADP
hls-11340	5	9	vitamin	vitamin	NOUN
hls-11340	5	10	d	d	NOUN
hls-11340	5	11	deficiency	deficiency	NOUN
hls-11340	5	12	on	on	ADP
hls-11340	5	13	glycemic	glycemic	ADJ
hls-11340	5	14	control	control	NOUN
hls-11340	5	15	in	in	ADP
hls-11340	5	16	t2	t2	NOUN
hls-11340	5	17	dm	dm	NOUN
hls-11340	5	18	.	.	PUNCT
hls-11340	6	1	we	we	PRON
hls-11340	6	2	examined	examine	VERB
hls-11340	6	3	the	the	DET
hls-11340	6	4	vitamin	vitamin	NOUN
hls-11340	6	5	d	d	NOUN
hls-11340	6	6	levels	level	NOUN
hls-11340	6	7	of	of	ADP
hls-11340	6	8	100	100	NUM
hls-11340	6	9	patients	patient	NOUN
hls-11340	6	10	with	with	ADP
hls-11340	6	11	t2	t2	PROPN
hls-11340	6	12	dm	dm	PROPN
hls-11340	6	13	and	and	CCONJ
hls-11340	6	14	correlated	correlate	VERB
hls-11340	6	15	them	they	PRON
hls-11340	6	16	with	with	ADP
hls-11340	6	17	fasting	fast	VERB
hls-11340	6	18	blood	blood	NOUN
hls-11340	6	19	sugar	sugar	NOUN
hls-11340	6	20	and	and	CCONJ
hls-11340	6	21	glycated	glycate	VERB
hls-11340	6	22	hemoglobin	hemoglobin	NOUN
hls-11340	6	23	a1c	a1c	PROPN
hls-11340	6	24	(	(	PUNCT
hls-11340	6	25	hba1c	hba1c	NOUN
hls-11340	6	26	)	)	PUNCT
hls-11340	6	27	levels	level	NOUN
hls-11340	6	28	.	.	PUNCT
hls-11340	7	1	high	high	ADJ
hls-11340	7	2	levels	level	NOUN
hls-11340	7	3	of	of	ADP
hls-11340	7	4	fasting	fast	VERB
hls-11340	7	5	blood	blood	NOUN
hls-11340	7	6	sugar	sugar	NOUN
hls-11340	7	7	and	and	CCONJ
hls-11340	7	8	hba1c	hba1c	PROPN
hls-11340	7	9	levels	level	NOUN
hls-11340	7	10	were	be	AUX
hls-11340	7	11	significantly	significantly	ADV
hls-11340	7	12	associated	associate	VERB
hls-11340	7	13	with	with	ADP
hls-11340	7	14	vitamin	vitamin	NOUN
hls-11340	7	15	d	d	NOUN
hls-11340	7	16	deficiency	deficiency	NOUN
hls-11340	7	17	.	.	PUNCT
hls-11340	8	1	vitamin	vitamin	NOUN
hls-11340	8	2	d	d	NOUN
hls-11340	8	3	deficiency	deficiency	NOUN
hls-11340	8	4	negatively	negatively	ADV
hls-11340	8	5	affects	affect	VERB
hls-11340	8	6	glycemic	glycemic	ADJ
hls-11340	8	7	control	control	NOUN
hls-11340	8	8	in	in	ADP
hls-11340	8	9	patients	patient	NOUN
hls-11340	8	10	with	with	ADP
hls-11340	8	11	t2	t2	PROPN
hls-11340	8	12	dm	dm	PROPN
hls-11340	8	13	.	.	PUNCT
hls-11340	8	14	introduction	introduction	NOUN
hls-11340	8	15	type	type	NOUN
hls-11340	8	16	2	2	NUM
hls-11340	8	17	diabetes	diabetes	NOUN
hls-11340	8	18	mellitus	mellitus	NOUN
hls-11340	8	19	(	(	PUNCT
hls-11340	8	20	t2	t2	NOUN
hls-11340	8	21	dm	dm	NOUN
hls-11340	8	22	)	)	PUNCT
hls-11340	8	23	is	be	AUX
hls-11340	8	24	highly	highly	ADV
hls-11340	8	25	prevalent	prevalent	ADJ
hls-11340	8	26	worldwide	worldwide	ADV
hls-11340	8	27	,	,	PUNCT
hls-11340	8	28	especially	especially	ADV
hls-11340	8	29	in	in	ADP
hls-11340	8	30	developing	develop	VERB
hls-11340	8	31	countries	country	NOUN
hls-11340	8	32	.	.	PUNCT
hls-11340	9	1	it	it	PRON
hls-11340	9	2	is	be	AUX
hls-11340	9	3	caused	cause	VERB
hls-11340	9	4	by	by	ADP
hls-11340	9	5	pancreatic	pancreatic	ADJ
hls-11340	9	6	β	β	NOUN
hls-11340	9	7	-	-	NOUN
hls-11340	9	8	cell	cell	NOUN
hls-11340	9	9	dysfunction	dysfunction	NOUN
hls-11340	9	10	and	and	CCONJ
hls-11340	9	11	insulin	insulin	NOUN
hls-11340	9	12	resistance	resistance	NOUN
hls-11340	9	13	,	,	PUNCT
hls-11340	9	14	it	it	PRON
hls-11340	9	15	places	place	VERB
hls-11340	9	16	a	a	DET
hls-11340	9	17	burden	burden	NOUN
hls-11340	9	18	on	on	ADP
hls-11340	9	19	health	health	NOUN
hls-11340	9	20	care	care	NOUN
hls-11340	9	21	institutions	institution	NOUN
hls-11340	9	22	due	due	ADP
hls-11340	9	23	to	to	ADP
hls-11340	9	24	its	its	PRON
hls-11340	9	25	many	many	ADJ
hls-11340	9	26	macrovascular	macrovascular	ADJ
hls-11340	9	27	and	and	CCONJ
hls-11340	9	28	microvascular	microvascular	ADJ
hls-11340	9	29	complications	complication	NOUN
hls-11340	9	30	,	,	PUNCT
hls-11340	9	31	which	which	PRON
hls-11340	9	32	lead	lead	VERB
hls-11340	9	33	to	to	ADP
hls-11340	9	34	high	high	ADJ
hls-11340	9	35	morbidity	morbidity	NOUN
hls-11340	9	36	and	and	CCONJ
hls-11340	9	37	mortality.1	mortality.1	VERB
hls-11340	9	38	some	some	DET
hls-11340	9	39	humoral	humoral	ADJ
hls-11340	9	40	substances	substance	NOUN
hls-11340	9	41	,	,	PUNCT
hls-11340	9	42	such	such	ADJ
hls-11340	9	43	as	as	ADP
hls-11340	9	44	adipokines	adipokine	NOUN
hls-11340	9	45	increase	increase	VERB
hls-11340	9	46	incidence	incidence	NOUN
hls-11340	9	47	of	of	ADP
hls-11340	9	48	diabetic	diabetic	ADJ
hls-11340	9	49	complications	complication	NOUN
hls-11340	9	50	.	.	PUNCT
hls-11340	10	1	one	one	NUM
hls-11340	10	2	of	of	ADP
hls-11340	10	3	these	these	DET
hls-11340	10	4	adipokines	adipokine	NOUN
hls-11340	10	5	is	be	AUX
hls-11340	10	6	pasma	pasma	NOUN
hls-11340	10	7	omentin	omentin	ADJ
hls-11340	10	8	-1	-1	PROPN
hls-11340	10	9	,	,	PUNCT
hls-11340	10	10	which	which	PRON
hls-11340	10	11	has	have	VERB
hls-11340	10	12	an	an	DET
hls-11340	10	13	anti	anti	ADJ
hls-11340	10	14	-	-	ADJ
hls-11340	10	15	diabetogenic	diabetogenic	ADJ
hls-11340	10	16	effect	effect	NOUN
hls-11340	10	17	and	and	CCONJ
hls-11340	10	18	its	its	PRON
hls-11340	10	19	level	level	NOUN
hls-11340	10	20	is	be	AUX
hls-11340	10	21	reduced	reduce	VERB
hls-11340	10	22	in	in	ADP
hls-11340	10	23	diabetic	diabetic	ADJ
hls-11340	10	24	patients	patient	NOUN
hls-11340	10	25	with	with	ADP
hls-11340	10	26	high	high	ADJ
hls-11340	10	27	insulin	insulin	NOUN
hls-11340	10	28	resistance	resistance	NOUN
hls-11340	10	29	,	,	PUNCT
hls-11340	10	30	as	as	SCONJ
hls-11340	10	31	it	it	PRON
hls-11340	10	32	is	be	AUX
hls-11340	10	33	found	find	VERB
hls-11340	10	34	that	that	SCONJ
hls-11340	10	35	plasma	plasma	NOUN
hls-11340	10	36	level	level	NOUN
hls-11340	10	37	of	of	ADP
hls-11340	10	38	omentin	omentin	ADJ
hls-11340	10	39	-1	-1	X
hls-11340	10	40	is	be	AUX
hls-11340	10	41	much	much	ADV
hls-11340	10	42	lower	low	ADJ
hls-11340	10	43	in	in	ADP
hls-11340	10	44	diabetic	diabetic	ADJ
hls-11340	10	45	patients	patient	NOUN
hls-11340	10	46	with	with	ADP
hls-11340	10	47	complications	complication	NOUN
hls-11340	10	48	than	than	ADP
hls-11340	10	49	in	in	ADP
hls-11340	10	50	diabetic	diabetic	ADJ
hls-11340	10	51	patients	patient	NOUN
hls-11340	10	52	without	without	ADP
hls-11340	10	53	complications.2	complications.2	ADP
hls-11340	10	54	another	another	DET
hls-11340	10	55	adipokine	adipokine	NOUN
hls-11340	10	56	is	be	AUX
hls-11340	10	57	neuregulin-4	neuregulin-4	PROPN
hls-11340	10	58	,	,	PUNCT
hls-11340	10	59	which	which	PRON
hls-11340	10	60	has	have	VERB
hls-11340	10	61	an	an	DET
hls-11340	10	62	important	important	ADJ
hls-11340	10	63	role	role	NOUN
hls-11340	10	64	in	in	ADP
hls-11340	10	65	regulating	regulate	VERB
hls-11340	10	66	energy	energy	NOUN
hls-11340	10	67	balance	balance	NOUN
hls-11340	10	68	,	,	PUNCT
hls-11340	10	69	and	and	CCONJ
hls-11340	10	70	metabolism	metabolism	NOUN
hls-11340	10	71	of	of	ADP
hls-11340	10	72	glucose	glucose	NOUN
hls-11340	10	73	and	and	CCONJ
hls-11340	10	74	lipid	lipid	NOUN
hls-11340	10	75	.	.	PUNCT
hls-11340	11	1	it	it	PRON
hls-11340	11	2	also	also	ADV
hls-11340	11	3	helps	help	VERB
hls-11340	11	4	in	in	ADP
hls-11340	11	5	chronic	chronic	ADJ
hls-11340	11	6	inflammation	inflammation	NOUN
hls-11340	11	7	down	down	ADJ
hls-11340	11	8	-	-	PUNCT
hls-11340	11	9	regulation	regulation	NOUN
hls-11340	11	10	and	and	CCONJ
hls-11340	11	11	it	it	PRON
hls-11340	11	12	is	be	AUX
hls-11340	11	13	a	a	DET
hls-11340	11	14	good	good	ADJ
hls-11340	11	15	predictor	predictor	NOUN
hls-11340	11	16	of	of	ADP
hls-11340	11	17	microvascular	microvascular	ADJ
hls-11340	11	18	complications	complication	NOUN
hls-11340	11	19	in	in	ADP
hls-11340	11	20	diabetic	diabetic	ADJ
hls-11340	11	21	patients.3	patients.3	PROPN
hls-11340	11	22	t2	t2	NOUN
hls-11340	11	23	dm	dm	NOUN
hls-11340	11	24	is	be	AUX
hls-11340	11	25	associated	associate	VERB
hls-11340	11	26	with	with	ADP
hls-11340	11	27	chronic	chronic	ADJ
hls-11340	11	28	low	low	ADJ
hls-11340	11	29	grade	grade	NOUN
hls-11340	11	30	of	of	ADP
hls-11340	11	31	inflammation	inflammation	NOUN
hls-11340	11	32	,	,	PUNCT
hls-11340	11	33	and	and	CCONJ
hls-11340	11	34	many	many	ADJ
hls-11340	11	35	inflammatory	inflammatory	ADJ
hls-11340	11	36	markers	marker	NOUN
hls-11340	11	37	are	be	AUX
hls-11340	11	38	produced	produce	VERB
hls-11340	11	39	.	.	PUNCT
hls-11340	12	1	these	these	DET
hls-11340	12	2	lead	lead	VERB
hls-11340	12	3	to	to	ADP
hls-11340	12	4	free	free	ADJ
hls-11340	12	5	radical	radical	ADJ
hls-11340	12	6	formation	formation	NOUN
hls-11340	12	7	that	that	PRON
hls-11340	12	8	needs	need	VERB
hls-11340	12	9	removal	removal	NOUN
hls-11340	12	10	by	by	ADP
hls-11340	12	11	antioxidant	antioxidant	NOUN
hls-11340	12	12	.	.	PUNCT
hls-11340	13	1	one	one	NUM
hls-11340	13	2	new	new	ADJ
hls-11340	13	3	cytokine	cytokine	NOUN
hls-11340	13	4	produced	produce	VERB
hls-11340	13	5	in	in	ADP
hls-11340	13	6	dm	dm	PROPN
hls-11340	13	7	is	be	AUX
hls-11340	13	8	cardiothrophin-1	cardiothrophin-1	NUM
hls-11340	13	9	(	(	PUNCT
hls-11340	13	10	ct-1	ct-1	ADJ
hls-11340	13	11	)	)	PUNCT
hls-11340	13	12	,	,	PUNCT
hls-11340	13	13	which	which	PRON
hls-11340	13	14	is	be	AUX
hls-11340	13	15	composed	compose	VERB
hls-11340	13	16	of	of	ADP
hls-11340	13	17	201	201	NUM
hls-11340	13	18	amino	amino	NOUN
hls-11340	13	19	acid	acid	NOUN
hls-11340	13	20	,	,	PUNCT
hls-11340	13	21	and	and	CCONJ
hls-11340	13	22	has	have	VERB
hls-11340	13	23	protective	protective	ADJ
hls-11340	13	24	effects	effect	NOUN
hls-11340	13	25	against	against	ADP
hls-11340	13	26	apoptosis	apoptosis	NOUN
hls-11340	13	27	.	.	PUNCT
hls-11340	14	1	aktas	aktas	PROPN
hls-11340	14	2	et	et	PROPN
hls-11340	14	3	al	al	PROPN
hls-11340	14	4	.	.	PROPN
hls-11340	14	5	,	,	PUNCT
hls-11340	14	6	found	find	VERB
hls-11340	14	7	that	that	SCONJ
hls-11340	14	8	there	there	PRON
hls-11340	14	9	are	be	VERB
hls-11340	14	10	increased	increased	ADJ
hls-11340	14	11	levels	level	NOUN
hls-11340	14	12	of	of	ADP
hls-11340	14	13	ct1	ct1	PROPN
hls-11340	14	14	in	in	ADP
hls-11340	14	15	diabetic	diabetic	ADJ
hls-11340	14	16	patients	patient	NOUN
hls-11340	14	17	independently	independently	ADV
hls-11340	14	18	of	of	ADP
hls-11340	14	19	hypertension	hypertension	NOUN
hls-11340	14	20	and	and	CCONJ
hls-11340	14	21	heart	heart	NOUN
hls-11340	14	22	failure	failure	NOUN
hls-11340	14	23	.	.	PUNCT
hls-11340	15	1	the	the	DET
hls-11340	15	2	cause	cause	NOUN
hls-11340	15	3	of	of	ADP
hls-11340	15	4	elevation	elevation	NOUN
hls-11340	15	5	of	of	ADP
hls-11340	15	6	ct-1	ct-1	PUNCT
hls-11340	15	7	in	in	ADP
hls-11340	15	8	type	type	NOUN
hls-11340	15	9	2	2	NUM
hls-11340	15	10	diabetes	diabetes	NOUN
hls-11340	15	11	is	be	AUX
hls-11340	15	12	that	that	PRON
hls-11340	15	13	pancreatic	pancreatic	ADJ
hls-11340	15	14	beta	beta	NOUN
hls-11340	15	15	cell	cell	NOUN
hls-11340	15	16	volume	volume	NOUN
hls-11340	15	17	and	and	CCONJ
hls-11340	15	18	function	function	NOUN
hls-11340	15	19	progressively	progressively	ADV
hls-11340	15	20	dimensioned	dimension	VERB
hls-11340	15	21	and	and	CCONJ
hls-11340	15	22	ct-1	ct-1	PUNCT
hls-11340	15	23	protect	protect	VERB
hls-11340	15	24	pancreatic	pancreatic	ADJ
hls-11340	15	25	beta	beta	NOUN
hls-11340	15	26	cells	cell	NOUN
hls-11340	15	27	from	from	ADP
hls-11340	15	28	apoptosis	apoptosis	NOUN
hls-11340	15	29	.	.	PUNCT
hls-11340	16	1	however	however	ADV
hls-11340	16	2	,	,	PUNCT
hls-11340	16	3	the	the	DET
hls-11340	16	4	elevated	elevated	ADJ
hls-11340	16	5	levels	level	NOUN
hls-11340	16	6	lead	lead	VERB
hls-11340	16	7	to	to	ADP
hls-11340	16	8	left	left	ADJ
hls-11340	16	9	ventricular	ventricular	ADJ
hls-11340	16	10	failure	failure	NOUN
hls-11340	16	11	as	as	SCONJ
hls-11340	16	12	they	they	PRON
hls-11340	16	13	cause	cause	VERB
hls-11340	16	14	structural	structural	ADJ
hls-11340	16	15	modification	modification	NOUN
hls-11340	16	16	of	of	ADP
hls-11340	16	17	myocytes.4	myocytes.4	PROPN
hls-11340	16	18	another	another	DET
hls-11340	16	19	set	set	NOUN
hls-11340	16	20	of	of	ADP
hls-11340	16	21	markers	marker	NOUN
hls-11340	16	22	of	of	ADP
hls-11340	16	23	inflammation	inflammation	NOUN
hls-11340	16	24	derived	derive	VERB
hls-11340	16	25	from	from	ADP
hls-11340	16	26	hemogram	hemogram	PROPN
hls-11340	16	27	in	in	ADP
hls-11340	16	28	diabetic	diabetic	ADJ
hls-11340	16	29	patients	patient	NOUN
hls-11340	16	30	are	be	AUX
hls-11340	16	31	neutrophil	neutrophil	ADJ
hls-11340	16	32	/	/	SYM
hls-11340	16	33	lymphocyte	lymphocyte	ADJ
hls-11340	16	34	ratio	ratio	NOUN
hls-11340	16	35	and	and	CCONJ
hls-11340	16	36	mean	mean	VERB
hls-11340	16	37	platelet	platelet	NOUN
hls-11340	16	38	volume	volume	NOUN
hls-11340	16	39	/	/	SYM
hls-11340	16	40	lymphocyte	lymphocyte	ADJ
hls-11340	16	41	ratio	ratio	NOUN
hls-11340	16	42	(	(	PUNCT
hls-11340	16	43	mpvlr	mpvlr	ADV
hls-11340	16	44	)	)	PUNCT
hls-11340	16	45	.	.	PUNCT
hls-11340	17	1	they	they	PRON
hls-11340	17	2	are	be	AUX
hls-11340	17	3	found	find	VERB
hls-11340	17	4	to	to	PART
hls-11340	17	5	be	be	AUX
hls-11340	17	6	associated	associate	VERB
hls-11340	17	7	with	with	ADP
hls-11340	17	8	frailty	frailty	NOUN
hls-11340	17	9	in	in	ADP
hls-11340	17	10	diabetes	diabetes	NOUN
hls-11340	17	11	and	and	CCONJ
hls-11340	17	12	are	be	AUX
hls-11340	17	13	considered	consider	VERB
hls-11340	17	14	to	to	PART
hls-11340	17	15	be	be	AUX
hls-11340	17	16	independent	independent	ADJ
hls-11340	17	17	predictors	predictor	NOUN
hls-11340	17	18	of	of	ADP
hls-11340	17	19	gestational	gestational	ADJ
hls-11340	17	20	diabetes.5,6	diabetes.5,6	VERB
hls-11340	17	21	another	another	DET
hls-11340	17	22	novel	novel	ADJ
hls-11340	17	23	marker	marker	NOUN
hls-11340	17	24	of	of	ADP
hls-11340	17	25	inflammation	inflammation	NOUN
hls-11340	17	26	increased	increase	VERB
hls-11340	17	27	in	in	ADP
hls-11340	17	28	diabetes	diabetes	NOUN
hls-11340	17	29	,	,	PUNCT
hls-11340	17	30	especially	especially	ADV
hls-11340	17	31	correspondence	correspondence	NOUN
hls-11340	17	32	:	:	PUNCT
hls-11340	17	33	neveen	neveen	PROPN
hls-11340	17	34	rashad	rashad	PROPN
hls-11340	17	35	mostafa	mostafa	PROPN
hls-11340	17	36	,	,	PUNCT
hls-11340	17	37	department	department	PROPN
hls-11340	17	38	of	of	ADP
hls-11340	17	39	internal	internal	ADJ
hls-11340	17	40	medicine	medicine	NOUN
hls-11340	17	41	,	,	PUNCT
hls-11340	17	42	medical	medical	ADJ
hls-11340	17	43	research	research	PROPN
hls-11340	17	44	institute	institute	PROPN
hls-11340	17	45	,	,	PUNCT
hls-11340	17	46	alexandria	alexandria	PROPN
hls-11340	17	47	university	university	PROPN
hls-11340	17	48	,	,	PUNCT
hls-11340	17	49	egypt	egypt	PROPN
hls-11340	17	50	.	.	PUNCT
hls-11340	18	1	e	e	X
hls-11340	18	2	-	-	NOUN
hls-11340	18	3	mail	mail	NOUN
hls-11340	18	4	:	:	PUNCT
hls-11340	19	1	nevomos@gmail.com	nevomos@gmail.com	X
hls-11340	19	2	key	key	ADJ
hls-11340	19	3	words	word	NOUN
hls-11340	19	4	:	:	PUNCT
hls-11340	19	5	vitamin	vitamin	NOUN
hls-11340	19	6	d	d	NOUN
hls-11340	19	7	;	;	PUNCT
hls-11340	19	8	diabetes	diabetes	NOUN
hls-11340	19	9	mellitus	mellitus	NOUN
hls-11340	19	10	type	type	VERB
hls-11340	19	11	2	2	NUM
hls-11340	19	12	;	;	PUNCT
hls-11340	19	13	glycemic	glycemic	ADJ
hls-11340	19	14	control	control	NOUN
hls-11340	19	15	,	,	PUNCT
hls-11340	19	16	inflammation	inflammation	NOUN
hls-11340	19	17	.	.	PUNCT
hls-11340	20	1	conflict	conflict	NOUN
hls-11340	20	2	of	of	ADP
hls-11340	20	3	interest	interest	NOUN
hls-11340	20	4	:	:	PUNCT
hls-11340	20	5	the	the	DET
hls-11340	20	6	authors	author	NOUN
hls-11340	20	7	declare	declare	VERB
hls-11340	20	8	no	no	DET
hls-11340	20	9	conflict	conflict	NOUN
hls-11340	20	10	of	of	ADP
hls-11340	20	11	interest	interest	NOUN
hls-11340	20	12	.	.	PUNCT
hls-11340	21	1	ethics	ethic	NOUN
hls-11340	21	2	approval	approval	NOUN
hls-11340	21	3	and	and	CCONJ
hls-11340	21	4	consent	consent	NOUN
hls-11340	21	5	to	to	PART
hls-11340	21	6	participate	participate	VERB
hls-11340	21	7	:	:	PUNCT
hls-11340	21	8	the	the	DET
hls-11340	21	9	ethics	ethics	PROPN
hls-11340	21	10	committee	committee	PROPN
hls-11340	21	11	of	of	ADP
hls-11340	21	12	medical	medical	PROPN
hls-11340	21	13	research	research	PROPN
hls-11340	21	14	institute	institute	PROPN
hls-11340	21	15	approved	approve	VERB
hls-11340	21	16	this	this	DET
hls-11340	21	17	study	study	NOUN
hls-11340	21	18	(	(	PUNCT
hls-11340	21	19	e	e	NOUN
hls-11340	21	20	/	/	SYM
hls-11340	21	21	c.s	c.s	PROPN
hls-11340	21	22	/	/	SYM
hls-11340	21	23	n.r6/2022	n.r6/2022	PROPN
hls-11340	21	24	)	)	PUNCT
hls-11340	21	25	.	.	PUNCT
hls-11340	22	1	the	the	DET
hls-11340	22	2	study	study	NOUN
hls-11340	22	3	is	be	AUX
hls-11340	22	4	conformed	conform	VERB
hls-11340	22	5	with	with	ADP
hls-11340	22	6	the	the	DET
hls-11340	22	7	helsinki	helsinki	PROPN
hls-11340	22	8	declaration	declaration	NOUN
hls-11340	22	9	of	of	ADP
hls-11340	22	10	1964	1964	NUM
hls-11340	22	11	,	,	PUNCT
hls-11340	22	12	as	as	SCONJ
hls-11340	22	13	revised	revise	VERB
hls-11340	22	14	in	in	ADP
hls-11340	22	15	2013	2013	NUM
hls-11340	22	16	,	,	PUNCT
hls-11340	22	17	concerning	concern	VERB
hls-11340	22	18	human	human	ADJ
hls-11340	22	19	and	and	CCONJ
hls-11340	22	20	animal	animal	NOUN
hls-11340	22	21	rights	right	NOUN
hls-11340	22	22	.	.	PUNCT
hls-11340	23	1	informed	informed	ADJ
hls-11340	23	2	consent	consent	NOUN
hls-11340	23	3	:	:	PUNCT
hls-11340	23	4	all	all	DET
hls-11340	23	5	patients	patient	NOUN
hls-11340	23	6	participating	participate	VERB
hls-11340	23	7	in	in	ADP
hls-11340	23	8	this	this	DET
hls-11340	23	9	study	study	NOUN
hls-11340	23	10	signed	sign	VERB
hls-11340	23	11	a	a	DET
hls-11340	23	12	written	write	VERB
hls-11340	23	13	informed	inform	VERB
hls-11340	23	14	consent	consent	NOUN
hls-11340	23	15	form	form	NOUN
hls-11340	23	16	for	for	ADP
hls-11340	23	17	participating	participate	VERB
hls-11340	23	18	in	in	ADP
hls-11340	23	19	this	this	DET
hls-11340	23	20	study	study	NOUN
hls-11340	23	21	.	.	PUNCT
hls-11340	24	1	patient	patient	ADJ
hls-11340	24	2	consent	consent	NOUN
hls-11340	24	3	for	for	ADP
hls-11340	24	4	publication	publication	NOUN
hls-11340	24	5	:	:	PUNCT
hls-11340	24	6	written	write	VERB
hls-11340	24	7	informed	informed	ADJ
hls-11340	24	8	consent	consent	NOUN
hls-11340	24	9	was	be	AUX
hls-11340	24	10	obtained	obtain	VERB
hls-11340	24	11	from	from	ADP
hls-11340	24	12	a	a	DET
hls-11340	24	13	legally	legally	ADV
hls-11340	24	14	authorized	authorize	VERB
hls-11340	24	15	representative(s	representative(s	NOUN
hls-11340	24	16	)	)	PUNCT
hls-11340	24	17	for	for	ADP
hls-11340	24	18	anonymized	anonymize	VERB
hls-11340	24	19	patient	patient	ADJ
hls-11340	24	20	information	information	NOUN
hls-11340	24	21	to	to	PART
hls-11340	24	22	be	be	AUX
hls-11340	24	23	published	publish	VERB
hls-11340	24	24	in	in	ADP
hls-11340	24	25	this	this	DET
hls-11340	24	26	article	article	NOUN
hls-11340	24	27	.	.	PUNCT
hls-11340	25	1	availability	availability	NOUN
hls-11340	25	2	of	of	ADP
hls-11340	25	3	data	datum	NOUN
hls-11340	25	4	and	and	CCONJ
hls-11340	25	5	materials	material	NOUN
hls-11340	25	6	:	:	PUNCT
hls-11340	25	7	all	all	DET
hls-11340	25	8	data	datum	NOUN
hls-11340	25	9	generated	generate	VERB
hls-11340	25	10	or	or	CCONJ
hls-11340	25	11	analyzed	analyze	VERB
hls-11340	25	12	during	during	ADP
hls-11340	25	13	this	this	DET
hls-11340	25	14	study	study	NOUN
hls-11340	25	15	are	be	AUX
hls-11340	25	16	included	include	VERB
hls-11340	25	17	in	in	ADP
hls-11340	25	18	this	this	DET
hls-11340	25	19	published	publish	VERB
hls-11340	25	20	article	article	NOUN
hls-11340	25	21	.	.	PUNCT
hls-11340	26	1	received	receive	VERB
hls-11340	26	2	for	for	ADP
hls-11340	26	3	publication	publication	NOUN
hls-11340	26	4	:	:	PUNCT
hls-11340	26	5	27	27	NUM
hls-11340	26	6	march	march	NOUN
hls-11340	26	7	2023	2023	NUM
hls-11340	26	8	.	.	PUNCT
hls-11340	27	1	accepted	accept	VERB
hls-11340	27	2	for	for	ADP
hls-11340	27	3	publication	publication	NOUN
hls-11340	27	4	:	:	PUNCT
hls-11340	27	5	3	3	NUM
hls-11340	27	6	may	may	PROPN
hls-11340	27	7	2023	2023	NUM
hls-11340	27	8	.	.	PUNCT
hls-11340	28	1	conference	conference	NOUN
hls-11340	28	2	presentation	presentation	NOUN
hls-11340	28	3	:	:	PUNCT
hls-11340	28	4	part	part	NOUN
hls-11340	28	5	of	of	ADP
hls-11340	28	6	this	this	DET
hls-11340	28	7	paper	paper	NOUN
hls-11340	28	8	was	be	AUX
hls-11340	28	9	presented	present	VERB
hls-11340	28	10	at	at	ADP
hls-11340	28	11	the	the	DET
hls-11340	28	12	2nd	2nd	ADJ
hls-11340	28	13	international	international	ADJ
hls-11340	28	14	nursing	nursing	NOUN
hls-11340	28	15	and	and	CCONJ
hls-11340	28	16	health	health	NOUN
hls-11340	28	17	sciences	science	NOUN
hls-11340	28	18	symposium	symposium	NOUN
hls-11340	28	19	that	that	PRON
hls-11340	28	20	took	take	VERB
hls-11340	28	21	place	place	NOUN
hls-11340	28	22	at	at	ADP
hls-11340	28	23	the	the	DET
hls-11340	28	24	faculty	faculty	NOUN
hls-11340	28	25	of	of	ADP
hls-11340	28	26	medicine	medicine	NOUN
hls-11340	28	27	,	,	PUNCT
hls-11340	28	28	universitas	universita	NOUN
hls-11340	28	29	brawijaya	brawijaya	PROPN
hls-11340	28	30	,	,	PUNCT
hls-11340	28	31	malang	malang	PROPN
hls-11340	28	32	,	,	PUNCT
hls-11340	28	33	indonesia	indonesia	PROPN
hls-11340	28	34	this	this	DET
hls-11340	28	35	work	work	NOUN
hls-11340	28	36	is	be	AUX
hls-11340	28	37	licensed	license	VERB
hls-11340	28	38	under	under	ADP
hls-11340	28	39	a	a	DET
hls-11340	28	40	creative	creative	ADJ
hls-11340	28	41	commons	common	NOUN
hls-11340	28	42	attribution	attribution	NOUN
hls-11340	28	43	4.0	4.0	NUM
hls-11340	28	44	license	license	NOUN
hls-11340	28	45	(	(	PUNCT
hls-11340	28	46	by	by	ADP
hls-11340	28	47	-	-	PUNCT
hls-11340	28	48	nc	nc	PROPN
hls-11340	28	49	4.0	4.0	NUM
hls-11340	28	50	)	)	PUNCT
hls-11340	28	51	.	.	PUNCT
hls-11340	29	1	©	©	PROPN
hls-11340	29	2	copyright	copyright	NOUN
hls-11340	29	3	:	:	PUNCT
hls-11340	29	4	the	the	DET
hls-11340	29	5	author(s	author(s	PROPN
hls-11340	29	6	)	)	PUNCT
hls-11340	29	7	,	,	PUNCT
hls-11340	29	8	2023	2023	NUM
hls-11340	29	9	licensee	licensee	NOUN
hls-11340	29	10	pagepress	pagepress	NOUN
hls-11340	29	11	,	,	PUNCT
hls-11340	29	12	italy	italy	PROPN
hls-11340	29	13	healthcare	healthcare	PROPN
hls-11340	29	14	in	in	ADP
hls-11340	29	15	low	low	ADJ
hls-11340	29	16	-	-	PUNCT
hls-11340	29	17	resource	resource	NOUN
hls-11340	29	18	settings	setting	NOUN
hls-11340	29	19	2023	2023	NUM
hls-11340	29	20	;	;	PUNCT
hls-11340	29	21	11(s2):111340	11(s2):111340	NUM
hls-11340	29	22	doi:10.4081	doi:10.4081	PROPN
hls-11340	29	23	/	/	SYM
hls-11340	29	24	hls.2023.11340	hls.2023.11340	PROPN
hls-11340	29	25	publisher	publisher	NOUN
hls-11340	29	26	's	's	PART
hls-11340	29	27	note	note	NOUN
hls-11340	29	28	:	:	PUNCT
hls-11340	29	29	all	all	DET
hls-11340	29	30	claims	claim	NOUN
hls-11340	29	31	expressed	express	VERB
hls-11340	29	32	in	in	ADP
hls-11340	29	33	this	this	DET
hls-11340	29	34	article	article	NOUN
hls-11340	29	35	are	be	AUX
hls-11340	29	36	solely	solely	ADV
hls-11340	29	37	those	those	PRON
hls-11340	29	38	of	of	ADP
hls-11340	29	39	the	the	DET
hls-11340	29	40	authors	author	NOUN
hls-11340	29	41	and	and	CCONJ
hls-11340	29	42	do	do	AUX
hls-11340	29	43	not	not	PART
hls-11340	29	44	necessarily	necessarily	ADV
hls-11340	29	45	represent	represent	VERB
hls-11340	29	46	those	those	PRON
hls-11340	29	47	of	of	ADP
hls-11340	29	48	their	their	PRON
hls-11340	29	49	affiliated	affiliated	ADJ
hls-11340	29	50	organizations	organization	NOUN
hls-11340	29	51	,	,	PUNCT
hls-11340	29	52	or	or	CCONJ
hls-11340	29	53	those	those	PRON
hls-11340	29	54	of	of	ADP
hls-11340	29	55	the	the	DET
hls-11340	29	56	publisher	publisher	NOUN
hls-11340	29	57	,	,	PUNCT
hls-11340	29	58	the	the	DET
hls-11340	29	59	editors	editor	NOUN
hls-11340	29	60	and	and	CCONJ
hls-11340	29	61	the	the	DET
hls-11340	29	62	reviewers	reviewer	NOUN
hls-11340	29	63	.	.	PUNCT
hls-11340	30	1	any	any	DET
hls-11340	30	2	product	product	NOUN
hls-11340	30	3	that	that	PRON
hls-11340	30	4	may	may	AUX
hls-11340	30	5	be	be	AUX
hls-11340	30	6	evaluated	evaluate	VERB
hls-11340	30	7	in	in	ADP
hls-11340	30	8	this	this	DET
hls-11340	30	9	article	article	NOUN
hls-11340	30	10	or	or	CCONJ
hls-11340	30	11	claim	claim	NOUN
hls-11340	30	12	that	that	PRON
hls-11340	30	13	may	may	AUX
hls-11340	30	14	be	be	AUX
hls-11340	30	15	made	make	VERB
hls-11340	30	16	by	by	ADP
hls-11340	30	17	its	its	PRON
hls-11340	30	18	manufacturer	manufacturer	NOUN
hls-11340	30	19	is	be	AUX
hls-11340	30	20	not	not	PART
hls-11340	30	21	guaranteed	guarantee	VERB
hls-11340	30	22	or	or	CCONJ
hls-11340	30	23	endorsed	endorse	VERB
hls-11340	30	24	by	by	ADP
hls-11340	30	25	the	the	DET
hls-11340	30	26	publisher	publisher	NOUN
hls-11340	30	27	.	.	PUNCT
hls-11340	31	1	[	[	X
hls-11340	31	2	page	page	NOUN
hls-11340	31	3	8	8	NUM
hls-11340	31	4	]	]	PUNCT
hls-11340	32	1	[	[	X
hls-11340	32	2	healthcare	healthcare	NOUN
hls-11340	32	3	in	in	ADP
hls-11340	32	4	low	low	ADJ
hls-11340	32	5	-	-	PUNCT
hls-11340	32	6	resource	resource	NOUN
hls-11340	32	7	settings	setting	NOUN
hls-11340	32	8	2023	2023	NUM
hls-11340	32	9	;	;	PUNCT
hls-11340	32	10	11(s2):11340	11(s2):11340	X
hls-11340	32	11	]	]	SYM
hls-11340	32	12	non	non	ADJ
hls-11340	32	13	-co	-co	PROPN
hls-11340	32	14	mmerc	mmerc	PROPN
hls-11340	32	15	ial	ial	PROPN
hls-11340	32	16	us	us	PROPN
hls-11340	32	17	e	e	NOUN
hls-11340	32	18	o	o	NOUN
hls-11340	32	19	nly	nly	ADV
hls-11340	32	20	those	those	PRON
hls-11340	32	21	with	with	ADP
hls-11340	32	22	diabetic	diabetic	ADJ
hls-11340	32	23	nephropathy	nephropathy	NOUN
hls-11340	32	24	,	,	PUNCT
hls-11340	32	25	is	be	AUX
hls-11340	32	26	crp	crp	NOUN
hls-11340	32	27	to	to	ADP
hls-11340	32	28	albumin	albumin	ADJ
hls-11340	32	29	ratio	ratio	NOUN
hls-11340	32	30	.	.	PUNCT
hls-11340	33	1	this	this	DET
hls-11340	33	2	marker	marker	NOUN
hls-11340	33	3	is	be	AUX
hls-11340	33	4	found	find	VERB
hls-11340	33	5	to	to	PART
hls-11340	33	6	be	be	AUX
hls-11340	33	7	elevated	elevate	VERB
hls-11340	33	8	in	in	ADP
hls-11340	33	9	those	those	DET
hls-11340	33	10	patients	patient	NOUN
hls-11340	33	11	(	(	PUNCT
hls-11340	33	12	according	accord	VERB
hls-11340	33	13	to	to	ADP
hls-11340	33	14	the	the	DET
hls-11340	33	15	roc	roc	PROPN
hls-11340	33	16	curve	curve	NOUN
hls-11340	33	17	,	,	PUNCT
hls-11340	33	18	a	a	DET
hls-11340	33	19	level	level	NOUN
hls-11340	33	20	higher	high	ADJ
hls-11340	33	21	than	than	SCONJ
hls-11340	33	22	0.82	0.82	NUM
hls-11340	33	23	%	%	NOUN
hls-11340	33	24	presents	present	VERB
hls-11340	33	25	the	the	DET
hls-11340	33	26	best	good	ADJ
hls-11340	33	27	sensitivity	sensitivity	NOUN
hls-11340	33	28	and	and	CCONJ
hls-11340	33	29	specificity	specificity	NOUN
hls-11340	33	30	in	in	ADP
hls-11340	33	31	the	the	DET
hls-11340	33	32	association	association	NOUN
hls-11340	33	33	with	with	ADP
hls-11340	33	34	diabetic	diabetic	ADJ
hls-11340	33	35	nephropathy).7	nephropathy).7	VERB
hls-11340	33	36	many	many	ADJ
hls-11340	33	37	predictors	predictor	NOUN
hls-11340	33	38	of	of	ADP
hls-11340	33	39	diabetic	diabetic	ADJ
hls-11340	33	40	control	control	NOUN
hls-11340	33	41	have	have	AUX
hls-11340	33	42	emerged	emerge	VERB
hls-11340	33	43	to	to	PART
hls-11340	33	44	help	help	VERB
hls-11340	33	45	in	in	ADP
hls-11340	33	46	differentiating	differentiate	VERB
hls-11340	33	47	well	well	ADV
hls-11340	33	48	from	from	ADP
hls-11340	33	49	poorly	poorly	ADV
hls-11340	33	50	controlled	control	VERB
hls-11340	33	51	diabetes	diabetes	NOUN
hls-11340	33	52	.	.	PUNCT
hls-11340	34	1	one	one	NUM
hls-11340	34	2	of	of	ADP
hls-11340	34	3	them	they	PRON
hls-11340	34	4	is	be	AUX
hls-11340	34	5	uric	uric	ADJ
hls-11340	34	6	acid	acid	NOUN
hls-11340	34	7	/	/	SYM
hls-11340	34	8	hdl	hdl	PROPN
hls-11340	34	9	cholesterol	cholesterol	PROPN
hls-11340	34	10	ratio	ratio	NOUN
hls-11340	34	11	,	,	PUNCT
hls-11340	34	12	which	which	PRON
hls-11340	34	13	has	have	VERB
hls-11340	34	14	a	a	DET
hls-11340	34	15	strong	strong	ADJ
hls-11340	34	16	association	association	NOUN
hls-11340	34	17	with	with	ADP
hls-11340	34	18	fasting	fast	VERB
hls-11340	34	19	blood	blood	NOUN
hls-11340	34	20	sugar	sugar	NOUN
hls-11340	34	21	and	and	CCONJ
hls-11340	34	22	hba1c.8	hba1c.8	ADJ
hls-11340	34	23	vitamin	vitamin	NOUN
hls-11340	34	24	d	d	NOUN
hls-11340	34	25	is	be	AUX
hls-11340	34	26	a	a	DET
hls-11340	34	27	fat	fat	ADJ
hls-11340	34	28	soluble	soluble	ADJ
hls-11340	34	29	vitamin	vitamin	NOUN
hls-11340	34	30	that	that	PRON
hls-11340	34	31	is	be	AUX
hls-11340	34	32	produced	produce	VERB
hls-11340	34	33	through	through	ADP
hls-11340	34	34	the	the	DET
hls-11340	34	35	effect	effect	NOUN
hls-11340	34	36	of	of	ADP
hls-11340	34	37	ultraviolet	ultraviolet	PROPN
hls-11340	34	38	b	b	PROPN
hls-11340	34	39	radiation	radiation	NOUN
hls-11340	34	40	on	on	ADP
hls-11340	34	41	the	the	DET
hls-11340	34	42	epidermis	epidermis	NOUN
hls-11340	34	43	of	of	ADP
hls-11340	34	44	the	the	DET
hls-11340	34	45	skin	skin	NOUN
hls-11340	34	46	.	.	PUNCT
hls-11340	35	1	it	it	PRON
hls-11340	35	2	is	be	AUX
hls-11340	35	3	also	also	ADV
hls-11340	35	4	found	find	VERB
hls-11340	35	5	in	in	ADP
hls-11340	35	6	food	food	NOUN
hls-11340	35	7	substances	substance	NOUN
hls-11340	35	8	like	like	ADP
hls-11340	35	9	fish	fish	NOUN
hls-11340	35	10	oil	oil	NOUN
hls-11340	35	11	and	and	CCONJ
hls-11340	35	12	egg	egg	NOUN
hls-11340	35	13	yolk	yolk	NOUN
hls-11340	35	14	.	.	PUNCT
hls-11340	36	1	to	to	PART
hls-11340	36	2	become	become	VERB
hls-11340	36	3	active	active	ADJ
hls-11340	36	4	,	,	PUNCT
hls-11340	36	5	it	it	PRON
hls-11340	36	6	needs	need	VERB
hls-11340	36	7	two	two	NUM
hls-11340	36	8	hydroxylation	hydroxylation	NOUN
hls-11340	36	9	processes	process	NOUN
hls-11340	36	10	,	,	PUNCT
hls-11340	36	11	one	one	NUM
hls-11340	36	12	in	in	ADP
hls-11340	36	13	the	the	DET
hls-11340	36	14	liver	liver	NOUN
hls-11340	36	15	that	that	PRON
hls-11340	36	16	produce	produce	VERB
hls-11340	36	17	25	25	NUM
hls-11340	36	18	-	-	PUNCT
hls-11340	36	19	hydroxyvitamin	hydroxyvitamin	NOUN
hls-11340	36	20	d	d	NOUN
hls-11340	36	21	,	,	PUNCT
hls-11340	36	22	and	and	CCONJ
hls-11340	36	23	the	the	DET
hls-11340	36	24	other	other	ADJ
hls-11340	36	25	in	in	ADP
hls-11340	36	26	the	the	DET
hls-11340	36	27	kidney	kidney	NOUN
hls-11340	36	28	that	that	PRON
hls-11340	36	29	produce	produce	VERB
hls-11340	36	30	1	1	NUM
hls-11340	36	31	,	,	PUNCT
hls-11340	36	32	25	25	NUM
hls-11340	36	33	-	-	PUNCT
hls-11340	36	34	hydroxyvitamin	hydroxyvitamin	NOUN
hls-11340	36	35	d.9	d.9	NOUN
hls-11340	36	36	vitamin	vitamin	NOUN
hls-11340	36	37	d	d	NOUN
hls-11340	36	38	receptors	receptor	NOUN
hls-11340	36	39	are	be	AUX
hls-11340	36	40	present	present	ADJ
hls-11340	36	41	in	in	ADP
hls-11340	36	42	the	the	DET
hls-11340	36	43	pancreatic	pancreatic	ADJ
hls-11340	36	44	βcells	βcell	NOUN
hls-11340	36	45	as	as	SCONJ
hls-11340	36	46	vitamin	vitamin	NOUN
hls-11340	36	47	d	d	NOUN
hls-11340	36	48	is	be	AUX
hls-11340	36	49	involved	involve	VERB
hls-11340	36	50	in	in	ADP
hls-11340	36	51	regulation	regulation	NOUN
hls-11340	36	52	of	of	ADP
hls-11340	36	53	insulin	insulin	NOUN
hls-11340	36	54	secretion	secretion	NOUN
hls-11340	36	55	,	,	PUNCT
hls-11340	36	56	that	that	PRON
hls-11340	36	57	’s	’	VERB
hls-11340	36	58	why	why	SCONJ
hls-11340	36	59	some	some	DET
hls-11340	36	60	hypothesis	hypothesis	NOUN
hls-11340	36	61	postulated	postulate	VERB
hls-11340	36	62	that	that	SCONJ
hls-11340	36	63	vitamin	vitamin	NOUN
hls-11340	36	64	d	d	NOUN
hls-11340	36	65	is	be	AUX
hls-11340	36	66	involved	involve	VERB
hls-11340	36	67	in	in	ADP
hls-11340	36	68	the	the	DET
hls-11340	36	69	pathogenesis	pathogenesis	NOUN
hls-11340	36	70	of	of	ADP
hls-11340	36	71	diabetes	diabetes	NOUN
hls-11340	36	72	mellitus.10	mellitus.10	NOUN
hls-11340	36	73	many	many	ADJ
hls-11340	36	74	studies	study	NOUN
hls-11340	36	75	have	have	AUX
hls-11340	36	76	been	be	AUX
hls-11340	36	77	conducted	conduct	VERB
hls-11340	36	78	to	to	PART
hls-11340	36	79	determine	determine	VERB
hls-11340	36	80	the	the	DET
hls-11340	36	81	relation	relation	NOUN
hls-11340	36	82	between	between	ADP
hls-11340	36	83	vitamin	vitamin	NOUN
hls-11340	36	84	d	d	NOUN
hls-11340	36	85	deficiency	deficiency	NOUN
hls-11340	36	86	and	and	CCONJ
hls-11340	36	87	progression	progression	NOUN
hls-11340	36	88	of	of	ADP
hls-11340	36	89	diabetes	diabetes	NOUN
hls-11340	36	90	,	,	PUNCT
hls-11340	36	91	especially	especially	ADV
hls-11340	36	92	its	its	PRON
hls-11340	36	93	macrovascular	macrovascular	ADJ
hls-11340	36	94	complications	complication	NOUN
hls-11340	36	95	.	.	PUNCT
hls-11340	37	1	vitamin	vitamin	NOUN
hls-11340	37	2	d	d	NOUN
hls-11340	37	3	deficiency	deficiency	NOUN
hls-11340	37	4	is	be	AUX
hls-11340	37	5	associated	associate	VERB
hls-11340	37	6	with	with	ADP
hls-11340	37	7	high	high	ADJ
hls-11340	37	8	inflammatory	inflammatory	ADJ
hls-11340	37	9	burden	burden	NOUN
hls-11340	37	10	,	,	PUNCT
hls-11340	37	11	and	and	CCONJ
hls-11340	37	12	many	many	ADJ
hls-11340	37	13	inflammatory	inflammatory	ADJ
hls-11340	37	14	markers	marker	NOUN
hls-11340	37	15	have	have	AUX
hls-11340	37	16	been	be	AUX
hls-11340	37	17	found	find	VERB
hls-11340	37	18	to	to	PART
hls-11340	37	19	be	be	AUX
hls-11340	37	20	elevated	elevate	VERB
hls-11340	37	21	in	in	ADP
hls-11340	37	22	vitamin	vitamin	NOUN
hls-11340	37	23	d	d	NOUN
hls-11340	37	24	deficiency	deficiency	NOUN
hls-11340	37	25	patients.11	patients.11	VERB
hls-11340	37	26	other	other	ADJ
hls-11340	37	27	studies	study	NOUN
hls-11340	37	28	have	have	AUX
hls-11340	37	29	found	find	VERB
hls-11340	37	30	a	a	DET
hls-11340	37	31	significant	significant	ADJ
hls-11340	37	32	effect	effect	NOUN
hls-11340	37	33	of	of	ADP
hls-11340	37	34	vitamin	vitamin	NOUN
hls-11340	37	35	d	d	NOUN
hls-11340	37	36	supplementation	supplementation	NOUN
hls-11340	37	37	on	on	ADP
hls-11340	37	38	improving	improve	VERB
hls-11340	37	39	fasting	fast	VERB
hls-11340	37	40	blood	blood	NOUN
hls-11340	37	41	sugar	sugar	NOUN
hls-11340	37	42	and	and	CCONJ
hls-11340	37	43	glycated	glycate	VERB
hls-11340	37	44	hemoglobin	hemoglobin	NOUN
hls-11340	37	45	a1c.12	a1c.12	PROPN
hls-11340	37	46	however	however	ADV
hls-11340	37	47	,	,	PUNCT
hls-11340	37	48	more	more	ADJ
hls-11340	37	49	studies	study	NOUN
hls-11340	37	50	are	be	AUX
hls-11340	37	51	needed	need	VERB
hls-11340	37	52	to	to	PART
hls-11340	37	53	determine	determine	VERB
hls-11340	37	54	the	the	DET
hls-11340	37	55	relationship	relationship	NOUN
hls-11340	37	56	between	between	ADP
hls-11340	37	57	vitamin	vitamin	NOUN
hls-11340	37	58	d	d	NOUN
hls-11340	37	59	deficiency	deficiency	NOUN
hls-11340	37	60	and	and	CCONJ
hls-11340	37	61	glycemic	glycemic	ADJ
hls-11340	37	62	control	control	NOUN
hls-11340	37	63	in	in	ADP
hls-11340	37	64	diabetic	diabetic	ADJ
hls-11340	37	65	patients	patient	NOUN
hls-11340	37	66	and	and	CCONJ
hls-11340	37	67	whether	whether	SCONJ
hls-11340	37	68	vitamin	vitamin	NOUN
hls-11340	37	69	d	d	NOUN
hls-11340	37	70	supplement	supplement	NOUN
hls-11340	37	71	is	be	AUX
hls-11340	37	72	going	go	VERB
hls-11340	37	73	to	to	PART
hls-11340	37	74	help	help	VERB
hls-11340	37	75	in	in	ADP
hls-11340	37	76	controlling	control	VERB
hls-11340	37	77	the	the	DET
hls-11340	37	78	disease	disease	NOUN
hls-11340	37	79	progression	progression	NOUN
hls-11340	37	80	.	.	PUNCT
hls-11340	38	1	materials	material	NOUN
hls-11340	38	2	and	and	CCONJ
hls-11340	38	3	methods	method	NOUN
hls-11340	38	4	study	study	NOUN
hls-11340	38	5	design	design	NOUN
hls-11340	38	6	this	this	DET
hls-11340	38	7	study	study	NOUN
hls-11340	38	8	was	be	AUX
hls-11340	38	9	a	a	DET
hls-11340	38	10	prospective	prospective	ADJ
hls-11340	38	11	randomized	randomized	ADJ
hls-11340	38	12	clinical	clinical	ADJ
hls-11340	38	13	trial	trial	NOUN
hls-11340	38	14	conducted	conduct	VERB
hls-11340	38	15	on	on	ADP
hls-11340	38	16	100t2	100t2	NUM
hls-11340	38	17	dm	dm	NOUN
hls-11340	38	18	patients	patient	NOUN
hls-11340	38	19	.	.	PUNCT
hls-11340	39	1	the	the	DET
hls-11340	39	2	participants	participant	NOUN
hls-11340	39	3	‘	'	PUNCT
hls-11340	39	4	vitamin	vitamin	NOUN
hls-11340	39	5	d	d	NOUN
hls-11340	39	6	level	level	NOUN
hls-11340	39	7	,	,	PUNCT
hls-11340	39	8	fasting	fast	VERB
hls-11340	39	9	blood	blood	NOUN
hls-11340	39	10	sugar	sugar	NOUN
hls-11340	39	11	and	and	CCONJ
hls-11340	39	12	hba1c	hba1c	PROPN
hls-11340	39	13	were	be	AUX
hls-11340	39	14	measured	measure	VERB
hls-11340	39	15	,	,	PUNCT
hls-11340	39	16	all	all	DET
hls-11340	39	17	patients	patient	NOUN
hls-11340	39	18	were	be	AUX
hls-11340	39	19	treated	treat	VERB
hls-11340	39	20	with	with	ADP
hls-11340	39	21	oral	oral	ADJ
hls-11340	39	22	hypoglycemic	hypoglycemic	ADJ
hls-11340	39	23	medications	medication	NOUN
hls-11340	39	24	.	.	PUNCT
hls-11340	40	1	the	the	DET
hls-11340	40	2	study	study	NOUN
hls-11340	40	3	was	be	AUX
hls-11340	40	4	conducted	conduct	VERB
hls-11340	40	5	at	at	ADP
hls-11340	40	6	medical	medical	ADJ
hls-11340	40	7	research	research	PROPN
hls-11340	40	8	institute	institute	PROPN
hls-11340	40	9	,	,	PUNCT
hls-11340	40	10	alexandria	alexandria	PROPN
hls-11340	40	11	university	university	PROPN
hls-11340	40	12	,	,	PUNCT
hls-11340	40	13	between	between	ADP
hls-11340	40	14	june	june	PROPN
hls-11340	40	15	2021	2021	NUM
hls-11340	40	16	to	to	ADP
hls-11340	40	17	september	september	PROPN
hls-11340	40	18	2021	2021	NUM
hls-11340	40	19	.	.	PUNCT
hls-11340	41	1	patients	patient	NOUN
hls-11340	41	2	enrolled	enrol	VERB
hls-11340	41	3	in	in	ADP
hls-11340	41	4	the	the	DET
hls-11340	41	5	study	study	NOUN
hls-11340	41	6	were	be	AUX
hls-11340	41	7	selected	select	VERB
hls-11340	41	8	from	from	ADP
hls-11340	41	9	diabetic	diabetic	ADJ
hls-11340	41	10	population	population	NOUN
hls-11340	41	11	routinely	routinely	ADV
hls-11340	41	12	attending	attend	VERB
hls-11340	41	13	the	the	DET
hls-11340	41	14	outpatient	outpatient	NOUN
hls-11340	41	15	clinic	clinic	NOUN
hls-11340	41	16	or	or	CCONJ
hls-11340	41	17	admitted	admit	VERB
hls-11340	41	18	to	to	ADP
hls-11340	41	19	the	the	DET
hls-11340	41	20	inpatient	inpatient	NOUN
hls-11340	41	21	wards	ward	NOUN
hls-11340	41	22	for	for	AUX
hls-11340	41	23	follow	follow	VERB
hls-11340	41	24	up	up	ADP
hls-11340	41	25	and	and	CCONJ
hls-11340	41	26	treatment	treatment	NOUN
hls-11340	41	27	of	of	ADP
hls-11340	41	28	their	their	PRON
hls-11340	41	29	diabetes	diabete	NOUN
hls-11340	41	30	.	.	PUNCT
hls-11340	42	1	all	all	DET
hls-11340	42	2	patients	patient	NOUN
hls-11340	42	3	provided	provide	VERB
hls-11340	42	4	written	write	VERB
hls-11340	42	5	informed	inform	VERB
hls-11340	42	6	consent	consent	NOUN
hls-11340	42	7	,	,	PUNCT
hls-11340	42	8	and	and	CCONJ
hls-11340	42	9	the	the	DET
hls-11340	42	10	study	study	NOUN
hls-11340	42	11	was	be	AUX
hls-11340	42	12	approved	approve	VERB
hls-11340	42	13	by	by	ADP
hls-11340	42	14	the	the	DET
hls-11340	42	15	ethics	ethic	NOUN
hls-11340	42	16	committee	committee	PROPN
hls-11340	42	17	of	of	ADP
hls-11340	42	18	the	the	DET
hls-11340	42	19	institute	institute	NOUN
hls-11340	42	20	.	.	PUNCT
hls-11340	43	1	patients	patient	NOUN
hls-11340	43	2	type	type	VERB
hls-11340	43	3	2	2	NUM
hls-11340	43	4	diabetic	diabetic	ADJ
hls-11340	43	5	patients	patient	NOUN
hls-11340	43	6	were	be	AUX
hls-11340	43	7	randomly	randomly	ADV
hls-11340	43	8	selected	select	VERB
hls-11340	43	9	from	from	ADP
hls-11340	43	10	those	those	PRON
hls-11340	43	11	who	who	PRON
hls-11340	43	12	were	be	AUX
hls-11340	43	13	registered	register	VERB
hls-11340	43	14	at	at	ADP
hls-11340	43	15	our	our	PRON
hls-11340	43	16	outpatient	outpatient	NOUN
hls-11340	43	17	clinic	clinic	NOUN
hls-11340	43	18	or	or	CCONJ
hls-11340	43	19	admitted	admit	VERB
hls-11340	43	20	to	to	ADP
hls-11340	43	21	our	our	PRON
hls-11340	43	22	inpatient	inpatient	NOUN
hls-11340	43	23	wards	ward	NOUN
hls-11340	43	24	.	.	PUNCT
hls-11340	44	1	during	during	ADP
hls-11340	44	2	selection	selection	NOUN
hls-11340	44	3	,	,	PUNCT
hls-11340	44	4	diabetes	diabetes	NOUN
hls-11340	44	5	was	be	AUX
hls-11340	44	6	diagnosed	diagnose	VERB
hls-11340	44	7	and	and	CCONJ
hls-11340	44	8	confirmed	confirm	VERB
hls-11340	44	9	according	accord	VERB
hls-11340	44	10	to	to	ADP
hls-11340	44	11	the	the	DET
hls-11340	44	12	diagnostic	diagnostic	ADJ
hls-11340	44	13	criteria	criterion	NOUN
hls-11340	44	14	established	establish	VERB
hls-11340	44	15	by	by	ADP
hls-11340	44	16	the	the	DET
hls-11340	44	17	american	american	ADJ
hls-11340	44	18	diabetes	diabetes	PROPN
hls-11340	44	19	association	association	NOUN
hls-11340	44	20	at	at	ADP
hls-11340	44	21	the	the	DET
hls-11340	44	22	time	time	NOUN
hls-11340	44	23	of	of	ADP
hls-11340	44	24	the	the	DET
hls-11340	44	25	study,13	study,13	NOUN
hls-11340	44	26	with	with	ADP
hls-11340	44	27	no	no	DET
hls-11340	44	28	change	change	NOUN
hls-11340	44	29	in	in	ADP
hls-11340	44	30	their	their	PRON
hls-11340	44	31	diabetes	diabetes	NOUN
hls-11340	44	32	treatment	treatment	NOUN
hls-11340	44	33	protocol	protocol	NOUN
hls-11340	44	34	during	during	ADP
hls-11340	44	35	the	the	DET
hls-11340	44	36	study	study	NOUN
hls-11340	44	37	.	.	PUNCT
hls-11340	45	1	inclusion	inclusion	NOUN
hls-11340	45	2	criteria	criterion	NOUN
hls-11340	45	3	t2	t2	PROPN
hls-11340	45	4	dm	dm	PROPN
hls-11340	45	5	patients	patient	NOUN
hls-11340	45	6	above	above	ADP
hls-11340	45	7	18	18	NUM
hls-11340	45	8	years	year	NOUN
hls-11340	45	9	of	of	ADP
hls-11340	45	10	age	age	NOUN
hls-11340	45	11	,	,	PUNCT
hls-11340	45	12	non	non	ADJ
hls-11340	45	13	-	-	ADJ
hls-11340	45	14	obese	obese	ADJ
hls-11340	45	15	with	with	ADP
hls-11340	45	16	18.5	18.5	NUM
hls-11340	45	17	>	>	SYM
hls-11340	45	18	bmi	bmi	PROPN
hls-11340	45	19	<	<	X
hls-11340	45	20	25	25	NUM
hls-11340	45	21	kg	kg	NOUN
hls-11340	45	22	/	/	SYM
hls-11340	45	23	m2	m2	PROPN
hls-11340	45	24	according	accord	VERB
hls-11340	45	25	to	to	ADP
hls-11340	45	26	who	who	PRON
hls-11340	45	27	criteria.14	criteria.14	VERB
hls-11340	45	28	exclusion	exclusion	NOUN
hls-11340	45	29	criteria	criterion	NOUN
hls-11340	45	30	individuals	individual	NOUN
hls-11340	45	31	with	with	ADP
hls-11340	45	32	any	any	PRON
hls-11340	45	33	of	of	ADP
hls-11340	45	34	the	the	DET
hls-11340	45	35	following	follow	VERB
hls-11340	45	36	were	be	AUX
hls-11340	45	37	excluded	exclude	VERB
hls-11340	45	38	:	:	PUNCT
hls-11340	45	39	type	type	NOUN
hls-11340	45	40	1	1	NUM
hls-11340	45	41	dm	dm	NOUN
hls-11340	45	42	,	,	PUNCT
hls-11340	45	43	gestational	gestational	ADJ
hls-11340	45	44	dm	dm	NOUN
hls-11340	45	45	,	,	PUNCT
hls-11340	45	46	chronic	chronic	ADJ
hls-11340	45	47	kidney	kidney	NOUN
hls-11340	45	48	disease	disease	NOUN
hls-11340	45	49	,	,	PUNCT
hls-11340	45	50	chronic	chronic	ADJ
hls-11340	45	51	liver	liver	NOUN
hls-11340	45	52	disease	disease	NOUN
hls-11340	45	53	,	,	PUNCT
hls-11340	45	54	article	article	NOUN
hls-11340	45	55	figure	figure	VERB
hls-11340	45	56	1	1	NUM
hls-11340	45	57	.	.	PUNCT
hls-11340	45	58	relation	relation	NOUN
hls-11340	45	59	between	between	ADP
hls-11340	45	60	vitamin	vitamin	NOUN
hls-11340	45	61	-	-	PUNCT
hls-11340	45	62	d	d	NOUN
hls-11340	45	63	level	level	NOUN
hls-11340	45	64	and	and	CCONJ
hls-11340	45	65	parameters	parameter	NOUN
hls-11340	45	66	of	of	ADP
hls-11340	45	67	glycemic	glycemic	ADJ
hls-11340	45	68	control	control	NOUN
hls-11340	45	69	.	.	PUNCT
hls-11340	46	1	table	table	NOUN
hls-11340	46	2	1	1	NUM
hls-11340	46	3	.	.	PUNCT
hls-11340	47	1	distribution	distribution	NOUN
hls-11340	47	2	of	of	ADP
hls-11340	47	3	the	the	DET
hls-11340	47	4	studied	study	VERB
hls-11340	47	5	cases	case	NOUN
hls-11340	47	6	according	accord	VERB
hls-11340	47	7	to	to	ADP
hls-11340	47	8	demographic	demographic	ADJ
hls-11340	47	9	data	datum	NOUN
hls-11340	47	10	and	and	CCONJ
hls-11340	47	11	vitamin	vitamin	NOUN
hls-11340	47	12	d	d	NOUN
hls-11340	47	13	level	level	NOUN
hls-11340	47	14	(	(	PUNCT
hls-11340	47	15	n=100	n=100	NUM
hls-11340	47	16	)	)	PUNCT
hls-11340	47	17	.	.	PUNCT
hls-11340	48	1	variable	variable	ADJ
hls-11340	48	2	no	no	INTJ
hls-11340	48	3	.	.	PUNCT
hls-11340	49	1	(	(	PUNCT
hls-11340	49	2	%	%	INTJ
hls-11340	49	3	)	)	PUNCT
hls-11340	49	4	gender	gender	NOUN
hls-11340	49	5	male	male	NOUN
hls-11340	49	6	40	40	NUM
hls-11340	49	7	(	(	PUNCT
hls-11340	49	8	40	40	NUM
hls-11340	49	9	)	)	PUNCT
hls-11340	49	10	female	female	NOUN
hls-11340	49	11	60	60	NUM
hls-11340	49	12	(	(	PUNCT
hls-11340	49	13	60	60	NUM
hls-11340	49	14	)	)	PUNCT
hls-11340	49	15	age	age	NOUN
hls-11340	49	16	(	(	PUNCT
hls-11340	49	17	years	year	NOUN
hls-11340	49	18	)	)	PUNCT
hls-11340	49	19	mean	mean	PROPN
hls-11340	49	20	±	±	NUM
hls-11340	49	21	sd	sd	NOUN
hls-11340	49	22	.	.	PUNCT
hls-11340	50	1	56.7±12.9	56.7±12.9	NUM
hls-11340	50	2	median	median	NOUN
hls-11340	50	3	(	(	PUNCT
hls-11340	50	4	min	min	PROPN
hls-11340	50	5	.	.	PROPN
hls-11340	50	6	–	–	PUNCT
hls-11340	50	7	max	max	PROPN
hls-11340	50	8	.	.	PUNCT
hls-11340	50	9	)	)	PUNCT
hls-11340	51	1	60.5	60.5	NUM
hls-11340	51	2	(	(	PUNCT
hls-11340	51	3	25–75	25–75	NUM
hls-11340	51	4	)	)	PUNCT
hls-11340	51	5	vitamin	vitamin	NOUN
hls-11340	51	6	-	-	PUNCT
hls-11340	51	7	d	d	NOUN
hls-11340	51	8	(	(	PUNCT
hls-11340	51	9	ng	ng	PROPN
hls-11340	51	10	/	/	SYM
hls-11340	51	11	ml	ml	NOUN
hls-11340	51	12	)	)	PUNCT
hls-11340	51	13	deficient	deficient	ADJ
hls-11340	51	14	(	(	PUNCT
hls-11340	51	15	<	<	X
hls-11340	51	16	30	30	NUM
hls-11340	51	17	)	)	SYM
hls-11340	51	18	60	60	NUM
hls-11340	51	19	(	(	PUNCT
hls-11340	51	20	60	60	NUM
hls-11340	51	21	)	)	PUNCT
hls-11340	51	22	normal	normal	ADJ
hls-11340	51	23	(	(	PUNCT
hls-11340	51	24	30	30	NUM
hls-11340	51	25	–	–	SYM
hls-11340	51	26	100	100	NUM
hls-11340	51	27	)	)	PUNCT
hls-11340	51	28	40	40	NUM
hls-11340	51	29	(	(	PUNCT
hls-11340	51	30	40	40	NUM
hls-11340	51	31	)	)	PUNCT
hls-11340	52	1	mean	mean	VERB
hls-11340	52	2	±	±	NUM
hls-11340	52	3	sd	sd	NOUN
hls-11340	52	4	.	.	PUNCT
hls-11340	53	1	27.5±15.4	27.5±15.4	NUM
hls-11340	53	2	median	median	NOUN
hls-11340	53	3	(	(	PUNCT
hls-11340	53	4	min	min	PROPN
hls-11340	53	5	.	.	PROPN
hls-11340	53	6	–	–	PUNCT
hls-11340	53	7	max	max	PROPN
hls-11340	53	8	.	.	PUNCT
hls-11340	53	9	)	)	PUNCT
hls-11340	54	1	23.5	23.5	NUM
hls-11340	54	2	(	(	PUNCT
hls-11340	54	3	8.1–63.3	8.1–63.3	NUM
hls-11340	54	4	)	)	PUNCT
hls-11340	54	5	sd	sd	NOUN
hls-11340	54	6	,	,	PUNCT
hls-11340	54	7	standard	standard	ADJ
hls-11340	54	8	deviation	deviation	NOUN
hls-11340	54	9	.	.	PUNCT
hls-11340	55	1	table	table	NOUN
hls-11340	55	2	2	2	NUM
hls-11340	55	3	.	.	X
hls-11340	55	4	relation	relation	NOUN
hls-11340	55	5	between	between	ADP
hls-11340	55	6	vitamin	vitamin	NOUN
hls-11340	55	7	-	-	PUNCT
hls-11340	55	8	d	d	NOUN
hls-11340	55	9	and	and	CCONJ
hls-11340	55	10	demographic	demographic	ADJ
hls-11340	55	11	data	datum	NOUN
hls-11340	55	12	(	(	PUNCT
hls-11340	55	13	n=	n=	ADJ
hls-11340	55	14	100	100	NUM
hls-11340	55	15	)	)	PUNCT
hls-11340	55	16	.	.	PUNCT
hls-11340	56	1	vitamin	vitamin	NOUN
hls-11340	56	2	-	-	PUNCT
hls-11340	56	3	d	d	PROPN
hls-11340	56	4	(	(	PUNCT
hls-11340	56	5	ng	ng	PROPN
hls-11340	56	6	/	/	SYM
hls-11340	56	7	ml	ml	PROPN
hls-11340	56	8	)	)	PUNCT
hls-11340	56	9	p	p	NOUN
hls-11340	56	10	deficient	deficient	ADJ
hls-11340	56	11	normal	normal	ADJ
hls-11340	56	12	(	(	PUNCT
hls-11340	56	13	<	<	NOUN
hls-11340	56	14	30	30	NUM
hls-11340	56	15	)	)	PUNCT
hls-11340	56	16	(	(	PUNCT
hls-11340	56	17	30	30	NUM
hls-11340	56	18	–	–	SYM
hls-11340	56	19	100	100	NUM
hls-11340	56	20	)	)	PUNCT
hls-11340	56	21	test	test	NOUN
hls-11340	56	22	of	of	ADP
hls-11340	56	23	sig	sig	NOUN
hls-11340	56	24	.	.	PUNCT
hls-11340	56	25	(	(	PUNCT
hls-11340	56	26	n	n	NOUN
hls-11340	56	27	=	=	SYM
hls-11340	56	28	60	60	NUM
hls-11340	56	29	)	)	PUNCT
hls-11340	56	30	(	(	PUNCT
hls-11340	56	31	n	n	NOUN
hls-11340	56	32	=	=	SYM
hls-11340	56	33	40	40	NUM
hls-11340	56	34	)	)	PUNCT
hls-11340	56	35	gender	gender	NOUN
hls-11340	56	36	male	male	NOUN
hls-11340	56	37	28	28	NUM
hls-11340	56	38	(	(	PUNCT
hls-11340	56	39	46.7	46.7	NUM
hls-11340	56	40	%	%	NOUN
hls-11340	56	41	)	)	PUNCT
hls-11340	56	42	12	12	NUM
hls-11340	56	43	(	(	PUNCT
hls-11340	56	44	30	30	NUM
hls-11340	56	45	%	%	NOUN
hls-11340	56	46	)	)	PUNCT
hls-11340	56	47	χ2=	χ2=	VERB
hls-11340	56	48	2.788	2.788	NUM
hls-11340	56	49	0.096	0.096	NUM
hls-11340	56	50	female	female	ADJ
hls-11340	56	51	32	32	NUM
hls-11340	56	52	(	(	PUNCT
hls-11340	56	53	53.3	53.3	NUM
hls-11340	56	54	%	%	NOUN
hls-11340	56	55	)	)	PUNCT
hls-11340	56	56	28	28	NUM
hls-11340	56	57	(	(	PUNCT
hls-11340	56	58	70	70	NUM
hls-11340	56	59	%	%	NOUN
hls-11340	56	60	)	)	PUNCT
hls-11340	56	61	age	age	NOUN
hls-11340	56	62	(	(	PUNCT
hls-11340	56	63	years	year	NOUN
hls-11340	56	64	)	)	PUNCT
hls-11340	56	65	mean	mean	VERB
hls-11340	57	1	±	±	NUM
hls-11340	57	2	sd	sd	ADP
hls-11340	57	3	56.37±14.24	56.37±14.24	NUM
hls-11340	57	4	57.3±	57.3±	NUM
hls-11340	57	5	0.6	0.6	NUM
hls-11340	57	6	t=0.355	t=0.355	NUM
hls-11340	57	7	0.723	0.723	NUM
hls-11340	57	8	median	median	NOUN
hls-11340	57	9	(	(	PUNCT
hls-11340	57	10	min	min	NOUN
hls-11340	57	11	.	.	PROPN
hls-11340	57	12	–	–	PUNCT
hls-11340	57	13	max.)61	max.)61	PROPN
hls-11340	57	14	(	(	PUNCT
hls-11340	57	15	25–75	25–75	NUM
hls-11340	57	16	)	)	PUNCT
hls-11340	57	17	60.5	60.5	NUM
hls-11340	57	18	(	(	PUNCT
hls-11340	57	19	27–74	27–74	NUM
hls-11340	57	20	)	)	PUNCT
hls-11340	57	21	sd	sd	NOUN
hls-11340	57	22	,	,	PUNCT
hls-11340	57	23	standard	standard	ADJ
hls-11340	57	24	deviation	deviation	NOUN
hls-11340	57	25	;	;	PUNCT
hls-11340	57	26	t	t	PROPN
hls-11340	57	27	,	,	PUNCT
hls-11340	57	28	student	student	NOUN
hls-11340	57	29	t	t	PROPN
hls-11340	57	30	-	-	PUNCT
hls-11340	57	31	test	test	NOUN
hls-11340	57	32	,	,	PUNCT
hls-11340	57	33	χ2	χ2	PROPN
hls-11340	57	34	,	,	PUNCT
hls-11340	57	35	chi	chi	PROPN
hls-11340	57	36	square	square	PROPN
hls-11340	57	37	test	test	NOUN
hls-11340	57	38	;	;	PUNCT
hls-11340	57	39	*	*	PUNCT
hls-11340	57	40	statistically	statistically	ADV
hls-11340	57	41	significant	significant	ADJ
hls-11340	57	42	at	at	ADP
hls-11340	57	43	p≤0.05	p≤0.05	NOUN
hls-11340	57	44	.	.	PUNCT
hls-11340	57	45	table	table	NOUN
hls-11340	57	46	3	3	NUM
hls-11340	57	47	.	.	X
hls-11340	57	48	relation	relation	NOUN
hls-11340	57	49	between	between	ADP
hls-11340	57	50	vitamin	vitamin	NOUN
hls-11340	57	51	-	-	PUNCT
hls-11340	57	52	d	d	NOUN
hls-11340	57	53	level	level	NOUN
hls-11340	57	54	and	and	CCONJ
hls-11340	57	55	parameters	parameter	NOUN
hls-11340	57	56	of	of	ADP
hls-11340	57	57	glycemic	glycemic	ADJ
hls-11340	57	58	control	control	NOUN
hls-11340	57	59	(	(	PUNCT
hls-11340	57	60	n=100	n=100	NUM
hls-11340	57	61	)	)	PUNCT
hls-11340	57	62	.	.	PUNCT
hls-11340	58	1	vitamin	vitamin	NOUN
hls-11340	58	2	-	-	PUNCT
hls-11340	58	3	d	d	PROPN
hls-11340	58	4	(	(	PUNCT
hls-11340	58	5	ng	ng	PROPN
hls-11340	58	6	/	/	SYM
hls-11340	58	7	ml	ml	NOUN
hls-11340	58	8	)	)	PUNCT
hls-11340	58	9	u	u	NOUN
hls-11340	58	10	p	p	NOUN
hls-11340	58	11	mean	mean	NOUN
hls-11340	58	12	±	±	NUM
hls-11340	58	13	sd	sd	NOUN
hls-11340	58	14	.	.	PUNCT
hls-11340	59	1	median	median	PROPN
hls-11340	59	2	(	(	PUNCT
hls-11340	59	3	min.–max	min.–max	NOUN
hls-11340	59	4	.	.	PUNCT
hls-11340	59	5	)	)	PUNCT
hls-11340	60	1	fasting	fast	VERB
hls-11340	60	2	blood	blood	NOUN
hls-11340	60	3	sugar	sugar	NOUN
hls-11340	60	4	controlled	control	VERB
hls-11340	60	5	(	(	PUNCT
hls-11340	60	6	≤130	≤130	NUM
hls-11340	60	7	)	)	PUNCT
hls-11340	60	8	32.4±14.7	32.4±14.7	NUM
hls-11340	60	9	31.7	31.7	NUM
hls-11340	60	10	(	(	PUNCT
hls-11340	60	11	11.6–57.5	11.6–57.5	NUM
hls-11340	60	12	)	)	PUNCT
hls-11340	60	13	774.0	774.0	NUM
hls-11340	60	14	*	*	SYM
hls-11340	60	15	0.003	0.003	NUM
hls-11340	60	16	*	*	PUNCT
hls-11340	60	17	uncontrolled	uncontrolled	ADJ
hls-11340	60	18	(	(	PUNCT
hls-11340	60	19	>	>	NOUN
hls-11340	60	20	130	130	NUM
hls-11340	60	21	)	)	PUNCT
hls-11340	60	22	24.3±15.1	24.3±15.1	NUM
hls-11340	60	23	18.7	18.7	NUM
hls-11340	60	24	(	(	PUNCT
hls-11340	60	25	8.1–63.3	8.1–63.3	NUM
hls-11340	60	26	)	)	PUNCT
hls-11340	60	27	hba1c	hba1c	PROPN
hls-11340	60	28	(	(	PUNCT
hls-11340	60	29	%	%	INTJ
hls-11340	60	30	)	)	PUNCT
hls-11340	60	31	controlled	control	VERB
hls-11340	60	32	(	(	PUNCT
hls-11340	60	33	≤7	≤7	ADJ
hls-11340	60	34	)	)	PUNCT
hls-11340	60	35	31.6±15.3	31.6±15.3	NUM
hls-11340	60	36	31.7	31.7	NUM
hls-11340	60	37	(	(	PUNCT
hls-11340	60	38	10.4–57.5	10.4–57.5	NUM
hls-11340	60	39	)	)	PUNCT
hls-11340	60	40	838.0	838.0	NUM
hls-11340	60	41	*	*	SYM
hls-11340	60	42	0.005	0.005	NUM
hls-11340	60	43	*	*	PUNCT
hls-11340	60	44	uncontrolled	uncontrolled	ADJ
hls-11340	60	45	(	(	PUNCT
hls-11340	60	46	>	>	NOUN
hls-11340	60	47	7	7	NUM
hls-11340	60	48	)	)	PUNCT
hls-11340	60	49	23.2±14.4	23.2±14.4	NUM
hls-11340	60	50	18.7	18.7	NUM
hls-11340	60	51	(	(	PUNCT
hls-11340	60	52	8.1–63.3	8.1–63.3	NUM
hls-11340	60	53	)	)	PUNCT
hls-11340	60	54	sd	sd	NOUN
hls-11340	60	55	,	,	PUNCT
hls-11340	60	56	standard	standard	ADJ
hls-11340	60	57	deviation	deviation	NOUN
hls-11340	60	58	;	;	PUNCT
hls-11340	60	59	u	u	NOUN
hls-11340	60	60	,	,	PUNCT
hls-11340	60	61	mann	mann	PROPN
hls-11340	60	62	whitney	whitney	PROPN
hls-11340	60	63	test	test	NOUN
hls-11340	60	64	;	;	PUNCT
hls-11340	60	65	*	*	PUNCT
hls-11340	60	66	statistically	statistically	ADV
hls-11340	60	67	significant	significant	ADJ
hls-11340	60	68	at	at	ADP
hls-11340	60	69	p≤0.05	p≤0.05	NOUN
hls-11340	60	70	.	.	PUNCT
hls-11340	61	1	[	[	X
hls-11340	61	2	healthcare	healthcare	NOUN
hls-11340	61	3	in	in	ADP
hls-11340	61	4	low	low	ADJ
hls-11340	61	5	-	-	PUNCT
hls-11340	61	6	resource	resource	NOUN
hls-11340	61	7	settings	setting	NOUN
hls-11340	61	8	2023	2023	NUM
hls-11340	61	9	;	;	PUNCT
hls-11340	61	10	11(s2):11340	11(s2):11340	X
hls-11340	61	11	]	]	X
hls-11340	62	1	[	[	X
hls-11340	62	2	page	page	NOUN
hls-11340	62	3	9	9	NUM
hls-11340	62	4	]	]	X
hls-11340	62	5	non	non	ADJ
hls-11340	62	6	-co	-co	PROPN
hls-11340	62	7	mmerc	mmerc	PROPN
hls-11340	62	8	ial	ial	PROPN
hls-11340	62	9	us	us	PROPN
hls-11340	62	10	e	e	NOUN
hls-11340	62	11	o	o	PUNCT
hls-11340	62	12	nly	nly	ADV
hls-11340	62	13	and	and	CCONJ
hls-11340	62	14	hypoparathyroidism	hypoparathyroidism	NOUN
hls-11340	62	15	:	:	PUNCT
hls-11340	62	16	i	i	PRON
hls-11340	62	17	)	)	PUNCT
hls-11340	62	18	thorough	thorough	ADJ
hls-11340	62	19	clinical	clinical	ADJ
hls-11340	62	20	examination	examination	NOUN
hls-11340	62	21	including	include	VERB
hls-11340	62	22	weight	weight	NOUN
hls-11340	62	23	and	and	CCONJ
hls-11340	62	24	height	height	NOUN
hls-11340	62	25	;	;	PUNCT
hls-11340	62	26	ii	ii	X
hls-11340	62	27	)	)	PUNCT
hls-11340	62	28	routine	routine	ADJ
hls-11340	62	29	laboratory	laboratory	NOUN
hls-11340	62	30	investigations	investigation	NOUN
hls-11340	62	31	including	include	VERB
hls-11340	62	32	:	:	PUNCT
hls-11340	62	33	liver	liver	NOUN
hls-11340	62	34	function	function	NOUN
hls-11340	62	35	tests	test	NOUN
hls-11340	62	36	,	,	PUNCT
hls-11340	62	37	renal	renal	ADJ
hls-11340	62	38	function	function	NOUN
hls-11340	62	39	tests	test	NOUN
hls-11340	62	40	,	,	PUNCT
hls-11340	62	41	electrolytes	electrolyte	NOUN
hls-11340	62	42	,	,	PUNCT
hls-11340	62	43	complete	complete	ADJ
hls-11340	62	44	blood	blood	NOUN
hls-11340	62	45	picture	picture	NOUN
hls-11340	62	46	,	,	PUNCT
hls-11340	62	47	and	and	CCONJ
hls-11340	62	48	lipid	lipid	PROPN
hls-11340	62	49	profile;14,15	profile;14,15	PROPN
hls-11340	62	50	iii	iii	PROPN
hls-11340	62	51	)	)	PUNCT
hls-11340	62	52	glycemic	glycemic	ADJ
hls-11340	62	53	control	control	NOUN
hls-11340	62	54	was	be	AUX
hls-11340	62	55	assessed	assess	VERB
hls-11340	62	56	by	by	ADP
hls-11340	62	57	fasting	fast	VERB
hls-11340	62	58	blood	blood	NOUN
hls-11340	62	59	sugar	sugar	NOUN
hls-11340	62	60	and	and	CCONJ
hls-11340	62	61	hba1c;13	hba1c;13	NOUN
hls-11340	62	62	iv	iv	NUM
hls-11340	62	63	)	)	PUNCT
hls-11340	62	64	vitamin	vitamin	NOUN
hls-11340	62	65	d	d	NOUN
hls-11340	62	66	assessment	assessment	NOUN
hls-11340	62	67	by	by	ADP
hls-11340	62	68	high	high	ADJ
hls-11340	62	69	performance	performance	NOUN
hls-11340	62	70	liquid	liquid	ADJ
hls-11340	62	71	chromatography.16	chromatography.16	NOUN
hls-11340	62	72	statistical	statistical	ADJ
hls-11340	62	73	analysis	analysis	NOUN
hls-11340	62	74	data	datum	NOUN
hls-11340	62	75	were	be	AUX
hls-11340	62	76	fed	feed	VERB
hls-11340	62	77	to	to	ADP
hls-11340	62	78	the	the	DET
hls-11340	62	79	computer	computer	NOUN
hls-11340	62	80	and	and	CCONJ
hls-11340	62	81	analyzed	analyze	VERB
hls-11340	62	82	using	use	VERB
hls-11340	62	83	ibm	ibm	PROPN
hls-11340	62	84	spss	spss	PROPN
hls-11340	62	85	software	software	NOUN
hls-11340	62	86	package	package	NOUN
hls-11340	62	87	version	version	NOUN
hls-11340	62	88	20.0	20.0	NUM
hls-11340	62	89	.	.	PUNCT
hls-11340	63	1	(	(	PUNCT
hls-11340	63	2	armonk	armonk	PROPN
hls-11340	63	3	,	,	PUNCT
hls-11340	63	4	ny	ny	PROPN
hls-11340	63	5	:	:	PROPN
hls-11340	63	6	ibm	ibm	PROPN
hls-11340	63	7	corp	corp	PROPN
hls-11340	63	8	)	)	PUNCT
hls-11340	63	9	.	.	PUNCT
hls-11340	64	1	the	the	DET
hls-11340	64	2	kolmogorovsmirnov	kolmogorovsmirnov	PROPN
hls-11340	64	3	test	test	NOUN
hls-11340	64	4	was	be	AUX
hls-11340	64	5	used	use	VERB
hls-11340	64	6	to	to	PART
hls-11340	64	7	verify	verify	VERB
hls-11340	64	8	the	the	DET
hls-11340	64	9	normality	normality	NOUN
hls-11340	64	10	of	of	ADP
hls-11340	64	11	distribution	distribution	NOUN
hls-11340	64	12	of	of	ADP
hls-11340	64	13	variables	variable	NOUN
hls-11340	64	14	.	.	PUNCT
hls-11340	65	1	paired	pair	VERB
hls-11340	65	2	t	t	PROPN
hls-11340	65	3	-	-	PUNCT
hls-11340	65	4	test	test	NOUN
hls-11340	65	5	was	be	AUX
hls-11340	65	6	assessed	assess	VERB
hls-11340	65	7	for	for	ADP
hls-11340	65	8	comparison	comparison	NOUN
hls-11340	65	9	between	between	ADP
hls-11340	65	10	two	two	NUM
hls-11340	65	11	periods	period	NOUN
hls-11340	65	12	for	for	ADP
hls-11340	65	13	normally	normally	ADV
hls-11340	65	14	distributed	distribute	VERB
hls-11340	65	15	quantitative	quantitative	ADJ
hls-11340	65	16	variables	variable	NOUN
hls-11340	65	17	,	,	PUNCT
hls-11340	65	18	while	while	SCONJ
hls-11340	65	19	wilcoxon	wilcoxon	PROPN
hls-11340	65	20	signed	sign	VERB
hls-11340	65	21	ranks	rank	NOUN
hls-11340	65	22	test	test	NOUN
hls-11340	65	23	was	be	AUX
hls-11340	65	24	assessed	assess	VERB
hls-11340	65	25	for	for	ADP
hls-11340	65	26	comparison	comparison	NOUN
hls-11340	65	27	between	between	ADP
hls-11340	65	28	two	two	NUM
hls-11340	65	29	periods	period	NOUN
hls-11340	65	30	for	for	ADP
hls-11340	65	31	abnormally	abnormally	ADV
hls-11340	65	32	distributed	distribute	VERB
hls-11340	65	33	quantitative	quantitative	ADJ
hls-11340	65	34	variables	variable	NOUN
hls-11340	65	35	.	.	PUNCT
hls-11340	66	1	significance	significance	NOUN
hls-11340	66	2	of	of	ADP
hls-11340	66	3	the	the	DET
hls-11340	66	4	obtained	obtain	VERB
hls-11340	66	5	results	result	NOUN
hls-11340	66	6	was	be	AUX
hls-11340	66	7	judged	judge	VERB
hls-11340	66	8	at	at	ADP
hls-11340	66	9	value	value	NOUN
hls-11340	66	10	<	<	NOUN
hls-11340	66	11	0.05	0.05	NUM
hls-11340	66	12	.	.	PUNCT
hls-11340	67	1	results	result	NOUN
hls-11340	67	2	according	accord	VERB
hls-11340	67	3	to	to	ADP
hls-11340	67	4	the	the	DET
hls-11340	67	5	inclusion	inclusion	NOUN
hls-11340	67	6	and	and	CCONJ
hls-11340	67	7	exclusion	exclusion	NOUN
hls-11340	67	8	criteria	criterion	NOUN
hls-11340	67	9	,	,	PUNCT
hls-11340	67	10	100	100	NUM
hls-11340	67	11	type	type	NOUN
hls-11340	67	12	2	2	NUM
hls-11340	67	13	diabetic	diabetic	ADJ
hls-11340	67	14	patients	patient	NOUN
hls-11340	67	15	were	be	AUX
hls-11340	67	16	involved	involve	VERB
hls-11340	67	17	in	in	ADP
hls-11340	67	18	the	the	DET
hls-11340	67	19	study	study	NOUN
hls-11340	67	20	.	.	PUNCT
hls-11340	68	1	vitamin	vitamin	NOUN
hls-11340	68	2	d	d	PROPN
hls-11340	68	3	was	be	AUX
hls-11340	68	4	deficient	deficient	ADJ
hls-11340	68	5	in	in	ADP
hls-11340	68	6	60	60	NUM
hls-11340	68	7	(	(	PUNCT
hls-11340	68	8	60	60	NUM
hls-11340	68	9	%	%	NOUN
hls-11340	68	10	)	)	PUNCT
hls-11340	68	11	of	of	ADP
hls-11340	68	12	cases	case	NOUN
hls-11340	68	13	,	,	PUNCT
hls-11340	68	14	and	and	CCONJ
hls-11340	68	15	normal	normal	ADJ
hls-11340	68	16	in	in	ADP
hls-11340	68	17	40	40	NUM
hls-11340	68	18	(	(	PUNCT
hls-11340	68	19	40	40	NUM
hls-11340	68	20	%	%	NOUN
hls-11340	68	21	;	;	PUNCT
hls-11340	68	22	table	table	NOUN
hls-11340	68	23	1	1	NUM
hls-11340	68	24	)	)	PUNCT
hls-11340	68	25	.	.	PUNCT
hls-11340	69	1	the	the	DET
hls-11340	69	2	demographic	demographic	ADJ
hls-11340	69	3	data	datum	NOUN
hls-11340	69	4	of	of	ADP
hls-11340	69	5	diabetic	diabetic	ADJ
hls-11340	69	6	patients	patient	NOUN
hls-11340	69	7	at	at	ADP
hls-11340	69	8	baseline	baseline	PROPN
hls-11340	69	9	were	be	AUX
hls-11340	69	10	:	:	PUNCT
hls-11340	69	11	40	40	NUM
hls-11340	69	12	(	(	PUNCT
hls-11340	69	13	40	40	NUM
hls-11340	69	14	%	%	NOUN
hls-11340	69	15	)	)	PUNCT
hls-11340	69	16	males	male	NOUN
hls-11340	69	17	,	,	PUNCT
hls-11340	69	18	28	28	NUM
hls-11340	69	19	(	(	PUNCT
hls-11340	69	20	46.7	46.7	NUM
hls-11340	69	21	%	%	NOUN
hls-11340	69	22	)	)	PUNCT
hls-11340	69	23	had	have	VERB
hls-11340	69	24	vitamin	vitamin	NOUN
hls-11340	69	25	d	d	NOUN
hls-11340	69	26	deficiency	deficiency	NOUN
hls-11340	69	27	and	and	CCONJ
hls-11340	69	28	12	12	NUM
hls-11340	69	29	(	(	PUNCT
hls-11340	69	30	30	30	NUM
hls-11340	69	31	%	%	NOUN
hls-11340	69	32	)	)	PUNCT
hls-11340	69	33	had	have	VERB
hls-11340	69	34	normal	normal	ADJ
hls-11340	69	35	vitamin	vitamin	NOUN
hls-11340	69	36	d	d	NOUN
hls-11340	69	37	level	level	NOUN
hls-11340	69	38	.	.	PUNCT
hls-11340	70	1	60	60	NUM
hls-11340	70	2	(	(	PUNCT
hls-11340	70	3	60	60	NUM
hls-11340	70	4	%	%	NOUN
hls-11340	70	5	)	)	PUNCT
hls-11340	70	6	females	female	NOUN
hls-11340	70	7	,	,	PUNCT
hls-11340	70	8	32	32	NUM
hls-11340	70	9	(	(	PUNCT
hls-11340	70	10	53.3	53.3	NUM
hls-11340	70	11	%	%	NOUN
hls-11340	70	12	)	)	PUNCT
hls-11340	70	13	had	have	VERB
hls-11340	70	14	vitamin	vitamin	NOUN
hls-11340	70	15	d	d	NOUN
hls-11340	70	16	deficiency	deficiency	NOUN
hls-11340	70	17	and	and	CCONJ
hls-11340	70	18	28	28	NUM
hls-11340	70	19	(	(	PUNCT
hls-11340	70	20	70	70	NUM
hls-11340	70	21	%	%	NOUN
hls-11340	70	22	)	)	PUNCT
hls-11340	70	23	had	have	VERB
hls-11340	70	24	normal	normal	ADJ
hls-11340	70	25	vitamin	vitamin	NOUN
hls-11340	70	26	d	d	NOUN
hls-11340	70	27	level	level	NOUN
hls-11340	70	28	,	,	PUNCT
hls-11340	70	29	p=	p=	NOUN
hls-11340	70	30	0.096	0.096	NUM
hls-11340	70	31	(	(	PUNCT
hls-11340	70	32	tables	table	NOUN
hls-11340	70	33	1	1	NUM
hls-11340	70	34	,	,	PUNCT
hls-11340	70	35	2	2	NUM
hls-11340	70	36	)	)	PUNCT
hls-11340	70	37	.	.	PUNCT
hls-11340	71	1	the	the	DET
hls-11340	71	2	mean	mean	ADJ
hls-11340	71	3	age	age	NOUN
hls-11340	71	4	of	of	ADP
hls-11340	71	5	diabetic	diabetic	ADJ
hls-11340	71	6	patients	patient	NOUN
hls-11340	71	7	with	with	ADP
hls-11340	71	8	vitamin	vitamin	NOUN
hls-11340	71	9	d	d	NOUN
hls-11340	71	10	deficiency	deficiency	NOUN
hls-11340	71	11	was	be	AUX
hls-11340	71	12	56.7	56.7	NUM
hls-11340	71	13	±	±	NUM
hls-11340	71	14	12.9	12.9	NUM
hls-11340	71	15	years	year	NOUN
hls-11340	71	16	,	,	PUNCT
hls-11340	71	17	and	and	CCONJ
hls-11340	71	18	mean	mean	VERB
hls-11340	71	19	age	age	NOUN
hls-11340	71	20	of	of	ADP
hls-11340	71	21	diabetic	diabetic	ADJ
hls-11340	71	22	patient	patient	NOUN
hls-11340	71	23	with	with	ADP
hls-11340	71	24	normal	normal	ADJ
hls-11340	71	25	vitamin	vitamin	NOUN
hls-11340	71	26	d	d	NOUN
hls-11340	71	27	level	level	NOUN
hls-11340	71	28	was	be	AUX
hls-11340	71	29	57.3	57.3	NUM
hls-11340	71	30	±	±	NUM
hls-11340	71	31	10.6	10.6	NUM
hls-11340	71	32	years	year	NOUN
hls-11340	71	33	,	,	PUNCT
hls-11340	71	34	p=0.723	p=0.723	PUNCT
hls-11340	71	35	(	(	PUNCT
hls-11340	71	36	table	table	NOUN
hls-11340	71	37	2	2	NUM
hls-11340	71	38	)	)	PUNCT
hls-11340	71	39	.	.	PUNCT
hls-11340	72	1	mean	mean	VERB
hls-11340	72	2	vitamin	vitamin	NOUN
hls-11340	72	3	d	d	NOUN
hls-11340	72	4	level	level	NOUN
hls-11340	72	5	in	in	ADP
hls-11340	72	6	diabetic	diabetic	ADJ
hls-11340	72	7	patients	patient	NOUN
hls-11340	72	8	with	with	ADP
hls-11340	72	9	controlled	control	VERB
hls-11340	72	10	fasting	fast	VERB
hls-11340	72	11	blood	blood	NOUN
hls-11340	72	12	sugar	sugar	NOUN
hls-11340	72	13	was	be	AUX
hls-11340	72	14	32.4±14.7ng	32.4±14.7ng	NUM
hls-11340	72	15	/	/	SYM
hls-11340	72	16	ml	ml	ADP
hls-11340	72	17	,	,	PUNCT
hls-11340	72	18	while	while	SCONJ
hls-11340	72	19	the	the	DET
hls-11340	72	20	mean	mean	ADJ
hls-11340	72	21	vitamin	vitamin	NOUN
hls-11340	72	22	d	d	NOUN
hls-11340	72	23	level	level	NOUN
hls-11340	72	24	in	in	ADP
hls-11340	72	25	diabetic	diabetic	ADJ
hls-11340	72	26	patients	patient	NOUN
hls-11340	72	27	with	with	ADP
hls-11340	72	28	uncontrolled	uncontrolled	ADJ
hls-11340	72	29	fasting	fast	VERB
hls-11340	72	30	blood	blood	NOUN
hls-11340	72	31	sugar	sugar	NOUN
hls-11340	72	32	was	be	AUX
hls-11340	72	33	24.3±15.1ng	24.3±15.1ng	PROPN
hls-11340	72	34	/	/	SYM
hls-11340	72	35	ml	ml	PROPN
hls-11340	72	36	,	,	PUNCT
hls-11340	72	37	p=	p=	PROPN
hls-11340	72	38	0.003*(table	0.003*(table	ADJ
hls-11340	72	39	3	3	NUM
hls-11340	72	40	,	,	PUNCT
hls-11340	72	41	figure	figure	NOUN
hls-11340	72	42	1	1	NUM
hls-11340	72	43	)	)	PUNCT
hls-11340	72	44	.	.	PUNCT
hls-11340	73	1	the	the	DET
hls-11340	73	2	mean	mean	ADJ
hls-11340	73	3	vitamin	vitamin	NOUN
hls-11340	73	4	d	d	NOUN
hls-11340	73	5	level	level	NOUN
hls-11340	73	6	in	in	ADP
hls-11340	73	7	diabetic	diabetic	ADJ
hls-11340	73	8	patients	patient	NOUN
hls-11340	73	9	with	with	ADP
hls-11340	73	10	controlled	control	VERB
hls-11340	73	11	hba1c	hba1c	PROPN
hls-11340	73	12	level	level	NOUN
hls-11340	73	13	was	be	AUX
hls-11340	73	14	31.6±15.3ng	31.6±15.3ng	NOUN
hls-11340	73	15	/	/	SYM
hls-11340	73	16	ml	ml	NOUN
hls-11340	73	17	,	,	PUNCT
hls-11340	73	18	while	while	SCONJ
hls-11340	73	19	the	the	DET
hls-11340	73	20	mean	mean	ADJ
hls-11340	73	21	vitamin	vitamin	NOUN
hls-11340	73	22	d	d	NOUN
hls-11340	73	23	level	level	NOUN
hls-11340	73	24	in	in	ADP
hls-11340	73	25	diabetic	diabetic	ADJ
hls-11340	73	26	patients	patient	NOUN
hls-11340	73	27	with	with	ADP
hls-11340	73	28	uncontrolled	uncontrolled	ADJ
hls-11340	73	29	hba1c	hba1c	PROPN
hls-11340	73	30	level	level	NOUN
hls-11340	73	31	was	be	AUX
hls-11340	73	32	23.2±14.4ng	23.2±14.4ng	NOUN
hls-11340	73	33	/	/	SYM
hls-11340	73	34	ml	ml	NOUN
hls-11340	73	35	,	,	PUNCT
hls-11340	73	36	p=0.005	p=0.005	VERB
hls-11340	73	37	*	*	PUNCT
hls-11340	73	38	(	(	PUNCT
hls-11340	73	39	table	table	NOUN
hls-11340	73	40	3	3	NUM
hls-11340	73	41	,	,	PUNCT
hls-11340	73	42	figure	figure	NOUN
hls-11340	73	43	1	1	NUM
hls-11340	73	44	)	)	PUNCT
hls-11340	73	45	.	.	PUNCT
hls-11340	74	1	discussion	discussion	NOUN
hls-11340	74	2	vitamin	vitamin	NOUN
hls-11340	74	3	d	d	NOUN
hls-11340	74	4	deficiency	deficiency	NOUN
hls-11340	74	5	is	be	AUX
hls-11340	74	6	a	a	DET
hls-11340	74	7	common	common	ADJ
hls-11340	74	8	finding	finding	NOUN
hls-11340	74	9	in	in	ADP
hls-11340	74	10	diabetic	diabetic	ADJ
hls-11340	74	11	patients	patient	NOUN
hls-11340	74	12	,	,	PUNCT
hls-11340	74	13	and	and	CCONJ
hls-11340	74	14	prevalence	prevalence	NOUN
hls-11340	74	15	varying	vary	VERB
hls-11340	74	16	between	between	ADP
hls-11340	74	17	regions	region	NOUN
hls-11340	74	18	.	.	PUNCT
hls-11340	75	1	for	for	ADP
hls-11340	75	2	instance	instance	NOUN
hls-11340	75	3	,	,	PUNCT
hls-11340	75	4	a	a	DET
hls-11340	75	5	study	study	NOUN
hls-11340	75	6	conducted	conduct	VERB
hls-11340	75	7	in	in	ADP
hls-11340	75	8	a	a	DET
hls-11340	75	9	referral	referral	ADJ
hls-11340	75	10	hospital	hospital	NOUN
hls-11340	75	11	in	in	ADP
hls-11340	75	12	kenya	kenya	PROPN
hls-11340	75	13	reported	report	VERB
hls-11340	75	14	lower	low	ADJ
hls-11340	75	15	prevalence	prevalence	NOUN
hls-11340	75	16	rates	rate	NOUN
hls-11340	75	17	of	of	ADP
hls-11340	75	18	vitamin	vitamin	NOUN
hls-11340	75	19	d	d	NOUN
hls-11340	75	20	deficiency	deficiency	NOUN
hls-11340	75	21	and	and	CCONJ
hls-11340	75	22	insufficiency	insufficiency	NOUN
hls-11340	75	23	among	among	ADP
hls-11340	75	24	diabetic	diabetic	ADJ
hls-11340	75	25	patients	patient	NOUN
hls-11340	75	26	(	(	PUNCT
hls-11340	75	27	38.4	38.4	NUM
hls-11340	75	28	%	%	NOUN
hls-11340	75	29	and	and	CCONJ
hls-11340	75	30	21.9	21.9	NUM
hls-11340	75	31	%	%	NOUN
hls-11340	75	32	respectively	respectively	ADV
hls-11340	75	33	)	)	PUNCT
hls-11340	75	34	,	,	PUNCT
hls-11340	75	35	compared	compare	VERB
hls-11340	75	36	to	to	ADP
hls-11340	75	37	other	other	ADJ
hls-11340	75	38	countries	country	NOUN
hls-11340	75	39	in	in	ADP
hls-11340	75	40	asia	asia	PROPN
hls-11340	75	41	,	,	PUNCT
hls-11340	75	42	europe	europe	PROPN
hls-11340	75	43	,	,	PUNCT
hls-11340	75	44	and	and	CCONJ
hls-11340	75	45	north	north	NOUN
hls-11340	75	46	america.17	america.17	NOUN
hls-11340	75	47	however	however	ADV
hls-11340	75	48	,	,	PUNCT
hls-11340	75	49	in	in	ADP
hls-11340	75	50	a	a	DET
hls-11340	75	51	study	study	NOUN
hls-11340	75	52	conducted	conduct	VERB
hls-11340	75	53	in	in	ADP
hls-11340	75	54	saudi	saudi	PROPN
hls-11340	75	55	arabia	arabia	PROPN
hls-11340	75	56	found	find	VERB
hls-11340	75	57	higher	high	ADJ
hls-11340	75	58	rates	rate	NOUN
hls-11340	75	59	of	of	ADP
hls-11340	75	60	prevalence	prevalence	NOUN
hls-11340	75	61	of	of	ADP
hls-11340	75	62	vitamin	vitamin	NOUN
hls-11340	75	63	d	d	NOUN
hls-11340	75	64	deficiency	deficiency	NOUN
hls-11340	75	65	(	(	PUNCT
hls-11340	75	66	59.8	59.8	NUM
hls-11340	75	67	%	%	NOUN
hls-11340	75	68	)	)	PUNCT
hls-11340	75	69	and	and	CCONJ
hls-11340	75	70	insufficiency	insufficiency	NOUN
hls-11340	75	71	(	(	PUNCT
hls-11340	75	72	38.6	38.6	NUM
hls-11340	75	73	%	%	NOUN
hls-11340	75	74	)	)	PUNCT
hls-11340	75	75	among	among	ADP
hls-11340	75	76	diabetic	diabetic	ADJ
hls-11340	75	77	patients	patient	NOUN
hls-11340	75	78	,	,	PUNCT
hls-11340	75	79	which	which	PRON
hls-11340	75	80	is	be	AUX
hls-11340	75	81	similar	similar	ADJ
hls-11340	75	82	to	to	ADP
hls-11340	75	83	our	our	PRON
hls-11340	75	84	findings	finding	NOUN
hls-11340	75	85	where	where	SCONJ
hls-11340	75	86	60	60	NUM
hls-11340	75	87	%	%	NOUN
hls-11340	75	88	of	of	ADP
hls-11340	75	89	diabetic	diabetic	ADJ
hls-11340	75	90	patients	patient	NOUN
hls-11340	75	91	were	be	AUX
hls-11340	75	92	vitamin	vitamin	NOUN
hls-11340	75	93	d	d	X
hls-11340	75	94	deficient.18	deficient.18	NOUN
hls-11340	75	95	gender	gender	NOUN
hls-11340	75	96	may	may	AUX
hls-11340	75	97	also	also	ADV
hls-11340	75	98	play	play	VERB
hls-11340	75	99	a	a	DET
hls-11340	75	100	role	role	NOUN
hls-11340	75	101	in	in	ADP
hls-11340	75	102	the	the	DET
hls-11340	75	103	prevalence	prevalence	NOUN
hls-11340	75	104	of	of	ADP
hls-11340	75	105	vitamin	vitamin	NOUN
hls-11340	75	106	d	d	NOUN
hls-11340	75	107	deficiency	deficiency	NOUN
hls-11340	75	108	among	among	ADP
hls-11340	75	109	diabetic	diabetic	ADJ
hls-11340	75	110	patients	patient	NOUN
hls-11340	75	111	,	,	PUNCT
hls-11340	75	112	as	as	SCONJ
hls-11340	75	113	recent	recent	ADJ
hls-11340	75	114	research	research	NOUN
hls-11340	75	115	has	have	AUX
hls-11340	75	116	shown	show	VERB
hls-11340	75	117	that	that	SCONJ
hls-11340	75	118	female	female	ADJ
hls-11340	75	119	diabetic	diabetic	ADJ
hls-11340	75	120	patients	patient	NOUN
hls-11340	75	121	are	be	AUX
hls-11340	75	122	more	more	ADV
hls-11340	75	123	deficient	deficient	ADJ
hls-11340	75	124	in	in	ADP
hls-11340	75	125	vitamin	vitamin	NOUN
hls-11340	75	126	d	d	NOUN
hls-11340	75	127	than	than	ADP
hls-11340	75	128	male	male	ADJ
hls-11340	75	129	diabetic	diabetic	ADJ
hls-11340	75	130	patients.19	patients.19	NOUN
hls-11340	75	131	in	in	ADP
hls-11340	75	132	our	our	PRON
hls-11340	75	133	study	study	NOUN
hls-11340	75	134	,	,	PUNCT
hls-11340	75	135	we	we	PRON
hls-11340	75	136	found	find	VERB
hls-11340	75	137	that	that	SCONJ
hls-11340	75	138	53.3	53.3	NUM
hls-11340	75	139	%	%	NOUN
hls-11340	75	140	of	of	ADP
hls-11340	75	141	female	female	ADJ
hls-11340	75	142	diabetic	diabetic	ADJ
hls-11340	75	143	patients	patient	NOUN
hls-11340	75	144	were	be	AUX
hls-11340	75	145	vitamin	vitamin	ADJ
hls-11340	75	146	d	d	X
hls-11340	75	147	deficient	deficient	ADJ
hls-11340	75	148	,	,	PUNCT
hls-11340	75	149	while	while	SCONJ
hls-11340	75	150	46.7	46.7	NUM
hls-11340	75	151	%	%	NOUN
hls-11340	75	152	of	of	ADP
hls-11340	75	153	the	the	DET
hls-11340	75	154	male	male	ADJ
hls-11340	75	155	diabetic	diabetic	ADJ
hls-11340	75	156	patients	patient	NOUN
hls-11340	75	157	were	be	AUX
hls-11340	75	158	deficient	deficient	ADJ
hls-11340	75	159	,	,	PUNCT
hls-11340	75	160	but	but	CCONJ
hls-11340	75	161	this	this	PRON
hls-11340	75	162	was	be	AUX
hls-11340	75	163	not	not	PART
hls-11340	75	164	statistically	statistically	ADV
hls-11340	75	165	significant	significant	ADJ
hls-11340	75	166	.	.	PUNCT
hls-11340	76	1	the	the	DET
hls-11340	76	2	difference	difference	NOUN
hls-11340	76	3	may	may	AUX
hls-11340	76	4	be	be	AUX
hls-11340	76	5	attributed	attribute	VERB
hls-11340	76	6	to	to	ADP
hls-11340	76	7	factors	factor	NOUN
hls-11340	76	8	such	such	ADJ
hls-11340	76	9	as	as	ADP
hls-11340	76	10	poor	poor	ADJ
hls-11340	76	11	sun	sun	NOUN
hls-11340	76	12	exposure	exposure	NOUN
hls-11340	76	13	,	,	PUNCT
hls-11340	76	14	poor	poor	ADJ
hls-11340	76	15	dietary	dietary	ADJ
hls-11340	76	16	vitamin	vitamin	NOUN
hls-11340	76	17	d	d	NOUN
hls-11340	76	18	,	,	PUNCT
hls-11340	76	19	obesity	obesity	NOUN
hls-11340	76	20	and	and	CCONJ
hls-11340	76	21	sedentary	sedentary	ADJ
hls-11340	76	22	life	life	NOUN
hls-11340	76	23	in	in	ADP
hls-11340	76	24	middle	middle	PROPN
hls-11340	76	25	east	east	PROPN
hls-11340	76	26	females	female	NOUN
hls-11340	76	27	.	.	PUNCT
hls-11340	77	1	in	in	ADP
hls-11340	77	2	addition	addition	NOUN
hls-11340	77	3	,	,	PUNCT
hls-11340	77	4	elderly	elderly	ADJ
hls-11340	77	5	people	people	NOUN
hls-11340	77	6	,	,	PUNCT
hls-11340	77	7	including	include	VERB
hls-11340	77	8	diabetic	diabetic	ADJ
hls-11340	77	9	patients	patient	NOUN
hls-11340	77	10	,	,	PUNCT
hls-11340	77	11	are	be	AUX
hls-11340	77	12	more	more	ADV
hls-11340	77	13	susceptible	susceptible	ADJ
hls-11340	77	14	to	to	ADP
hls-11340	77	15	vitamin	vitamin	NOUN
hls-11340	77	16	d	d	NOUN
hls-11340	77	17	deficiency	deficiency	NOUN
hls-11340	77	18	,	,	PUNCT
hls-11340	77	19	especially	especially	ADV
hls-11340	77	20	in	in	ADP
hls-11340	77	21	european	european	ADJ
hls-11340	77	22	countries	country	NOUN
hls-11340	77	23	with	with	ADP
hls-11340	77	24	low	low	ADJ
hls-11340	77	25	sun	sun	NOUN
hls-11340	77	26	exposure	exposure	NOUN
hls-11340	77	27	,	,	PUNCT
hls-11340	77	28	decreased	decrease	VERB
hls-11340	77	29	synthesis	synthesis	NOUN
hls-11340	77	30	,	,	PUNCT
hls-11340	77	31	absorption	absorption	NOUN
hls-11340	77	32	,	,	PUNCT
hls-11340	77	33	and	and	CCONJ
hls-11340	77	34	metabolism	metabolism	NOUN
hls-11340	77	35	because	because	SCONJ
hls-11340	77	36	of	of	ADP
hls-11340	77	37	aging.17	aging.17	PROPN
hls-11340	77	38	however	however	ADV
hls-11340	77	39	,	,	PUNCT
hls-11340	77	40	in	in	ADP
hls-11340	77	41	our	our	PRON
hls-11340	77	42	study	study	NOUN
hls-11340	77	43	,	,	PUNCT
hls-11340	77	44	there	there	PRON
hls-11340	77	45	was	be	VERB
hls-11340	77	46	no	no	DET
hls-11340	77	47	significant	significant	ADJ
hls-11340	77	48	difference	difference	NOUN
hls-11340	77	49	in	in	ADP
hls-11340	77	50	the	the	DET
hls-11340	77	51	mean	mean	ADJ
hls-11340	77	52	age	age	NOUN
hls-11340	77	53	between	between	ADP
hls-11340	77	54	diabetic	diabetic	ADJ
hls-11340	77	55	patients	patient	NOUN
hls-11340	77	56	with	with	ADP
hls-11340	77	57	or	or	CCONJ
hls-11340	77	58	without	without	ADP
hls-11340	77	59	vitamin	vitamin	NOUN
hls-11340	77	60	d	d	NOUN
hls-11340	77	61	deficiency	deficiency	NOUN
hls-11340	77	62	,	,	PUNCT
hls-11340	77	63	probably	probably	ADV
hls-11340	77	64	because	because	SCONJ
hls-11340	77	65	the	the	DET
hls-11340	77	66	study	study	NOUN
hls-11340	77	67	population	population	NOUN
hls-11340	77	68	had	have	AUX
hls-11340	77	69	mean	mean	VERB
hls-11340	77	70	age	age	NOUN
hls-11340	77	71	of	of	ADP
hls-11340	77	72	56.7	56.7	NUM
hls-11340	77	73	years	year	NOUN
hls-11340	77	74	,	,	PUNCT
hls-11340	77	75	and	and	CCONJ
hls-11340	77	76	diabetes	diabetes	NOUN
hls-11340	77	77	is	be	AUX
hls-11340	77	78	more	more	ADV
hls-11340	77	79	common	common	ADJ
hls-11340	77	80	in	in	ADP
hls-11340	77	81	old	old	ADJ
hls-11340	77	82	age	age	NOUN
hls-11340	77	83	group	group	NOUN
hls-11340	77	84	.	.	PUNCT
hls-11340	78	1	as	as	SCONJ
hls-11340	78	2	diabetes	diabetes	NOUN
hls-11340	78	3	continues	continue	VERB
hls-11340	78	4	to	to	PART
hls-11340	78	5	pose	pose	VERB
hls-11340	78	6	a	a	DET
hls-11340	78	7	major	major	ADJ
hls-11340	78	8	health	health	NOUN
hls-11340	78	9	problem	problem	NOUN
hls-11340	78	10	,	,	PUNCT
hls-11340	78	11	researchers	researcher	NOUN
hls-11340	78	12	have	have	AUX
hls-11340	78	13	explored	explore	VERB
hls-11340	78	14	other	other	ADJ
hls-11340	78	15	pathogenic	pathogenic	ADJ
hls-11340	78	16	mechanisms	mechanism	NOUN
hls-11340	78	17	that	that	PRON
hls-11340	78	18	contribute	contribute	VERB
hls-11340	78	19	to	to	ADP
hls-11340	78	20	its	its	PRON
hls-11340	78	21	development	development	NOUN
hls-11340	78	22	and	and	CCONJ
hls-11340	78	23	progression	progression	NOUN
hls-11340	78	24	,	,	PUNCT
hls-11340	78	25	such	such	ADJ
hls-11340	78	26	as	as	ADP
hls-11340	78	27	the	the	DET
hls-11340	78	28	relationship	relationship	NOUN
hls-11340	78	29	between	between	ADP
hls-11340	78	30	vitamin	vitamin	NOUN
hls-11340	78	31	d	d	NOUN
hls-11340	78	32	deficiency	deficiency	NOUN
hls-11340	78	33	and	and	CCONJ
hls-11340	78	34	progression	progression	NOUN
hls-11340	78	35	of	of	ADP
hls-11340	78	36	diabetes	diabetes	NOUN
hls-11340	78	37	.	.	PUNCT
hls-11340	79	1	this	this	PRON
hls-11340	79	2	is	be	AUX
hls-11340	79	3	due	due	ADJ
hls-11340	79	4	to	to	ADP
hls-11340	79	5	the	the	DET
hls-11340	79	6	presence	presence	NOUN
hls-11340	79	7	of	of	ADP
hls-11340	79	8	vitamin	vitamin	NOUN
hls-11340	79	9	d	d	NOUN
hls-11340	79	10	receptors	receptor	NOUN
hls-11340	79	11	in	in	ADP
hls-11340	79	12	pancreatic	pancreatic	ADJ
hls-11340	79	13	b	b	NOUN
hls-11340	79	14	cells	cell	NOUN
hls-11340	79	15	and	and	CCONJ
hls-11340	79	16	other	other	ADJ
hls-11340	79	17	tissues	tissue	NOUN
hls-11340	79	18	such	such	ADJ
hls-11340	79	19	as	as	ADP
hls-11340	79	20	liver	liver	NOUN
hls-11340	79	21	and	and	CCONJ
hls-11340	79	22	muscle	muscle	NOUN
hls-11340	79	23	tissue	tissue	NOUN
hls-11340	79	24	,	,	PUNCT
hls-11340	79	25	suggesting	suggest	VERB
hls-11340	79	26	that	that	SCONJ
hls-11340	79	27	vitamin	vitamin	NOUN
hls-11340	79	28	d	d	NOUN
hls-11340	79	29	may	may	AUX
hls-11340	79	30	be	be	AUX
hls-11340	79	31	involved	involve	VERB
hls-11340	79	32	in	in	ADP
hls-11340	79	33	glucose	glucose	NOUN
hls-11340	79	34	homeostasis.20	homeostasis.20	PROPN
hls-11340	79	35	studies	study	NOUN
hls-11340	79	36	have	have	AUX
hls-11340	79	37	shown	show	VERB
hls-11340	79	38	that	that	DET
hls-11340	79	39	optimum	optimum	ADJ
hls-11340	79	40	level	level	NOUN
hls-11340	79	41	of	of	ADP
hls-11340	79	42	vitamin	vitamin	NOUN
hls-11340	79	43	d	d	NOUN
hls-11340	79	44	in	in	ADP
hls-11340	79	45	serum	serum	NOUN
hls-11340	79	46	reduces	reduce	VERB
hls-11340	79	47	insulin	insulin	NOUN
hls-11340	79	48	resistance	resistance	NOUN
hls-11340	79	49	,	,	PUNCT
hls-11340	79	50	and	and	CCONJ
hls-11340	79	51	hba1c	hba1c	PROPN
hls-11340	79	52	level	level	NOUN
hls-11340	79	53	and	and	CCONJ
hls-11340	79	54	leading	lead	VERB
hls-11340	79	55	to	to	ADP
hls-11340	79	56	more	more	ADJ
hls-11340	79	57	control	control	NOUN
hls-11340	79	58	of	of	ADP
hls-11340	79	59	hyperglycemia.21	hyperglycemia.21	NOUN
hls-11340	79	60	in	in	ADP
hls-11340	79	61	another	another	DET
hls-11340	79	62	case	case	NOUN
hls-11340	79	63	control	control	NOUN
hls-11340	79	64	study	study	NOUN
hls-11340	79	65	,	,	PUNCT
hls-11340	79	66	hba1c	hba1c	PROPN
hls-11340	79	67	found	find	VERB
hls-11340	79	68	to	to	PART
hls-11340	79	69	be	be	AUX
hls-11340	79	70	higher	high	ADJ
hls-11340	79	71	in	in	ADP
hls-11340	79	72	the	the	DET
hls-11340	79	73	group	group	NOUN
hls-11340	79	74	with	with	ADP
hls-11340	79	75	vitamin	vitamin	NOUN
hls-11340	79	76	d	d	NOUN
hls-11340	79	77	deficiency	deficiency	NOUN
hls-11340	79	78	than	than	ADP
hls-11340	79	79	the	the	DET
hls-11340	79	80	group	group	NOUN
hls-11340	79	81	with	with	ADP
hls-11340	79	82	no	no	DET
hls-11340	79	83	vitamin	vitamin	NOUN
hls-11340	79	84	d	d	NOUN
hls-11340	79	85	deficiency.22	deficiency.22	NOUN
hls-11340	79	86	a	a	DET
hls-11340	79	87	recent	recent	ADJ
hls-11340	79	88	study	study	NOUN
hls-11340	79	89	done	do	VERB
hls-11340	79	90	by	by	ADP
hls-11340	79	91	erkus	erkus	PROPN
hls-11340	79	92	e	e	PROPN
hls-11340	79	93	,	,	PUNCT
hls-11340	79	94	et	et	PROPN
hls-11340	79	95	al	al	PROPN
hls-11340	79	96	.	.	PROPN
hls-11340	79	97	involved	involve	VERB
hls-11340	79	98	a	a	DET
hls-11340	79	99	controlled	control	VERB
hls-11340	79	100	group	group	NOUN
hls-11340	79	101	of	of	ADP
hls-11340	79	102	diabetic	diabetic	ADJ
hls-11340	79	103	patients	patient	NOUN
hls-11340	79	104	and	and	CCONJ
hls-11340	79	105	uncontrolled	uncontrolled	ADJ
hls-11340	79	106	group	group	NOUN
hls-11340	79	107	,	,	PUNCT
hls-11340	79	108	assessing	assess	VERB
hls-11340	79	109	vitamin	vitamin	NOUN
hls-11340	79	110	d	d	NOUN
hls-11340	79	111	levels	level	NOUN
hls-11340	79	112	in	in	ADP
hls-11340	79	113	both	both	DET
hls-11340	79	114	controlled	controlled	ADJ
hls-11340	79	115	and	and	CCONJ
hls-11340	79	116	uncontrolled	uncontrolled	ADJ
hls-11340	79	117	groups	group	NOUN
hls-11340	79	118	.	.	PUNCT
hls-11340	80	1	they	they	PRON
hls-11340	80	2	found	find	VERB
hls-11340	80	3	that	that	SCONJ
hls-11340	80	4	vitamin	vitamin	NOUN
hls-11340	80	5	d	d	NOUN
hls-11340	80	6	levels	level	NOUN
hls-11340	80	7	were	be	AUX
hls-11340	80	8	much	much	ADV
hls-11340	80	9	lower	low	ADJ
hls-11340	80	10	in	in	ADP
hls-11340	80	11	the	the	DET
hls-11340	80	12	uncontrolled	uncontrolled	ADJ
hls-11340	80	13	group	group	NOUN
hls-11340	80	14	of	of	ADP
hls-11340	80	15	patients	patient	NOUN
hls-11340	80	16	and	and	CCONJ
hls-11340	80	17	suggested	suggest	VERB
hls-11340	80	18	that	that	SCONJ
hls-11340	80	19	vitamin	vitamin	NOUN
hls-11340	80	20	d	d	NOUN
hls-11340	80	21	could	could	AUX
hls-11340	80	22	be	be	AUX
hls-11340	80	23	used	use	VERB
hls-11340	80	24	as	as	ADP
hls-11340	80	25	a	a	DET
hls-11340	80	26	treatment	treatment	NOUN
hls-11340	80	27	modality	modality	NOUN
hls-11340	80	28	for	for	ADP
hls-11340	80	29	diabetes	diabetes	NOUN
hls-11340	80	30	in	in	ADP
hls-11340	80	31	the	the	DET
hls-11340	80	32	future.23	future.23	NOUN
hls-11340	80	33	another	another	DET
hls-11340	80	34	interventional	interventional	ADJ
hls-11340	80	35	study	study	NOUN
hls-11340	80	36	used	use	VERB
hls-11340	80	37	a	a	DET
hls-11340	80	38	vitamin	vitamin	NOUN
hls-11340	80	39	d	d	NOUN
hls-11340	80	40	supplement	supplement	VERB
hls-11340	80	41	4500	4500	NUM
hls-11340	80	42	iu	iu	NOUN
hls-11340	80	43	/	/	SYM
hls-11340	80	44	day	day	NOUN
hls-11340	80	45	for	for	ADP
hls-11340	80	46	2	2	NUM
hls-11340	80	47	months	month	NOUN
hls-11340	80	48	and	and	CCONJ
hls-11340	80	49	assessed	assess	VERB
hls-11340	80	50	fasting	fast	VERB
hls-11340	80	51	blood	blood	NOUN
hls-11340	80	52	sugar	sugar	NOUN
hls-11340	80	53	and	and	CCONJ
hls-11340	80	54	hba1c	hba1c	PROPN
hls-11340	80	55	at	at	ADP
hls-11340	80	56	baseline	baseline	NOUN
hls-11340	80	57	and	and	CCONJ
hls-11340	80	58	after	after	SCONJ
hls-11340	80	59	giving	give	VERB
hls-11340	80	60	the	the	DET
hls-11340	80	61	supplement	supplement	NOUN
hls-11340	80	62	was	be	AUX
hls-11340	80	63	given	give	VERB
hls-11340	80	64	.	.	PUNCT
hls-11340	81	1	they	they	PRON
hls-11340	81	2	found	find	VERB
hls-11340	81	3	a	a	DET
hls-11340	81	4	reduction	reduction	NOUN
hls-11340	81	5	in	in	ADP
hls-11340	81	6	fasting	fast	VERB
hls-11340	81	7	blood	blood	NOUN
hls-11340	81	8	sugar	sugar	NOUN
hls-11340	81	9	from	from	ADP
hls-11340	81	10	a	a	DET
hls-11340	81	11	mean	mean	NOUN
hls-11340	81	12	of	of	ADP
hls-11340	81	13	133	133	NUM
hls-11340	81	14	mg	mg	PROPN
hls-11340	81	15	/	/	SYM
hls-11340	81	16	dl	dl	PROPN
hls-11340	81	17	to	to	PART
hls-11340	81	18	mean	mean	VERB
hls-11340	81	19	of	of	ADP
hls-11340	81	20	127	127	NUM
hls-11340	81	21	mg	mg	PROPN
hls-11340	81	22	/	/	SYM
hls-11340	81	23	dl	dl	PROPN
hls-11340	81	24	and	and	CCONJ
hls-11340	81	25	reduction	reduction	NOUN
hls-11340	81	26	of	of	ADP
hls-11340	81	27	mean	mean	PROPN
hls-11340	81	28	hba1c	hba1c	PROPN
hls-11340	81	29	from	from	ADP
hls-11340	81	30	7.7	7.7	NUM
hls-11340	81	31	%	%	NOUN
hls-11340	81	32	to	to	ADP
hls-11340	81	33	7.2%.24	7.2%.24	NUM
hls-11340	81	34	in	in	ADP
hls-11340	81	35	a	a	DET
hls-11340	81	36	double	double	ADJ
hls-11340	81	37	-	-	PUNCT
hls-11340	81	38	blind	blind	ADJ
hls-11340	81	39	,	,	PUNCT
hls-11340	81	40	placebocontrolled	placebocontrolle	VERB
hls-11340	81	41	study	study	NOUN
hls-11340	81	42	conducted	conduct	VERB
hls-11340	81	43	by	by	ADP
hls-11340	81	44	lemieux	lemieux	PROPN
hls-11340	81	45	et	et	PROPN
hls-11340	81	46	al	al	PROPN
hls-11340	81	47	.	.	PROPN
hls-11340	81	48	,25	,25	PUNCT
hls-11340	81	49	on	on	ADP
hls-11340	81	50	96	96	NUM
hls-11340	81	51	subjects	subject	NOUN
hls-11340	81	52	at	at	ADP
hls-11340	81	53	risk	risk	NOUN
hls-11340	81	54	to	to	PART
hls-11340	81	55	develop	develop	VERB
hls-11340	81	56	diabetes	diabetes	NOUN
hls-11340	81	57	or	or	CCONJ
hls-11340	81	58	with	with	ADP
hls-11340	81	59	early	early	ADJ
hls-11340	81	60	diabetes	diabetes	NOUN
hls-11340	81	61	,	,	PUNCT
hls-11340	81	62	they	they	PRON
hls-11340	81	63	found	find	VERB
hls-11340	81	64	a	a	DET
hls-11340	81	65	significant	significant	ADJ
hls-11340	81	66	increase	increase	NOUN
hls-11340	81	67	in	in	ADP
hls-11340	81	68	peripheral	peripheral	ADJ
hls-11340	81	69	insulin	insulin	NOUN
hls-11340	81	70	sensitivity	sensitivity	NOUN
hls-11340	81	71	and	and	CCONJ
hls-11340	81	72	b	b	NOUN
hls-11340	81	73	cell	cell	NOUN
hls-11340	81	74	function	function	NOUN
hls-11340	81	75	after	after	ADP
hls-11340	81	76	administrating	administrate	VERB
hls-11340	81	77	5000	5000	NUM
hls-11340	81	78	iu	iu	ADP
hls-11340	81	79	vitamin	vitamin	NOUN
hls-11340	81	80	d	d	PROPN
hls-11340	81	81	daily	daily	ADV
hls-11340	81	82	for	for	ADP
hls-11340	81	83	6	6	NUM
hls-11340	81	84	months	month	NOUN
hls-11340	81	85	.	.	PUNCT
hls-11340	82	1	however	however	ADV
hls-11340	82	2	,	,	PUNCT
hls-11340	82	3	some	some	DET
hls-11340	82	4	authors	author	NOUN
hls-11340	82	5	,	,	PUNCT
hls-11340	82	6	such	such	ADJ
hls-11340	82	7	as	as	ADP
hls-11340	82	8	kumar	kumar	PROPN
hls-11340	82	9	et	et	PROPN
hls-11340	82	10	al.26	al.26	VERB
hls-11340	82	11	in	in	ADP
hls-11340	82	12	a	a	DET
hls-11340	82	13	retrospective	retrospective	ADJ
hls-11340	82	14	case	case	NOUN
hls-11340	82	15	-	-	PUNCT
hls-11340	82	16	control	control	NOUN
hls-11340	82	17	study	study	NOUN
hls-11340	82	18	,	,	PUNCT
hls-11340	82	19	did	do	AUX
hls-11340	82	20	not	not	PART
hls-11340	82	21	find	find	VERB
hls-11340	82	22	any	any	DET
hls-11340	82	23	relation	relation	NOUN
hls-11340	82	24	between	between	ADP
hls-11340	82	25	vitamin	vitamin	NOUN
hls-11340	82	26	d	d	NOUN
hls-11340	82	27	deficiency	deficiency	NOUN
hls-11340	82	28	and	and	CCONJ
hls-11340	82	29	glycemic	glycemic	ADJ
hls-11340	82	30	control	control	NOUN
hls-11340	82	31	.	.	PUNCT
hls-11340	83	1	they	they	PRON
hls-11340	83	2	evaluate	evaluate	VERB
hls-11340	83	3	78	78	NUM
hls-11340	83	4	cases	case	NOUN
hls-11340	83	5	and	and	CCONJ
hls-11340	83	6	69	69	NUM
hls-11340	83	7	controls	control	NOUN
hls-11340	83	8	for	for	ADP
hls-11340	83	9	vitamin	vitamin	NOUN
hls-11340	83	10	d	d	NOUN
hls-11340	83	11	and	and	CCONJ
hls-11340	83	12	hba1c	hba1c	PROPN
hls-11340	83	13	levels	level	NOUN
hls-11340	83	14	and	and	CCONJ
hls-11340	83	15	found	find	VERB
hls-11340	83	16	no	no	DET
hls-11340	83	17	significant	significant	ADJ
hls-11340	83	18	correlation	correlation	NOUN
hls-11340	83	19	between	between	ADP
hls-11340	83	20	them	they	PRON
hls-11340	83	21	.	.	PUNCT
hls-11340	84	1	in	in	ADP
hls-11340	84	2	our	our	PRON
hls-11340	84	3	study	study	NOUN
hls-11340	84	4	,	,	PUNCT
hls-11340	84	5	we	we	PRON
hls-11340	84	6	found	find	VERB
hls-11340	84	7	that	that	SCONJ
hls-11340	84	8	the	the	DET
hls-11340	84	9	mean	mean	ADJ
hls-11340	84	10	vitamin	vitamin	NOUN
hls-11340	84	11	d	d	NOUN
hls-11340	84	12	level	level	NOUN
hls-11340	84	13	was	be	AUX
hls-11340	84	14	32.4ng	32.4ng	NUM
hls-11340	84	15	/	/	SYM
hls-11340	84	16	ml	ml	X
hls-11340	84	17	in	in	ADP
hls-11340	84	18	patients	patient	NOUN
hls-11340	84	19	with	with	ADP
hls-11340	84	20	controlled	control	VERB
hls-11340	84	21	fasting	fast	VERB
hls-11340	84	22	blood	blood	NOUN
hls-11340	84	23	sugar	sugar	NOUN
hls-11340	84	24	,	,	PUNCT
hls-11340	84	25	while	while	SCONJ
hls-11340	84	26	it	it	PRON
hls-11340	84	27	was	be	AUX
hls-11340	84	28	24.3ng	24.3ng	NUM
hls-11340	84	29	/	/	SYM
hls-11340	84	30	ml	ml	NOUN
hls-11340	84	31	in	in	ADP
hls-11340	84	32	patients	patient	NOUN
hls-11340	84	33	with	with	ADP
hls-11340	84	34	uncontrolled	uncontrolled	ADJ
hls-11340	84	35	fasting	fast	VERB
hls-11340	84	36	blood	blood	NOUN
hls-11340	84	37	sugar	sugar	NOUN
hls-11340	84	38	levels	level	NOUN
hls-11340	84	39	.	.	PUNCT
hls-11340	85	1	regarding	regard	VERB
hls-11340	85	2	hba1c	hba1c	PROPN
hls-11340	85	3	,	,	PUNCT
hls-11340	85	4	the	the	DET
hls-11340	85	5	mean	mean	ADJ
hls-11340	85	6	vitamin	vitamin	NOUN
hls-11340	85	7	level	level	NOUN
hls-11340	85	8	was	be	AUX
hls-11340	85	9	31.6ng	31.6ng	NOUN
hls-11340	85	10	/	/	SYM
hls-11340	85	11	ml	ml	X
hls-11340	85	12	in	in	ADP
hls-11340	85	13	patients	patient	NOUN
hls-11340	85	14	with	with	ADP
hls-11340	85	15	values	value	NOUN
hls-11340	85	16	≤	≤	NUM
hls-11340	85	17	7	7	NUM
hls-11340	85	18	and	and	CCONJ
hls-11340	85	19	23.2ng	23.2ng	NUM
hls-11340	85	20	/	/	SYM
hls-11340	85	21	ml	ml	X
hls-11340	85	22	in	in	ADP
hls-11340	85	23	patients	patient	NOUN
hls-11340	85	24	with	with	ADP
hls-11340	85	25	hba1c	hba1c	PROPN
hls-11340	85	26	values	value	NOUN
hls-11340	85	27	>	>	X
hls-11340	85	28	7	7	X
hls-11340	85	29	.	.	PUNCT
hls-11340	86	1	these	these	DET
hls-11340	86	2	results	result	NOUN
hls-11340	86	3	suggest	suggest	VERB
hls-11340	86	4	that	that	SCONJ
hls-11340	86	5	vitamin	vitamin	NOUN
hls-11340	86	6	d	d	NOUN
hls-11340	86	7	deficiency	deficiency	NOUN
hls-11340	86	8	is	be	AUX
hls-11340	86	9	associated	associate	VERB
hls-11340	86	10	with	with	ADP
hls-11340	86	11	higher	high	ADJ
hls-11340	86	12	levels	level	NOUN
hls-11340	86	13	of	of	ADP
hls-11340	86	14	fasting	fast	VERB
hls-11340	86	15	blood	blood	NOUN
hls-11340	86	16	sugar	sugar	NOUN
hls-11340	86	17	and	and	CCONJ
hls-11340	86	18	hba1c	hba1c	PROPN
hls-11340	86	19	.	.	PUNCT
hls-11340	87	1	these	these	DET
hls-11340	87	2	results	result	NOUN
hls-11340	87	3	may	may	AUX
hls-11340	87	4	be	be	AUX
hls-11340	87	5	attributed	attribute	VERB
hls-11340	87	6	to	to	ADP
hls-11340	87	7	the	the	DET
hls-11340	87	8	postulated	postulate	VERB
hls-11340	87	9	role	role	NOUN
hls-11340	87	10	of	of	ADP
hls-11340	87	11	vitamin	vitamin	NOUN
hls-11340	87	12	d	d	NOUN
hls-11340	87	13	in	in	ADP
hls-11340	87	14	glycemic	glycemic	ADJ
hls-11340	87	15	control	control	NOUN
hls-11340	87	16	where	where	SCONJ
hls-11340	87	17	it	it	PRON
hls-11340	87	18	reduces	reduce	VERB
hls-11340	87	19	systemic	systemic	ADJ
hls-11340	87	20	inflammation	inflammation	NOUN
hls-11340	87	21	by	by	ADP
hls-11340	87	22	modulating	modulate	VERB
hls-11340	87	23	the	the	DET
hls-11340	87	24	immune	immune	ADJ
hls-11340	87	25	response	response	NOUN
hls-11340	87	26	and	and	CCONJ
hls-11340	87	27	decreasing	decrease	VERB
hls-11340	87	28	insulin	insulin	NOUN
hls-11340	87	29	resistance	resistance	NOUN
hls-11340	87	30	at	at	ADP
hls-11340	87	31	the	the	DET
hls-11340	87	32	peripheral	peripheral	ADJ
hls-11340	87	33	tissue.27	tissue.27	PROPN
hls-11340	87	34	moreover	moreover	ADV
hls-11340	87	35	,	,	PUNCT
hls-11340	87	36	vitamin	vitamin	NOUN
hls-11340	87	37	d	d	NOUN
hls-11340	87	38	increases	increase	VERB
hls-11340	87	39	insulin	insulin	NOUN
hls-11340	87	40	secretion	secretion	NOUN
hls-11340	87	41	via	via	ADP
hls-11340	87	42	direct	direct	ADJ
hls-11340	87	43	mechanism	mechanism	NOUN
hls-11340	87	44	in	in	ADP
hls-11340	87	45	which	which	PRON
hls-11340	87	46	it	it	PRON
hls-11340	87	47	increases	increase	VERB
hls-11340	87	48	intracellular	intracellular	ADJ
hls-11340	87	49	calcium	calcium	NOUN
hls-11340	87	50	through	through	ADP
hls-11340	87	51	calcium	calcium	NOUN
hls-11340	87	52	channel	channel	NOUN
hls-11340	87	53	leading	lead	VERB
hls-11340	87	54	to	to	PART
hls-11340	87	55	increase	increase	VERB
hls-11340	87	56	insulin	insulin	NOUN
hls-11340	87	57	secretion	secretion	NOUN
hls-11340	87	58	or	or	CCONJ
hls-11340	87	59	indirectly	indirectly	ADV
hls-11340	87	60	through	through	ADP
hls-11340	87	61	mediating	mediate	VERB
hls-11340	87	62	bcell	bcell	NOUN
hls-11340	87	63	calcium	calcium	NOUN
hls-11340	87	64	–	–	PUNCT
hls-11340	87	65	dependent	dependent	ADJ
hls-11340	87	66	activation	activation	NOUN
hls-11340	87	67	which	which	PRON
hls-11340	87	68	enhance	enhance	VERB
hls-11340	87	69	conversion	conversion	NOUN
hls-11340	87	70	of	of	ADP
hls-11340	87	71	pro	pro	ADJ
hls-11340	87	72	insulin	insulin	NOUN
hls-11340	87	73	to	to	PART
hls-11340	87	74	insulin.28	insulin.28	VERB
hls-11340	87	75	these	these	DET
hls-11340	87	76	results	result	NOUN
hls-11340	87	77	lead	lead	VERB
hls-11340	87	78	us	we	PRON
hls-11340	87	79	to	to	PART
hls-11340	87	80	consider	consider	VERB
hls-11340	87	81	evaluation	evaluation	NOUN
hls-11340	87	82	of	of	ADP
hls-11340	87	83	vitamin	vitamin	NOUN
hls-11340	87	84	d	d	NOUN
hls-11340	87	85	in	in	ADP
hls-11340	87	86	diabetic	diabetic	ADJ
hls-11340	87	87	patients	patient	NOUN
hls-11340	87	88	and	and	CCONJ
hls-11340	87	89	to	to	PART
hls-11340	87	90	correct	correct	VERB
hls-11340	87	91	the	the	DET
hls-11340	87	92	deficiency	deficiency	NOUN
hls-11340	87	93	if	if	SCONJ
hls-11340	87	94	present	present	ADJ
hls-11340	87	95	,	,	PUNCT
hls-11340	87	96	together	together	ADV
hls-11340	87	97	with	with	ADP
hls-11340	87	98	optimizing	optimize	VERB
hls-11340	87	99	diet	diet	NOUN
hls-11340	87	100	,	,	PUNCT
hls-11340	87	101	exercise	exercise	NOUN
hls-11340	87	102	and	and	CCONJ
hls-11340	87	103	medications	medication	NOUN
hls-11340	87	104	for	for	ADP
hls-11340	87	105	better	well	ADJ
hls-11340	87	106	glycemic	glycemic	ADJ
hls-11340	87	107	control	control	NOUN
hls-11340	87	108	.	.	PUNCT
hls-11340	88	1	article	article	NOUN
hls-11340	88	2	[	[	X
hls-11340	88	3	page	page	NOUN
hls-11340	88	4	10	10	NUM
hls-11340	88	5	]	]	PUNCT
hls-11340	89	1	[	[	X
hls-11340	89	2	healthcare	healthcare	NOUN
hls-11340	89	3	in	in	ADP
hls-11340	89	4	low	low	ADJ
hls-11340	89	5	-	-	PUNCT
hls-11340	89	6	resource	resource	NOUN
hls-11340	89	7	settings	setting	NOUN
hls-11340	89	8	2023	2023	NUM
hls-11340	89	9	;	;	PUNCT
hls-11340	89	10	11(s2):11340	11(s2):11340	X
hls-11340	89	11	]	]	SYM
hls-11340	89	12	non	non	ADJ
hls-11340	89	13	-co	-co	PROPN
hls-11340	89	14	mmerc	mmerc	PROPN
hls-11340	89	15	ial	ial	PROPN
hls-11340	89	16	us	us	PROPN
hls-11340	89	17	e	e	NOUN
hls-11340	89	18	o	o	PROPN
hls-11340	89	19	nly	nly	ADV
hls-11340	89	20	conclusions	conclusion	NOUN
hls-11340	89	21	in	in	ADP
hls-11340	89	22	conclusion	conclusion	NOUN
hls-11340	89	23	,	,	PUNCT
hls-11340	89	24	higher	high	ADJ
hls-11340	89	25	levels	level	NOUN
hls-11340	89	26	of	of	ADP
hls-11340	89	27	fasting	fast	VERB
hls-11340	89	28	blood	blood	NOUN
hls-11340	89	29	glucose	glucose	NOUN
hls-11340	89	30	,	,	PUNCT
hls-11340	89	31	and	and	CCONJ
hls-11340	89	32	hba1c	hba1c	PROPN
hls-11340	89	33	levels	level	NOUN
hls-11340	89	34	were	be	AUX
hls-11340	89	35	associated	associate	VERB
hls-11340	89	36	with	with	ADP
hls-11340	89	37	vitamin	vitamin	NOUN
hls-11340	89	38	d	d	NOUN
hls-11340	89	39	deficiency	deficiency	NOUN
hls-11340	89	40	that	that	PRON
hls-11340	89	41	may	may	AUX
hls-11340	89	42	affect	affect	VERB
hls-11340	89	43	glycemic	glycemic	ADJ
hls-11340	89	44	control	control	NOUN
hls-11340	89	45	in	in	ADP
hls-11340	89	46	type	type	NOUN
hls-11340	89	47	2	2	NUM
hls-11340	89	48	diabetic	diabetic	ADJ
hls-11340	89	49	patients	patient	NOUN
hls-11340	89	50	.	.	PUNCT
hls-11340	90	1	this	this	PRON
hls-11340	90	2	may	may	AUX
hls-11340	90	3	call	call	VERB
hls-11340	90	4	for	for	ADP
hls-11340	90	5	correction	correction	NOUN
hls-11340	90	6	of	of	ADP
hls-11340	90	7	vitamin	vitamin	NOUN
hls-11340	90	8	d	d	NOUN
hls-11340	90	9	deficiency	deficiency	NOUN
hls-11340	90	10	in	in	ADP
hls-11340	90	11	patients	patient	NOUN
hls-11340	90	12	with	with	ADP
hls-11340	90	13	uncontrolled	uncontrolled	ADJ
hls-11340	90	14	dm	dm	PROPN
hls-11340	90	15	.	.	PUNCT
hls-11340	90	16	references	reference	NOUN
hls-11340	90	17	1	1	NUM
hls-11340	91	1	.	.	PUNCT
hls-11340	91	2	ogurtsova	ogurtsova	PROPN
hls-11340	92	1	k	k	PROPN
hls-11340	92	2	,	,	PUNCT
hls-11340	92	3	rocha	rocha	PROPN
hls-11340	92	4	j	j	PROPN
hls-11340	92	5	,	,	PUNCT
hls-11340	92	6	fernandes	fernandes	PROPN
hls-11340	92	7	d	d	PROPN
hls-11340	92	8	,	,	PUNCT
hls-11340	93	1	et	et	PROPN
hls-11340	93	2	al	al	PROPN
hls-11340	93	3	.	.	PROPN
hls-11340	93	4	idf	idf	PROPN
hls-11340	93	5	diabetes	diabetes	PROPN
hls-11340	93	6	atlas	atlas	PROPN
hls-11340	93	7	:	:	PUNCT
hls-11340	93	8	global	global	ADJ
hls-11340	93	9	estimates	estimate	NOUN
hls-11340	93	10	for	for	ADP
hls-11340	93	11	the	the	DET
hls-11340	93	12	prevalence	prevalence	NOUN
hls-11340	93	13	of	of	ADP
hls-11340	93	14	diabetes	diabetes	NOUN
hls-11340	93	15	for	for	ADP
hls-11340	93	16	2015	2015	NUM
hls-11340	93	17	and	and	CCONJ
hls-11340	93	18	2040	2040	NUM
hls-11340	93	19	.	.	PUNCT
hls-11340	94	1	diabetes	diabetes	NOUN
hls-11340	94	2	res	re	VERB
hls-11340	94	3	clinical	clinical	ADJ
hls-11340	94	4	pract	pract	NOUN
hls-11340	94	5	2017;128:40	2017;128:40	PROPN
hls-11340	94	6	-	-	SYM
hls-11340	94	7	50	50	NUM
hls-11340	94	8	.	.	NOUN
hls-11340	95	1	2	2	X
hls-11340	95	2	.	.	X
hls-11340	95	3	latif	latif	PROPN
hls-11340	95	4	a	a	PROPN
hls-11340	95	5	,	,	PUNCT
hls-11340	95	6	anwar	anwar	PROPN
hls-11340	95	7	s	s	PROPN
hls-11340	95	8	,	,	PUNCT
hls-11340	95	9	gautham	gautham	PROPN
hls-11340	95	10	k	k	PROPN
hls-11340	95	11	,	,	PUNCT
hls-11340	96	1	et	et	PROPN
hls-11340	96	2	al	al	PROPN
hls-11340	96	3	.	.	PROPN
hls-11340	96	4	association	association	PROPN
hls-11340	96	5	of	of	ADP
hls-11340	96	6	plasma	plasma	NOUN
hls-11340	96	7	omentin-1	omentin-1	NUM
hls-11340	96	8	levels	level	NOUN
hls-11340	96	9	with	with	ADP
hls-11340	96	10	diabetes	diabetes	NOUN
hls-11340	96	11	and	and	CCONJ
hls-11340	96	12	its	its	PRON
hls-11340	96	13	complications	complication	NOUN
hls-11340	96	14	.	.	PUNCT
hls-11340	97	1	cureus	cureus	PROPN
hls-11340	97	2	2021;13	2021;13	NUM
hls-11340	97	3	:	:	PUNCT
hls-11340	97	4	e18203	e18203	PROPN
hls-11340	97	5	.	.	PUNCT
hls-11340	98	1	3	3	X
hls-11340	98	2	.	.	X
hls-11340	98	3	kocak	kocak	PROPN
hls-11340	98	4	z	z	PROPN
hls-11340	98	5	,	,	PUNCT
hls-11340	98	6	aktas	aktas	PROPN
hls-11340	98	7	g	g	PROPN
hls-11340	98	8	,	,	PUNCT
hls-11340	98	9	atak	atak	PROPN
hls-11340	98	10	b	b	PROPN
hls-11340	98	11	,	,	PUNCT
hls-11340	98	12	et	et	PROPN
hls-11340	98	13	al	al	PROPN
hls-11340	98	14	.	.	PROPN
hls-11340	98	15	is	be	AUX
hls-11340	98	16	neuregulin-4	neuregulin-4	NUM
hls-11340	98	17	a	a	DET
hls-11340	98	18	predictive	predictive	ADJ
hls-11340	98	19	marker	marker	NOUN
hls-11340	98	20	of	of	ADP
hls-11340	98	21	microvascular	microvascular	ADJ
hls-11340	98	22	complications	complication	NOUN
hls-11340	98	23	in	in	ADP
hls-11340	98	24	type	type	NOUN
hls-11340	98	25	2	2	NUM
hls-11340	98	26	diabetes	diabetes	NOUN
hls-11340	98	27	mellitus	mellitus	NOUN
hls-11340	98	28	?	?	PUNCT
hls-11340	99	1	eur	eur	PROPN
hls-11340	99	2	j	j	PROPN
hls-11340	99	3	clin	clin	PROPN
hls-11340	99	4	invest	invest	VERB
hls-11340	99	5	2020;50	2020;50	NUM
hls-11340	99	6	:	:	PUNCT
hls-11340	99	7	e13206	e13206	NOUN
hls-11340	99	8	.	.	NOUN
hls-11340	100	1	4	4	NUM
hls-11340	100	2	.	.	X
hls-11340	100	3	aktas	aktas	PROPN
hls-11340	100	4	g	g	PROPN
hls-11340	100	5	,	,	PUNCT
hls-11340	100	6	alcelk	alcelk	VERB
hls-11340	100	7	a	a	PRON
hls-11340	100	8	,	,	PUNCT
hls-11340	100	9	tosun	tosun	NOUN
hls-11340	100	10	m	m	PROPN
hls-11340	100	11	,	,	PUNCT
hls-11340	100	12	et	et	PROPN
hls-11340	100	13	al	al	PROPN
hls-11340	100	14	.	.	PROPN
hls-11340	101	1	diabetes	diabete	NOUN
hls-11340	101	2	mellitus	mellitus	NOUN
hls-11340	101	3	increases	increase	VERB
hls-11340	101	4	plasma	plasma	NOUN
hls-11340	101	5	cardiothrophin-1	cardiothrophin-1	NUM
hls-11340	101	6	levels	level	NOUN
hls-11340	101	7	independently	independently	ADV
hls-11340	101	8	of	of	ADP
hls-11340	101	9	heart	heart	NOUN
hls-11340	101	10	failure	failure	NOUN
hls-11340	101	11	and	and	CCONJ
hls-11340	101	12	hypertension	hypertension	NOUN
hls-11340	101	13	.	.	PUNCT
hls-11340	102	1	acta	acta	PROPN
hls-11340	102	2	med	med	PROPN
hls-11340	102	3	mediterr	mediterr	PROPN
hls-11340	102	4	2013;29:78	2013;29:78	NUM
hls-11340	102	5	.	.	PUNCT
hls-11340	103	1	5	5	NUM
hls-11340	103	2	.	.	PUNCT
hls-11340	103	3	liu	liu	PROPN
hls-11340	103	4	w	w	PROPN
hls-11340	103	5	,	,	PUNCT
hls-11340	103	6	lou	lou	PROPN
hls-11340	103	7	x	x	PROPN
hls-11340	103	8	,	,	PUNCT
hls-11340	103	9	zhang	zhang	PROPN
hls-11340	103	10	z	z	PROPN
hls-11340	103	11	,	,	PUNCT
hls-11340	103	12	et	et	PROPN
hls-11340	103	13	al	al	PROPN
hls-11340	103	14	.	.	PROPN
hls-11340	103	15	association	association	PROPN
hls-11340	103	16	of	of	ADP
hls-11340	103	17	neutrophil	neutrophil	NOUN
hls-11340	103	18	to	to	ADP
hls-11340	103	19	lymphocyte	lymphocyte	ADJ
hls-11340	103	20	ratio	ratio	NOUN
hls-11340	103	21	,	,	PUNCT
hls-11340	103	22	platelet	platelet	NOUN
hls-11340	103	23	to	to	ADP
hls-11340	103	24	lymphocyte	lymphocyte	ADJ
hls-11340	103	25	ratio	ratio	NOUN
hls-11340	103	26	,	,	PUNCT
hls-11340	103	27	mean	mean	VERB
hls-11340	103	28	platelet	platelet	NOUN
hls-11340	103	29	volume	volume	NOUN
hls-11340	103	30	with	with	ADP
hls-11340	103	31	the	the	DET
hls-11340	103	32	risk	risk	NOUN
hls-11340	103	33	of	of	ADP
hls-11340	103	34	gestational	gestational	ADJ
hls-11340	103	35	diabetes	diabetes	NOUN
hls-11340	103	36	mellitus	mellitus	NOUN
hls-11340	103	37	.	.	PUNCT
hls-11340	104	1	gynacol	gynacol	PROPN
hls-11340	104	2	endocrinol	endocrinol	VERB
hls-11340	104	3	2021;37:105	2021;37:105	PROPN
hls-11340	104	4	-	-	SYM
hls-11340	104	5	7	7	NUM
hls-11340	104	6	.	.	NOUN
hls-11340	104	7	6	6	NUM
hls-11340	104	8	.	.	PUNCT
hls-11340	105	1	bilgin	bilgin	PROPN
hls-11340	105	2	s	s	PROPN
hls-11340	105	3	,	,	PUNCT
hls-11340	105	4	aktaş	aktaş	PROPN
hls-11340	105	5	g	g	PROPN
hls-11340	105	6	,	,	PUNCT
hls-11340	105	7	kahveci	kahveci	PROPN
hls-11340	105	8	g	g	PROPN
hls-11340	105	9	,	,	PUNCT
hls-11340	105	10	et	et	PROPN
hls-11340	105	11	al	al	PROPN
hls-11340	105	12	.	.	PROPN
hls-11340	105	13	does	do	AUX
hls-11340	105	14	mean	mean	VERB
hls-11340	105	15	platelet	platelet	NOUN
hls-11340	105	16	volume	volume	NOUN
hls-11340	105	17	/	/	SYM
hls-11340	105	18	lymphocyte	lymphocyte	ADJ
hls-11340	105	19	count	count	NOUN
hls-11340	105	20	ratio	ratio	NOUN
hls-11340	105	21	associate	associate	NOUN
hls-11340	105	22	with	with	ADP
hls-11340	105	23	frailty	frailty	NOUN
hls-11340	105	24	in	in	ADP
hls-11340	105	25	type	type	NOUN
hls-11340	105	26	2	2	NUM
hls-11340	105	27	diabetes	diabetes	NOUN
hls-11340	105	28	mellitus	mellitus	NOUN
hls-11340	105	29	?	?	PUNCT
hls-11340	106	1	bratisl	bratisl	PROPN
hls-11340	106	2	lek	lek	PROPN
hls-11340	106	3	listy	listy	PROPN
hls-11340	106	4	2021;122:116	2021;122:116	PROPN
hls-11340	106	5	-	-	SYM
hls-11340	106	6	9	9	NUM
hls-11340	106	7	.	.	NOUN
hls-11340	106	8	7	7	NUM
hls-11340	106	9	.	.	X
hls-11340	106	10	bilgin	bilgin	PROPN
hls-11340	106	11	s	s	PROPN
hls-11340	106	12	,	,	PUNCT
hls-11340	106	13	kurtkulagi	kurtkulagi	PROPN
hls-11340	106	14	o	o	NOUN
hls-11340	106	15	,	,	PUNCT
hls-11340	106	16	atak	atak	PROPN
hls-11340	106	17	b	b	PROPN
hls-11340	106	18	,	,	PUNCT
hls-11340	106	19	et	et	PROPN
hls-11340	106	20	al	al	PROPN
hls-11340	106	21	.	.	PROPN
hls-11340	106	22	does	do	AUX
hls-11340	106	23	c	c	NOUN
hls-11340	106	24	-	-	PUNCT
hls-11340	106	25	reactive	reactive	ADJ
hls-11340	106	26	protein	protein	NOUN
hls-11340	106	27	to	to	PART
hls-11340	106	28	serum	serum	VERB
hls-11340	106	29	albumin	albumin	ADJ
hls-11340	106	30	ratio	ratio	NOUN
hls-11340	106	31	correlate	correlate	VERB
hls-11340	106	32	with	with	ADP
hls-11340	106	33	diabetic	diabetic	ADJ
hls-11340	106	34	nephropathy	nephropathy	NOUN
hls-11340	106	35	in	in	ADP
hls-11340	106	36	patients	patient	NOUN
hls-11340	106	37	with	with	ADP
hls-11340	106	38	type	type	NOUN
hls-11340	106	39	2	2	NUM
hls-11340	106	40	diabetes	diabetes	NOUN
hls-11340	106	41	mellitus	mellitus	NOUN
hls-11340	106	42	?	?	PUNCT
hls-11340	107	1	the	the	DET
hls-11340	107	2	care	care	NOUN
hls-11340	107	3	time	time	NOUN
hls-11340	107	4	study	study	PROPN
hls-11340	107	5	.	.	PUNCT
hls-11340	108	1	primary	primary	ADJ
hls-11340	108	2	care	care	NOUN
hls-11340	108	3	diab	diab	PROPN
hls-11340	108	4	2021;15:1071	2021;15:1071	PROPN
hls-11340	108	5	-	-	SYM
hls-11340	108	6	4	4	NUM
hls-11340	108	7	.	.	NOUN
hls-11340	108	8	8	8	NUM
hls-11340	108	9	.	.	PUNCT
hls-11340	108	10	aktas	aktas	PROPN
hls-11340	108	11	g	g	PROPN
hls-11340	108	12	,	,	PUNCT
hls-11340	108	13	kocak	kocak	PROPN
hls-11340	108	14	m	m	PROPN
hls-11340	108	15	,	,	PUNCT
hls-11340	108	16	bilgin	bilgin	NOUN
hls-11340	108	17	s	s	PROPN
hls-11340	108	18	,	,	PUNCT
hls-11340	108	19	et	et	PROPN
hls-11340	108	20	al	al	PROPN
hls-11340	108	21	.	.	PROPN
hls-11340	108	22	uric	uric	PROPN
hls-11340	108	23	acid	acid	PROPN
hls-11340	108	24	to	to	ADP
hls-11340	108	25	hdl	hdl	PROPN
hls-11340	108	26	cholesterol	cholesterol	PROPN
hls-11340	108	27	ratio	ratio	NOUN
hls-11340	108	28	is	be	AUX
hls-11340	108	29	a	a	DET
hls-11340	108	30	strong	strong	ADJ
hls-11340	108	31	predictor	predictor	NOUN
hls-11340	108	32	of	of	ADP
hls-11340	108	33	diabetic	diabetic	ADJ
hls-11340	108	34	control	control	NOUN
hls-11340	108	35	in	in	ADP
hls-11340	108	36	men	man	NOUN
hls-11340	108	37	with	with	ADP
hls-11340	108	38	type	type	NOUN
hls-11340	108	39	2	2	NUM
hls-11340	108	40	diabetes	diabetes	NOUN
hls-11340	108	41	mellitus	mellitus	NOUN
hls-11340	108	42	.	.	PUNCT
hls-11340	109	1	aging	age	VERB
hls-11340	109	2	male	male	NOUN
hls-11340	109	3	2020;23:1098	2020;23:1098	NUM
hls-11340	109	4	-	-	SYM
hls-11340	109	5	102	102	NUM
hls-11340	109	6	.	.	NOUN
hls-11340	109	7	9	9	NUM
hls-11340	109	8	.	.	X
hls-11340	109	9	pasquali	pasquali	PROPN
hls-11340	109	10	m	m	PROPN
hls-11340	109	11	,	,	PUNCT
hls-11340	109	12	tartaglione	tartaglione	NOUN
hls-11340	109	13	l	l	NOUN
hls-11340	109	14	,	,	PUNCT
hls-11340	109	15	rotondi	rotondi	VERB
hls-11340	109	16	s	s	PRON
hls-11340	109	17	,	,	PUNCT
hls-11340	109	18	et	et	PROPN
hls-11340	109	19	al	al	PROPN
hls-11340	109	20	.	.	PUNCT
hls-11340	109	21	calcitriol	calcitriol	PROPN
hls-11340	109	22	/	/	SYM
hls-11340	109	23	calcifediol	calcifediol	PROPN
hls-11340	109	24	ratio	ratio	NOUN
hls-11340	109	25	:	:	PUNCT
hls-11340	109	26	an	an	DET
hls-11340	109	27	indicator	indicator	NOUN
hls-11340	109	28	of	of	ADP
hls-11340	109	29	vitamin	vitamin	NOUN
hls-11340	109	30	d	d	NOUN
hls-11340	109	31	hydroxylation	hydroxylation	NOUN
hls-11340	109	32	efficiency	efficiency	NOUN
hls-11340	109	33	?	?	PUNCT
hls-11340	110	1	bba	bba	PROPN
hls-11340	110	2	clin	clin	PROPN
hls-11340	110	3	2015;3:251	2015;3:251	PROPN
hls-11340	110	4	-	-	PUNCT
hls-11340	110	5	6	6	NUM
hls-11340	110	6	.	.	NOUN
hls-11340	110	7	10	10	NUM
hls-11340	110	8	.	.	X
hls-11340	110	9	zatalia	zatalia	X
hls-11340	111	1	r	r	PROPN
hls-11340	111	2	,	,	PUNCT
hls-11340	111	3	sanusi	sanusi	PROPN
hls-11340	111	4	h.	h.	PROPN
hls-11340	112	1	the	the	DET
hls-11340	112	2	role	role	NOUN
hls-11340	112	3	of	of	ADP
hls-11340	112	4	antioxidants	antioxidant	NOUN
hls-11340	112	5	in	in	ADP
hls-11340	112	6	the	the	DET
hls-11340	112	7	pathophysiology	pathophysiology	NOUN
hls-11340	112	8	,	,	PUNCT
hls-11340	112	9	complications	complication	NOUN
hls-11340	112	10	,	,	PUNCT
hls-11340	112	11	and	and	CCONJ
hls-11340	112	12	management	management	NOUN
hls-11340	112	13	of	of	ADP
hls-11340	112	14	diabetes	diabetes	NOUN
hls-11340	112	15	mellitus	mellitus	NOUN
hls-11340	112	16	.	.	PUNCT
hls-11340	113	1	acta	acta	PROPN
hls-11340	113	2	med	med	PROPN
hls-11340	113	3	indones	indone	NOUN
hls-11340	113	4	2013;45:141–7	2013;45:141–7	NUM
hls-11340	113	5	.	.	PUNCT
hls-11340	113	6	11	11	NUM
hls-11340	113	7	.	.	PUNCT
hls-11340	114	1	erkus	erkus	PROPN
hls-11340	114	2	e	e	NOUN
hls-11340	114	3	,	,	PUNCT
hls-11340	114	4	aktas	aktas	PROPN
hls-11340	114	5	g	g	PROPN
hls-11340	114	6	,	,	PUNCT
hls-11340	114	7	atak	atak	PROPN
hls-11340	114	8	b	b	PROPN
hls-11340	114	9	,	,	PUNCT
hls-11340	114	10	et	et	PROPN
hls-11340	114	11	al	al	PROPN
hls-11340	114	12	.	.	PROPN
hls-11340	114	13	haemogram	haemogram	PROPN
hls-11340	114	14	parameters	parameter	NOUN
hls-11340	114	15	in	in	ADP
hls-11340	114	16	vitamin	vitamin	NOUN
hls-11340	114	17	d	d	NOUN
hls-11340	114	18	deficiency	deficiency	NOUN
hls-11340	114	19	.	.	PUNCT
hls-11340	115	1	j	j	PROPN
hls-11340	115	2	college	college	PROPN
hls-11340	115	3	phys	phys	PROPN
hls-11340	115	4	surg	surg	PROPN
hls-11340	115	5	pak	pak	VERB
hls-11340	115	6	2018;28:77982	2018;28:77982	NUM
hls-11340	115	7	.	.	PUNCT
hls-11340	115	8	12	12	NUM
hls-11340	115	9	.	.	PUNCT
hls-11340	116	1	vujosevic	vujosevic	PROPN
hls-11340	116	2	s	s	PROPN
hls-11340	116	3	,	,	PUNCT
hls-11340	116	4	borozan	borozan	NOUN
hls-11340	116	5	s	s	PROPN
hls-11340	116	6	,	,	PUNCT
hls-11340	116	7	radojevic	radojevic	ADJ
hls-11340	116	8	n	n	CCONJ
hls-11340	116	9	,	,	PUNCT
hls-11340	116	10	et	et	PROPN
hls-11340	116	11	al	al	PROPN
hls-11340	116	12	.	.	PROPN
hls-11340	116	13	relationship	relationship	NOUN
hls-11340	116	14	between	between	ADP
hls-11340	116	15	25	25	NUM
hls-11340	116	16	-	-	PUNCT
hls-11340	116	17	hydroxyvitamin	hydroxyvitamin	NOUN
hls-11340	116	18	d	d	NOUN
hls-11340	116	19	and	and	CCONJ
hls-11340	116	20	newly	newly	ADV
hls-11340	116	21	diagnosed	diagnose	VERB
hls-11340	116	22	type	type	NOUN
hls-11340	116	23	2	2	NUM
hls-11340	116	24	diabetes	diabetes	NOUN
hls-11340	116	25	mellitus	mellitus	NOUN
hls-11340	116	26	in	in	ADP
hls-11340	116	27	postmenopausal	postmenopausal	ADJ
hls-11340	116	28	women	woman	NOUN
hls-11340	116	29	with	with	ADP
hls-11340	116	30	osteoporosis	osteoporosis	NOUN
hls-11340	116	31	.	.	PUNCT
hls-11340	117	1	med	med	PROPN
hls-11340	117	2	princ	princ	PROPN
hls-11340	117	3	pract	pract	PROPN
hls-11340	117	4	2014;23:229–33	2014;23:229–33	PROPN
hls-11340	117	5	.	.	PUNCT
hls-11340	118	1	13	13	NUM
hls-11340	118	2	.	.	PUNCT
hls-11340	119	1	american	american	ADJ
hls-11340	119	2	diabetes	diabetes	PROPN
hls-11340	119	3	association	association	PROPN
hls-11340	119	4	.	.	PUNCT
hls-11340	120	1	classification	classification	NOUN
hls-11340	120	2	and	and	CCONJ
hls-11340	120	3	diagnosis	diagnosis	NOUN
hls-11340	120	4	of	of	ADP
hls-11340	120	5	diabetes	diabetes	NOUN
hls-11340	120	6	:	:	PUNCT
hls-11340	120	7	standards	standard	NOUN
hls-11340	120	8	of	of	ADP
hls-11340	120	9	medical	medical	ADJ
hls-11340	120	10	care	care	NOUN
hls-11340	120	11	in	in	ADP
hls-11340	120	12	diabetes	diabetes	NOUN
hls-11340	120	13	2018	2018	NUM
hls-11340	120	14	.	.	PUNCT
hls-11340	121	1	diabetes	diabetes	NOUN
hls-11340	121	2	care	care	VERB
hls-11340	121	3	2018;41	2018;41	NUM
hls-11340	121	4	:	:	PUNCT
hls-11340	121	5	s13	s13	PROPN
hls-11340	121	6	–	–	PUNCT
hls-11340	121	7	s27	s27	PROPN
hls-11340	121	8	.	.	PROPN
hls-11340	122	1	14	14	NUM
hls-11340	122	2	.	.	PUNCT
hls-11340	123	1	peterkova	peterkova	PROPN
hls-11340	123	2	va	va	PROPN
hls-11340	123	3	,	,	PUNCT
hls-11340	123	4	vasyukova	vasyukova	PROPN
hls-11340	123	5	ov	ov	PROPN
hls-11340	123	6	.	.	PROPN
hls-11340	124	1	about	about	ADP
hls-11340	124	2	the	the	DET
hls-11340	124	3	new	new	ADJ
hls-11340	124	4	classification	classification	NOUN
hls-11340	124	5	of	of	ADP
hls-11340	124	6	obesity	obesity	NOUN
hls-11340	124	7	in	in	ADP
hls-11340	124	8	the	the	DET
hls-11340	124	9	children	child	NOUN
hls-11340	124	10	and	and	CCONJ
hls-11340	124	11	adolescents	adolescent	NOUN
hls-11340	124	12	.	.	PUNCT
hls-11340	125	1	problems	problem	NOUN
hls-11340	125	2	endocrinol	endocrinol	VERB
hls-11340	125	3	2015;61:39	2015;61:39	NUM
hls-11340	125	4	-	-	SYM
hls-11340	125	5	44	44	NUM
hls-11340	125	6	.	.	PUNCT
hls-11340	126	1	15	15	NUM
hls-11340	126	2	.	.	PUNCT
hls-11340	127	1	doust	doust	PROPN
hls-11340	127	2	j	j	PROPN
hls-11340	127	3	,	,	PUNCT
hls-11340	127	4	glasziou	glasziou	NOUN
hls-11340	127	5	p.	p.	NOUN
hls-11340	127	6	monitoring	monitoring	NOUN
hls-11340	127	7	in	in	ADP
hls-11340	127	8	clinical	clinical	ADJ
hls-11340	127	9	biochemistry	biochemistry	NOUN
hls-11340	127	10	.	.	PUNCT
hls-11340	128	1	clin	clin	PROPN
hls-11340	128	2	biochem	biochem	PROPN
hls-11340	128	3	rev	rev	VERB
hls-11340	128	4	2013;34:85	2013;34:85	NUM
hls-11340	128	5	-	-	SYM
hls-11340	128	6	92	92	NUM
hls-11340	128	7	.	.	PUNCT
hls-11340	129	1	16	16	NUM
hls-11340	129	2	.	.	PUNCT
hls-11340	130	1	shan	shan	PROPN
hls-11340	130	2	i	i	PROPN
hls-11340	130	3	,	,	PUNCT
hls-11340	130	4	aktar	aktar	PROPN
hls-11340	130	5	m	m	PROPN
hls-11340	130	6	,	,	PUNCT
hls-11340	130	7	hisaindee	hisaindee	PROPN
hls-11340	130	8	s	s	PART
hls-11340	130	9	,	,	PUNCT
hls-11340	130	10	et	et	PROPN
hls-11340	130	11	al	al	PROPN
hls-11340	130	12	.	.	PROPN
hls-11340	131	1	clinical	clinical	ADJ
hls-11340	131	2	diagnostic	diagnostic	ADJ
hls-11340	131	3	tools	tool	NOUN
hls-11340	131	4	for	for	ADP
hls-11340	131	5	vitamin	vitamin	NOUN
hls-11340	131	6	d	d	NOUN
hls-11340	131	7	assessment	assessment	NOUN
hls-11340	131	8	.	.	PUNCT
hls-11340	132	1	j	j	PROPN
hls-11340	132	2	steroid	steroid	PROPN
hls-11340	132	3	biochem	biochem	PROPN
hls-11340	132	4	mol	mol	ADP
hls-11340	132	5	biol	biol	PROPN
hls-11340	132	6	2018;180:105	2018;180:105	NUM
hls-11340	132	7	-	-	SYM
hls-11340	132	8	17	17	NUM
hls-11340	132	9	.	.	PUNCT
hls-11340	132	10	17	17	NUM
hls-11340	132	11	.	.	PUNCT
hls-11340	133	1	karau	karau	PROPN
hls-11340	133	2	p	p	PROPN
hls-11340	133	3	,	,	PUNCT
hls-11340	133	4	kima	kima	PROPN
hls-11340	133	5	b	b	PROPN
hls-11340	133	6	,	,	PUNCT
hls-11340	133	7	amayo	amayo	PROPN
hls-11340	133	8	e	e	PROPN
hls-11340	133	9	,	,	PUNCT
hls-11340	133	10	et	et	PROPN
hls-11340	133	11	al	al	PROPN
hls-11340	133	12	.	.	PUNCT
hls-11340	134	1	the	the	DET
hls-11340	134	2	prevalence	prevalence	NOUN
hls-11340	134	3	of	of	ADP
hls-11340	134	4	vitamin	vitamin	NOUN
hls-11340	134	5	d	d	NOUN
hls-11340	134	6	deficiency	deficiency	NOUN
hls-11340	134	7	among	among	ADP
hls-11340	134	8	patients	patient	NOUN
hls-11340	134	9	with	with	ADP
hls-11340	134	10	type	type	NOUN
hls-11340	134	11	2	2	NUM
hls-11340	134	12	diabetes	diabetes	NOUN
hls-11340	134	13	seen	see	VERB
hls-11340	134	14	at	at	ADP
hls-11340	134	15	a	a	DET
hls-11340	134	16	referral	referral	ADJ
hls-11340	134	17	hospital	hospital	NOUN
hls-11340	134	18	in	in	ADP
hls-11340	134	19	kenya	kenya	PROPN
hls-11340	134	20	.	.	PUNCT
hls-11340	135	1	pan	pan	PROPN
hls-11340	135	2	afr	afr	PROPN
hls-11340	135	3	med	med	PROPN
hls-11340	135	4	j	j	PROPN
hls-11340	135	5	2019;34:8	2019;34:8	NUM
hls-11340	135	6	.	.	PROPN
hls-11340	135	7	18	18	NUM
hls-11340	135	8	.	.	PUNCT
hls-11340	136	1	al	al	PROPN
hls-11340	136	2	-	-	PUNCT
hls-11340	136	3	humaidi	humaidi	PROPN
hls-11340	136	4	m	m	PROPN
hls-11340	136	5	,	,	PUNCT
hls-11340	136	6	agha	agha	PROPN
hls-11340	136	7	a	a	PRON
hls-11340	136	8	,	,	PUNCT
hls-11340	136	9	dewish	dewish	ADJ
hls-11340	136	10	m.	m.	NOUN
hls-11340	136	11	vitamin	vitamin	NOUN
hls-11340	136	12	d	d	NOUN
hls-11340	136	13	deficiency	deficiency	NOUN
hls-11340	136	14	in	in	ADP
hls-11340	136	15	patients	patient	NOUN
hls-11340	136	16	with	with	ADP
hls-11340	136	17	type	type	NOUN
hls-11340	136	18	2	2	NUM
hls-11340	136	19	diabetes	diabetes	NOUN
hls-11340	136	20	mellitus	mellitus	NOUN
hls-11340	136	21	in	in	ADP
hls-11340	136	22	southern	southern	ADJ
hls-11340	136	23	region	region	NOUN
hls-11340	136	24	of	of	ADP
hls-11340	136	25	saudi	saudi	PROPN
hls-11340	136	26	arabia	arabia	PROPN
hls-11340	136	27	.	.	PUNCT
hls-11340	137	1	maedica	maedica	PROPN
hls-11340	137	2	2013;8:231	2013;8:231	PROPN
hls-11340	137	3	-	-	PUNCT
hls-11340	137	4	6	6	NUM
hls-11340	137	5	.	.	NOUN
hls-11340	137	6	19	19	NUM
hls-11340	137	7	.	.	PUNCT
hls-11340	138	1	a	a	X
hls-11340	138	2	-	-	PUNCT
hls-11340	138	3	zaharani	zaharani	NOUN
hls-11340	138	4	m.	m.	NOUN
hls-11340	138	5	the	the	DET
hls-11340	138	6	prevalence	prevalence	NOUN
hls-11340	138	7	of	of	ADP
hls-11340	138	8	vitamin	vitamin	NOUN
hls-11340	138	9	d	d	NOUN
hls-11340	138	10	deficiency	deficiency	NOUN
hls-11340	138	11	in	in	ADP
hls-11340	138	12	type	type	NOUN
hls-11340	138	13	2	2	NUM
hls-11340	138	14	diabetic	diabetic	ADJ
hls-11340	138	15	patients	patient	NOUN
hls-11340	138	16	.	.	PUNCT
hls-11340	139	1	majmaah	majmaah	PROPN
hls-11340	139	2	j	j	PROPN
hls-11340	139	3	health	health	PROPN
hls-11340	139	4	sci	sci	PROPN
hls-11340	139	5	2013;1:18	2013;1:18	PROPN
hls-11340	139	6	-	-	PUNCT
hls-11340	139	7	22	22	NUM
hls-11340	139	8	.	.	PUNCT
hls-11340	139	9	20	20	NUM
hls-11340	139	10	.	.	PUNCT
hls-11340	140	1	zhao	zhao	PROPN
hls-11340	140	2	h	h	PROPN
hls-11340	140	3	,	,	PUNCT
hls-11340	140	4	zhen	zhen	PROPN
hls-11340	140	5	y	y	PROPN
hls-11340	140	6	,	,	PUNCT
hls-11340	140	7	wang	wang	PROPN
hls-11340	140	8	z	z	PROPN
hls-11340	140	9	,	,	PUNCT
hls-11340	140	10	et	et	PROPN
hls-11340	140	11	al	al	PROPN
hls-11340	140	12	.	.	PUNCT
hls-11340	141	1	the	the	DET
hls-11340	141	2	relationship	relationship	NOUN
hls-11340	141	3	between	between	ADP
hls-11340	141	4	vitamin	vitamin	NOUN
hls-11340	141	5	d	d	NOUN
hls-11340	141	6	deficiency	deficiency	NOUN
hls-11340	141	7	and	and	CCONJ
hls-11340	141	8	glycated	glycate	VERB
hls-11340	141	9	hemoglobin	hemoglobin	NOUN
hls-11340	141	10	levels	level	NOUN
hls-11340	141	11	in	in	ADP
hls-11340	141	12	patients	patient	NOUN
hls-11340	141	13	with	with	ADP
hls-11340	141	14	type	type	NOUN
hls-11340	141	15	2	2	NUM
hls-11340	141	16	diabetes	diabetes	NOUN
hls-11340	141	17	mellitus	mellitus	NOUN
hls-11340	141	18	.	.	PUNCT
hls-11340	142	1	diabetes	diabetes	NOUN
hls-11340	142	2	metab	metab	NOUN
hls-11340	142	3	syndr	syndr	NOUN
hls-11340	142	4	obes	obe	NOUN
hls-11340	142	5	2020;13:3899	2020;13:3899	NUM
hls-11340	142	6	-	-	SYM
hls-11340	142	7	907	907	NUM
hls-11340	142	8	.	.	NOUN
hls-11340	142	9	21	21	NUM
hls-11340	142	10	.	.	PUNCT
hls-11340	143	1	szymczak	szymczak	NOUN
hls-11340	143	2	-	-	PUNCT
hls-11340	143	3	pajor	pajor	NOUN
hls-11340	143	4	i	i	PROPN
hls-11340	143	5	,	,	PUNCT
hls-11340	143	6	sliwinska	sliwinska	VERB
hls-11340	143	7	a.	a.	NOUN
hls-11340	143	8	analysis	analysis	NOUN
hls-11340	143	9	of	of	ADP
hls-11340	143	10	association	association	NOUN
hls-11340	143	11	between	between	ADP
hls-11340	143	12	vitamin	vitamin	NOUN
hls-11340	143	13	d	d	NOUN
hls-11340	143	14	deficiency	deficiency	NOUN
hls-11340	143	15	and	and	CCONJ
hls-11340	143	16	insulin	insulin	NOUN
hls-11340	143	17	resistance	resistance	NOUN
hls-11340	143	18	.	.	PUNCT
hls-11340	144	1	nutrient	nutrient	PROPN
hls-11340	144	2	2019;11:794	2019;11:794	PROPN
hls-11340	144	3	.	.	PUNCT
hls-11340	145	1	22	22	NUM
hls-11340	145	2	.	.	PUNCT
hls-11340	146	1	al	al	PROPN
hls-11340	146	2	quaiz	quaiz	PROPN
hls-11340	146	3	a	a	PROPN
hls-11340	146	4	,	,	PUNCT
hls-11340	146	5	al	al	PROPN
hls-11340	146	6	rasheed	rasheed	VERB
hls-11340	146	7	a	a	DET
hls-11340	146	8	,	,	PUNCT
hls-11340	146	9	kazi	kazi	PROPN
hls-11340	146	10	a	a	PROPN
hls-11340	146	11	,	,	PUNCT
hls-11340	146	12	et	et	PROPN
hls-11340	146	13	al	al	PROPN
hls-11340	146	14	.	.	PROPN
hls-11340	146	15	is	be	AUX
hls-11340	146	16	hydroxyvitamin	hydroxyvitamin	PROPN
hls-11340	146	17	d	d	NOUN
hls-11340	146	18	associated	associate	VERB
hls-11340	146	19	with	with	ADP
hls-11340	146	20	glycosylated	glycosylated	ADJ
hls-11340	146	21	hemoglobin	hemoglobin	NOUN
hls-11340	146	22	in	in	ADP
hls-11340	146	23	patients	patient	NOUN
hls-11340	146	24	with	with	ADP
hls-11340	146	25	type	type	NOUN
hls-11340	146	26	2	2	NUM
hls-11340	146	27	diabetes	diabetes	NOUN
hls-11340	146	28	mellitus	mellitus	NOUN
hls-11340	146	29	in	in	ADP
hls-11340	146	30	saudi	saudi	PROPN
hls-11340	146	31	arabia	arabia	PROPN
hls-11340	146	32	?	?	PUNCT
hls-11340	147	1	a	a	DET
hls-11340	147	2	population	population	NOUN
hls-11340	147	3	based	base	VERB
hls-11340	147	4	study	study	NOUN
hls-11340	147	5	.	.	PUNCT
hls-11340	148	1	int	int	PROPN
hls-11340	149	1	j	j	PROPN
hls-11340	149	2	environ	environ	PROPN
hls-11340	149	3	res	res	PROPN
hls-11340	149	4	puplic	puplic	PROPN
hls-11340	149	5	health	health	PROPN
hls-11340	149	6	2021;18:2805	2021;18:2805	PROPN
hls-11340	149	7	.	.	PROPN
hls-11340	150	1	23	23	NUM
hls-11340	150	2	.	.	PUNCT
hls-11340	151	1	erkus	erkus	PROPN
hls-11340	151	2	e	e	NOUN
hls-11340	151	3	,	,	PUNCT
hls-11340	151	4	aktas	aktas	PROPN
hls-11340	151	5	g	g	NOUN
hls-11340	151	6	,	,	PUNCT
hls-11340	151	7	kocak	kocak	PROPN
hls-11340	151	8	mz	mz	PROPN
hls-11340	151	9	,	,	PUNCT
hls-11340	151	10	et	et	PROPN
hls-11340	151	11	al	al	PROPN
hls-11340	151	12	.	.	PUNCT
hls-11340	152	1	diabetic	diabetic	ADJ
hls-11340	152	2	regulation	regulation	NOUN
hls-11340	152	3	of	of	ADP
hls-11340	152	4	subjects	subject	NOUN
hls-11340	152	5	with	with	ADP
hls-11340	152	6	type	type	NOUN
hls-11340	152	7	2	2	NUM
hls-11340	152	8	diabetes	diabetes	NOUN
hls-11340	152	9	mellitus	mellitus	NOUN
hls-11340	152	10	is	be	AUX
hls-11340	152	11	associated	associate	VERB
hls-11340	152	12	with	with	ADP
hls-11340	152	13	serum	serum	NOUN
hls-11340	152	14	vitamin	vitamin	NOUN
hls-11340	152	15	d	d	NOUN
hls-11340	152	16	levels	level	NOUN
hls-11340	152	17	.	.	PUNCT
hls-11340	153	1	rev	rev	PROPN
hls-11340	153	2	assoc	assoc	PROPN
hls-11340	153	3	med	med	PROPN
hls-11340	153	4	bras	bras	NOUN
hls-11340	153	5	(	(	PUNCT
hls-11340	153	6	1992	1992	NUM
hls-11340	153	7	)	)	PUNCT
hls-11340	153	8	2019;65:51	2019;65:51	NUM
hls-11340	153	9	-	-	SYM
hls-11340	153	10	55	55	NUM
hls-11340	153	11	.	.	PUNCT
hls-11340	154	1	24	24	NUM
hls-11340	154	2	.	.	PUNCT
hls-11340	155	1	mohamed	mohamed	PROPN
hls-11340	155	2	i	i	PROPN
hls-11340	155	3	,	,	PUNCT
hls-11340	155	4	elsherbeny	elsherbeny	VERB
hls-11340	155	5	e	e	NOUN
hls-11340	155	6	,	,	PUNCT
hls-11340	155	7	bekhet	bekhet	PROPN
hls-11340	155	8	m.	m.	NOUN
hls-11340	155	9	the	the	DET
hls-11340	155	10	effect	effect	NOUN
hls-11340	155	11	of	of	ADP
hls-11340	155	12	vitamin	vitamin	NOUN
hls-11340	155	13	d	d	NOUN
hls-11340	155	14	supplementation	supplementation	NOUN
hls-11340	155	15	on	on	ADP
hls-11340	155	16	glycemic	glycemic	ADJ
hls-11340	155	17	control	control	NOUN
hls-11340	155	18	and	and	CCONJ
hls-11340	155	19	lipid	lipid	NOUN
hls-11340	155	20	profile	profile	NOUN
hls-11340	155	21	in	in	ADP
hls-11340	155	22	patients	patient	NOUN
hls-11340	155	23	with	with	ADP
hls-11340	155	24	type	type	NOUN
hls-11340	155	25	2	2	NUM
hls-11340	155	26	diabetes	diabetes	NOUN
hls-11340	155	27	mellitus	mellitus	NOUN
hls-11340	155	28	.	.	PUNCT
hls-11340	156	1	j	j	PROPN
hls-11340	156	2	am	be	AUX
hls-11340	156	3	collnutr	collnutr	ADJ
hls-11340	156	4	2016;35:399	2016;35:399	NOUN
hls-11340	156	5	-	-	SYM
hls-11340	156	6	404	404	NUM
hls-11340	156	7	.	.	PUNCT
hls-11340	157	1	25	25	NUM
hls-11340	157	2	.	.	PUNCT
hls-11340	158	1	lemieux	lemieux	PROPN
hls-11340	158	2	p	p	PROPN
hls-11340	158	3	,	,	PUNCT
hls-11340	158	4	weisnagel	weisnagel	PROPN
hls-11340	158	5	j	j	PROPN
hls-11340	158	6	,	,	PUNCT
hls-11340	158	7	caron	caron	PROPN
hls-11340	158	8	z	z	PROPN
hls-11340	158	9	,	,	PUNCT
hls-11340	158	10	et	et	PROPN
hls-11340	158	11	al	al	PROPN
hls-11340	158	12	.	.	PROPN
hls-11340	158	13	effect	effect	NOUN
hls-11340	158	14	of	of	ADP
hls-11340	158	15	6	6	NUM
hls-11340	158	16	months	month	NOUN
hls-11340	158	17	vitamin	vitamin	NOUN
hls-11340	158	18	d	d	NOUN
hls-11340	158	19	supplementation	supplementation	NOUN
hls-11340	158	20	on	on	ADP
hls-11340	158	21	insulin	insulin	NOUN
hls-11340	158	22	sensitivity	sensitivity	NOUN
hls-11340	158	23	and	and	CCONJ
hls-11340	158	24	secretion	secretion	NOUN
hls-11340	158	25	in	in	ADP
hls-11340	158	26	a	a	DET
hls-11340	158	27	randomized	randomized	ADJ
hls-11340	158	28	placebocontrolled	placebocontrolle	VERB
hls-11340	158	29	trial	trial	NOUN
hls-11340	158	30	.	.	PUNCT
hls-11340	159	1	eur	eur	PROPN
hls-11340	159	2	j	j	PROPN
hls-11340	159	3	endocrinol	endocrinol	PROPN
hls-11340	159	4	2019;181:287	2019;181:287	NUM
hls-11340	159	5	-	-	SYM
hls-11340	159	6	99	99	NUM
hls-11340	159	7	.	.	PUNCT
hls-11340	159	8	26	26	NUM
hls-11340	159	9	.	.	PUNCT
hls-11340	160	1	kumar	kumar	PROPN
hls-11340	160	2	a	a	PROPN
hls-11340	160	3	,	,	PUNCT
hls-11340	160	4	nada	nada	PROPN
hls-11340	160	5	k	k	PROPN
hls-11340	160	6	,	,	PUNCT
hls-11340	160	7	bharathy	bharathy	ADJ
hls-11340	160	8	n	n	CCONJ
hls-11340	160	9	,	,	PUNCT
hls-11340	160	10	et	et	PROPN
hls-11340	160	11	al	al	PROPN
hls-11340	160	12	.	.	PUNCT
hls-11340	160	13	evaluation	evaluation	NOUN
hls-11340	160	14	of	of	ADP
hls-11340	160	15	vitamin	vitamin	NOUN
hls-11340	160	16	d	d	NOUN
hls-11340	160	17	status	status	NOUN
hls-11340	160	18	and	and	CCONJ
hls-11340	160	19	its	its	PRON
hls-11340	160	20	correlation	correlation	NOUN
hls-11340	160	21	with	with	ADP
hls-11340	160	22	glycated	glycate	VERB
hls-11340	160	23	hemoglobin	hemoglobin	NOUN
hls-11340	160	24	in	in	ADP
hls-11340	160	25	type	type	NOUN
hls-11340	160	26	2	2	NUM
hls-11340	160	27	diabetes	diabetes	NOUN
hls-11340	160	28	mellitus	mellitus	NOUN
hls-11340	160	29	.	.	PUNCT
hls-11340	160	30	biomed	biome	VERB
hls-11340	160	31	res	re	NOUN
hls-11340	160	32	2017;28:66	2017;28:66	PROPN
hls-11340	160	33	-	-	SYM
hls-11340	160	34	70	70	NUM
hls-11340	160	35	.	.	PUNCT
hls-11340	161	1	27	27	NUM
hls-11340	161	2	.	.	PUNCT
hls-11340	162	1	li	li	PROPN
hls-11340	162	2	x	x	PROPN
hls-11340	162	3	,	,	PUNCT
hls-11340	162	4	liu	liu	PROPN
hls-11340	162	5	y	y	PROPN
hls-11340	162	6	,	,	PUNCT
hls-11340	162	7	zheng	zheng	PROPN
hls-11340	162	8	y	y	PROPN
hls-11340	162	9	,	,	PUNCT
hls-11340	162	10	et	et	PROPN
hls-11340	162	11	al	al	PROPN
hls-11340	162	12	.	.	PUNCT
hls-11340	163	1	the	the	DET
hls-11340	163	2	effect	effect	NOUN
hls-11340	163	3	of	of	ADP
hls-11340	163	4	vitamin	vitamin	NOUN
hls-11340	163	5	d	d	NOUN
hls-11340	163	6	supplementation	supplementation	NOUN
hls-11340	163	7	on	on	ADP
hls-11340	163	8	glycemic	glycemic	ADJ
hls-11340	163	9	control	control	NOUN
hls-11340	163	10	in	in	ADP
hls-11340	163	11	type	type	NOUN
hls-11340	163	12	2	2	NUM
hls-11340	163	13	diabetic	diabetic	ADJ
hls-11340	163	14	patients	patient	NOUN
hls-11340	163	15	:	:	PUNCT
hls-11340	163	16	a	a	DET
hls-11340	163	17	systemic	systemic	ADJ
hls-11340	163	18	review	review	NOUN
hls-11340	163	19	and	and	CCONJ
hls-11340	163	20	meta	meta	ADJ
hls-11340	163	21	-	-	PUNCT
hls-11340	163	22	analysis	analysis	NOUN
hls-11340	163	23	.	.	PUNCT
hls-11340	164	1	nutrients	nutrient	NOUN
hls-11340	164	2	2018;10:375	2018;10:375	NUM
hls-11340	164	3	.	.	PUNCT
hls-11340	165	1	28	28	NUM
hls-11340	165	2	.	.	PUNCT
hls-11340	166	1	valdes	valde	NOUN
hls-11340	166	2	-	-	PUNCT
hls-11340	166	3	ramos	ramos	PROPN
hls-11340	166	4	r	r	PROPN
hls-11340	166	5	,	,	PUNCT
hls-11340	166	6	lopez	lopez	PROPN
hls-11340	166	7	ana	ana	PROPN
hls-11340	166	8	laura	laura	PROPN
hls-11340	166	9	g	g	PROPN
hls-11340	166	10	,	,	PUNCT
hls-11340	166	11	elina	elina	PROPN
hls-11340	166	12	m	m	PROPN
hls-11340	166	13	,	,	PUNCT
hls-11340	166	14	donaji	donaji	PROPN
hls-11340	166	15	b.	b.	PROPN
hls-11340	166	16	vitamins	vitamin	NOUN
hls-11340	166	17	and	and	CCONJ
hls-11340	166	18	type	type	NOUN
hls-11340	166	19	2	2	NUM
hls-11340	166	20	diabetes	diabetes	NOUN
hls-11340	166	21	mellitus	mellitus	NOUN
hls-11340	166	22	.	.	PUNCT
hls-11340	167	1	endocr	endocr	PROPN
hls-11340	167	2	metab	metab	PROPN
hls-11340	167	3	immne	immne	PROPN
hls-11340	167	4	disord	disord	NOUN
hls-11340	167	5	drug	drug	NOUN
hls-11340	167	6	targets	target	NOUN
hls-11340	167	7	2015;15:54	2015;15:54	NUM
hls-11340	167	8	-	-	SYM
hls-11340	167	9	63	63	NUM
hls-11340	167	10	.	.	PUNCT
hls-11340	168	1	article	article	NOUN
hls-11340	169	1	[	[	X
hls-11340	169	2	healthcare	healthcare	NOUN
hls-11340	169	3	in	in	ADP
hls-11340	169	4	low	low	ADJ
hls-11340	169	5	-	-	PUNCT
hls-11340	169	6	resource	resource	NOUN
hls-11340	169	7	settings	setting	NOUN
hls-11340	169	8	2023	2023	NUM
hls-11340	169	9	;	;	PUNCT
hls-11340	169	10	11(s2):11340	11(s2):11340	X
hls-11340	169	11	]	]	X
hls-11340	170	1	[	[	X
hls-11340	170	2	page	page	NOUN
hls-11340	170	3	11	11	NUM
hls-11340	170	4	]	]	PUNCT
hls-11340	170	5	non	non	ADJ
hls-11340	170	6	-co	-co	PROPN
hls-11340	170	7	mmerc	mmerc	PROPN
hls-11340	170	8	ial	ial	PROPN
hls-11340	170	9	us	us	PROPN
hls-11340	170	10	e	e	NOUN
hls-11340	170	11	o	o	NOUN
hls-11340	170	12	nly	nly	ADV